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ABSTRACT OF THE DISSERTATION
FUNCTIONALIZED APTAMERS FOR DETECTION
OF SMALL-MOLECULE TARGETS
by
Haixiang Yu
Florida International University, 2019
Miami, Florida
Professor Yi Xiao, Major Professor
Aptamers have recently gained considerable attention for small-molecule detection in
diverse applications such as drug identification, medical diagnostics, and environmental
monitoring. However, the performance of aptamer-based sensors has been greatly limited
by the low target affinity and responsiveness of small-molecule binding aptamers. This
dissertation describes several novel aptamer engineering and isolation strategies to
remedy this problem. Specifically, we first develop a generally applicable strategy to
engineer split aptamers containing two binding domains termed cooperative-binding split
aptamers (CBSAs). CBSAs exhibit higher target binding affinity and are far more
responsive in terms of target-induced split aptamer assembly compared to single-domain
parent split aptamers from which they are derived. Using a cocaine-binding CBSA, we
achieve specific fluorescence detection of as low as 50 nM cocaine in 10% saliva within
15 minutes. We then develop a general approach for creating rapid and sensitive CBSAbased enzyme-assisted target recycling (EATR)-amplified small-molecule sensors for
sensitive target detection. Using this strategy, we develop a fluorescence assay for
dehydroisoandrosterone-3-sulfate which achieves 100-fold enhanced target sensitivity
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relative to a non-EATR-based assay, and a colorimetric assay for visual detection of lowmicromolar concentrations of cocaine. To simplify the sensor development process, we
establish a novel and simple SELEX strategy for directly isolating aptamers with intrinsic
dye-displacement functionality which transduce target-binding events into a change of
dye absorbance. As a demonstration, we isolate an aptamer against the synthetic
cathinone 3,4-methylenedioxypyrovalerone (MDPV) that can detect MDPV at
concentrations as low as 300 nM in a label-free, rapid, and simple dye-displacement
assay. To further control the target-binding spectra of aptamers, we employ a novel
parallel-and-serial SELEX strategy to isolate an aptamer binding 12 synthetic cathinones
with nanomolar affinity but not 11 non-target compounds that are closely related in
structure. Using this aptamer, instantaneous visual detection of synthetic cathinones at
nanomolar concentrations in biological samples is achieved. In summary, this work
demonstrates the great potential of novel aptamer engineering and isolation strategies in
generating functional signal-reporting aptamers for sensitive small molecule detection.
Importantly, the strategies described here are generalizable and can be used to develop
aptamer-based assays for virtually any small-molecule targets.
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CHAPTER 1: Introduction
1.1. Overview
Aptamers are single-stranded oligonucleotide-based bioaffinity elements isolated in
vitro via a technology termed “systematic evolution of ligands by exponential
enrichment” (SELEX). Since 1990, hundreds of aptamers have been isolated for various
targets including proteins, small molecules, metal ions, and whole cells. More recently,
the analytical power of aptamers in biosensors has been demonstrated, particularly for the
detection of small-molecule targets such as illicit drugs, environmental toxins, antibiotics,
and biomarkers. Compared with antibodies, the dominant class of biorecognition
elements used in current biosensors, aptamers have several remarkable advantages. First,
unlike antibodies, which are isolated in vivo via immunization of animals, the aptamer
isolation process is entirely in vitro. Thus, aptamers can easily be isolated even for nonimmunogenic and toxic small-molecule targets. Moreover, aptamer properties such as
target-binding affinity and specificity can be controlled during the SELEX process by
adopting different selection strategies and manipulating the selection conditions. In
contrast, the in vivo nature of antibody generation forbids such control over antibody
binding properties. Second, isolated aptamers can be chemically synthesized at low cost
and with minimum batch-to-batch variation, overcoming two major drawbacks of
antibody production. Third, compared to peptide-based antibodies, which suffer from
irreversible degradation and denaturation under harsh conditions (e.g., high temperature),
aptamers (particularly DNA-based aptamers) have higher chemical and thermal stability,
conferring a much longer shelf life than antibodies—even at room temperature. Finally,
post-SELEX sequence engineering and chemical modification of aptamers can be
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routinely performed via chemical synthesis, which allows facile incorporation of different
sensing functionalities into aptamers for target detection. However, engineering of
antibodies is typically challenging and often limits their sensing utility. As a result,
numerous aptamers have been isolated for small molecules and adopted into various
sensing platforms for diverse applications such as drug detection, environmental
monitoring, food safety, and clinical diagnostic.
Newly-isolated aptamers usually have a fully-folded structure. Although they may
possess high target-binding affinity, these aptamers generally lack signal-reporting
functionality for target detection. A few assays based on fully-folded aptamers have been
reported; however, they are usually limited to specific aptamers or require specific
instruments, and there is currently no generalizable method to isolate fully-folded
aptamers with innate signal-reporting functionality. To incorporate such functionality,
aptamers are routinely cleaved to derive structure-switching aptamers or split aptamers.
These engineered aptamers have lower thermal stability compared with their fully-folded
parent aptamers, and predominately display a single-stranded conformation with
disrupted target binding domains in the absence of target. Nevertheless, these aptamer
fragments maintain target-binding affinity and can fold or assemble into a duplexed
structure similar to their parent aptamer upon addition of target molecules. When
modified with a fluorescent, electrochemical, or enzymatic label, such target-induced
conformational changes can be readily transduced into a measurable signal for target
detection. Unfortunately, the low thermal stability of structure-switching or split aptamers
inevitably leads to reduced target-binding affinity compared with their parent aptamers,
which results in poor assay sensitivity. This is particularly troublesome for small-
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molecule binding aptamers, which often have relatively low target-binding affinity, with
dissociation constants (KD) ranging from high nanomolar to low micromolar. Therefore,
general approaches for the development of highly sensitive aptamer-based sensors for
small-molecule targets would be highly valuable.
1.2. Motivation and goals
The primary research objective in this dissertation was to develop new general
strategies to isolate and engineer functionalized aptamers for sensitive detection of smallmolecule targets. To achieve this goal, we implemented four innovative approaches: 1)
engineering new aptamer constructs that have both high target-binding affinity and
sensitive target response, 2) developing an efficient signal amplification strategy to
increase the sensitivity of current aptamer-based sensors, 3) developing a generalizable
sensing platform utilizing fully-folded aptamers, and 4) establishing a novel selection
strategy to isolate class-specific small-molecule-binding aptamers.
First, we developed a general aptamer engineering strategy in which we incorporated
cooperative-binding functionality into split aptamers to enhance their target response for
more sensitive small-molecule detection (see Chapter 3). Conventional split aptamers
containing one target-binding domain typically possess low target affinity and weak
target response, resulting in low sensitivity when employed in biosensors. To overcome
this challenge, we engineered novel cooperative-binding split aptamer (CBSA)
constructs, which incorporate two cooperative binding domains such that target binding
at one domain greatly increases the affinity of the second domain. The cooperativebinding functionality of CBSAs allows them to achieve higher target-binding affinity and
more sensitive target-induced aptamer assembly compared to their parent split aptamer

3

with a single binding domain. This means that rapid ultrasensitive detection of smallmolecule targets can be readily achieved using a CBSA modified with a fluorophorequencher pair. Importantly, the strategy of CBSA engineering is straightforward and can
be generalized to any aptamer with a three-way junction (TWJ) secondary structure.
Given the fact that many TWJ-structured aptamers have been isolated for various small
molecules, CBSA-based sensors can be readily developed for the detection of various
small-molecule targets, such as illicit drugs, biomarkers, toxins, and therapeutics.
Upon successful engineering of CBSAs, we further developed a generalizable
enzyme-assisted target recycling (EATR) approach to enhance the analytical power of
CBSAs (see Chapter 4). Specifically, we introduced a C3 spacer abasic site between the
two target-binding domains of the CBSA. When the CBSA assembles upon target
binding, the C3 spacer in the CBSA duplex offers a substrate that can be efficiently
cleaved by Exo III. This cleavage event releases target molecules into solution, which
then mediates more cycles of target-induced CBSA assembly and enzyme cleavage until
all CBSAs are degraded. In the absence of target, the CBSA fragments remain separated,
forming no duplexed abasic site, and are thus spared from Exo III digestion. Our EATR
strategy serves two purposes. First, since a small amount of target can result in cleavage
of far large numbers of CBSAs, EATR can be used as an efficient signal amplification
mechanism to increase the sensitivity of CBSA-based sensors. Alternatively, EATRmediated aggregation of CBSA-modified gold nanoparticles (AuNPs) can be employed to
develop an instrument-free colorimetric assay. Given the generality of our CBSA
engineering strategy and the versatility of the EATR approach, such assays should
provide a valuable means for small-molecule detection in various fields.
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We have further developed a general strategy to isolate fully-folded aptamers with
intrinsic dye-displacement functionality for sensitive colorimetric detection of small
molecules (see Chapter 5). Previous studies have shown that dye-displacement assays
have several exceptional advantages, being rapid, highly sensitive, and label-free.
However, the implementation of such methods has been limited, since finding a signalreporting small-molecule dye for a specific aptamer is difficult. To solve this problem,
we first determined that the dye diethylthiatricarbocyanine (Cy7) can stack into DNA
TWJs in a sequence-independent fashion, producing a dramatic color change. We then
designed a SELEX strategy utilizing a structured library containing a TWJ target-binding
domain to isolate small-molecule binding aptamers. Aptamers isolated through this
library intrinsically bind to Cy7, and thus can be directly incorporated into a Cy7displacement assay for rapid, sensitive, and colorimetric target detection. Given the high
generality of our SELEX strategy and the excellent performance of the dye-displacement
platform, we foresee that our approaches can be used for sensitive colorimetric detection
of various small-molecule targets in diverse applications.
We finally developed a novel ‘parallel-and-serial’ selection strategy for isolating
class-specific oligonucleotide-based aptamers in vitro (see Chapter 6). This strategy first
entails parallel selection to selectively enrich cross-reactive binding sequences, followed
by serial selection that enriches aptamers binding to a designated target family. As a
demonstration, we isolated a class-specific DNA aptamer against a family of designer
drugs known as synthetic cathinones. The aptamer binds to 12 diverse synthetic
cathinones with nanomolar affinity and does not respond to 11 structurally similar nontarget compounds, some of which differ from the cathinone targets by a single atom. This
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is the first account of an aptamer exhibiting a combination of broad target crossreactivity, high affinity and remarkable specificity. Leveraging the qualities of this
aptamer, instantaneous colorimetric detection of synthetic cathinones at nanomolar
concentrations in biological samples was achieved. Our findings significantly expand the
binding capabilities of aptamers as class-specific bioreceptors and further demonstrate the
power of rationally designed selection strategies for isolating customized aptamers with
desired binding profiles. We believe that our aptamer isolation approach can be broadly
applied to isolate class-specific aptamers for various small molecule families.
1.3. Scope of the dissertation
Chapter 2 provides a general literature review of the historical background of
aptamers, SELEX, aptamer-based sensors for small molecule detection, AuNPs and their
use in aptamer-based sensors, EATR, and the small-molecule targets used in the work.
Chapter 3 details a strategy for engineering highly target-responsive CBSA for sensitive
detection of small molecules and demonstrates the application of CBSAs for rapid
fluorescent detection of cocaine in saliva samples. Chapter 4 further describes a
generalizable EATR approach both as a signal amplification method to increase the
sensitivity of the CBSA-based fluorescence assay and a signal reporting strategy for
colorimetric detection of small molecules. Chapter 5 describes a new SELEX strategy to
isolate fully-folded aptamers with intrinsic dye-displacement functionality for rapid,
sensitive, and colorimetric detection of any small-molecule targets. Chapter 6 describes a
generally applicable selection strategy to isolate class-specific aptamers as well as a rapid
sensitive assay for visual detection of a family of synthetic cathinones. Chapter 7
provides a summary of the dissertation and proposes future research directions.

6

CHAPTER 2: Background and Literature Review
2.1. Aptamers and their use as affinity reagents for small-molecule targets
Aptamers are single-stranded DNA- and RNA-based bioaffinity elements isolated in
vitro from randomized libraries via a procedure called SELEX.1 The term ‘aptamer’ was
derived from the Greek word aptus, or “to fit”.2 These oligonucleotides typically are
short in length, ranging from 20- to 80-nt, but often possess target-binding specificity that
rivals antibodies.3 Similar to antibodies, ligand recognition by aptamers is based on noncovalent interactions such as electrostatic interactions, hydrogen bonds, pi-pi interactions,
and van der Waals forces.4 The first aptamers targeting protein1 and small-molecule2
targets were isolated in 1990. Since then, hundreds of aptamers have been isolated for a
great diversity of targets including metal ions, small molecules, proteins, and even whole
cells.5
Inspired by naturally-occurring functional RNAs such as ribosomes and ribozymes,
the first aptamers were isolated from RNA-based libraries. However, RNA-based
aptamers have low chemical stability due to the presence of a reactive 2’ hydroxyl group
on their ribose backbone, and are prone to chemical and enzymatic hydrolysis.6 Although
substitution of the 2’ hydroxyl group with a fluorine or amine can increase the stability of
the aptamer, these chemical modifications significantly increase the cost of aptamer
production and may also reduce the binding affinity of the aptamer.7 In contrast, the
deoxyribose backbone of DNA does not have the 2’ hydroxyl group, and thus has much
higher chemical stability and resistance to hydrolysis. In 1992, the first DNA-based
aptamer was isolated against thrombin, with a KD of 25 nM.8 Since then, many DNA
aptamers have been isolated with comparable performance to RNA aptamers. At present,
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more than 50% of reported aptamers are composed of DNA due to their high stability,
ease of handling, and commercial availability.5
Recently, a number of groups have intensively explored the utility of aptamers as
biorecognition elements for small-molecule detection. Sensitive and accurate detection of
small-molecule targets is critical for diverse fields including law enforcement,
environmental monitoring, clinical diagnostics, and medical treatment.9–11 Instrumental
methods such as gas chromatography and mass spectroscopy have very high sensitivity
and specificity, but these methods are expensive, time-consuming, and rely on
cumbersome instruments and trained personnel.12 Moreover, lengthy sample preparation
steps are required when dealing with complex sample matrices such as biofluids.12 These
disadvantages greatly limit the utility of these methods for rapid and on-site applications.
12,13

Biosensors employing specific binding between targets and biorecognition elements

offer a powerful alternative for the rapid detection of small molecules. For example,
antibodies can bind to their targets with nanomolar or lower KDs with very high
specificity, allowing for highly sensitive detection of targets even in complex samples.14
Antibodies can also be coated onto paper substrates to fabricate low-cost lateral-flow
devices,14 and on-site biosensing currently relies heavily on such immunoassays.
2.1.1

Advantages of aptamers as biorecognition elements for small molecule

detection
Aptamers, as newly emerged biorecognition elements, offer several exceptional
advantages for sensors compared with antibodies (Table 2-1).15,16 The generation of
antibodies relies on antigen-induced immune response, but small molecules have low
molecular weight (<1,000 Da) and are typically poorly immunogenic. Therefore, small-

8

molecule targets generally need to be modified with a linker and conjugated to a carrier
protein prior to immunization.17 Such a process can be challenging due to the limited
number of functional groups on the target for conjugation chemistry. In contrast, the in
vitro nature of SELEX technology means that aptamers can be directly isolated for
virtually any small molecule. Furthermore, the whole process of antibody generation,
which includes target preparation, immunization of animals, antibody characterization,
and antibody purification, is lengthy and labor intensive, and can take more than six
months.18 In contrast, aptamer isolation is typically fast and only takes several weeks.
This is critical for rapidly evolving small-molecular targets such as designer drugs, where
the lengthy antibody-development process has become a significant barrier for forensic
laboratories in keeping up with the diversity of new drugs on the streets.18,19 The process
of antibody production is not only expensive, but also leads to large batch-to-batch
variation.5,14 Moreover, it is difficult to precisely engineer and chemically modify
antibodies for signal reporting, and such modifications can often significantly reduce
target-binding affinity of the antibodies.20 On the other hand, aptamers can be chemically
synthesized with low production cost and minimal batch-to-batch variation, and sequence
engineering of aptamers is also straightforward, enabling introduction of diverse sensing
functionalities. Indeed, various chemistries are commercially available to modify
aptamers with different fluorescent,21 electrochemical,22 or enzymatic23 tags for signal
reporting purposes.
Depending on the application, it may be crucial for biosensors to either be highly
specific to a single target (to prevent false-positive results) or broadly cross-reactive to a
class of structurally-related targets (to detect multiple targets using one bioreceptor).
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Because antibody generation is an in vivo process, neither affinity nor specificity of the
antibodies can be controlled.17 As a result, current immunoassays for small-molecule
detection routinely suffer from false-positives generated by non-specific antibody
binding. Meanwhile, immunoassays are usually not able to detect a class of structurallyrelated targets since a minor modification on a target’s core structure may completely
impair binding.24 On the other hand, various selection strategies such as “counterSELEX”25 or “toggle-SELEX”26 can be employed to customize the binding-profile of
isolated aptamers and generate highly specific or class-specific aptamers.
Table 2-1. Comparison between aptamer and antibody in sensor development.
Features

Antibody

Aptamer

Target limitation

Limited for small molecules
and toxic compounds

No limitation

Production period

Months to over a year

Weeks

Production cost

High

Low

Batch-to-batch variation

High

Low

Binding profile

Uncontrollable

Highly tunable

Chemical stability

Low

High

As proteins, antibodies are thermodynamically unstable and undergo irreversible
denaturation under harsh conditions, such as high temperature or high-salt condition.
Therefore, immunoassays generally need to be refrigerated and usually have a shelf life
of less than a year.15 In contrast, aptamers—especially those based on DNA—are more
chemically and thermally stable than antibodies, and can be kept at room temperature for
years without losing bioactivity.5 The stability of aptamers can be further enhanced by
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chemical modification of the ribose backbone with 2-fluorine or 2-O-methyl groups, to
resist degradation from enzymes in the blood.5
2.2. Isolation of small-molecule-binding aptamers via SELEX

Figure 2-1. General process of SELEX.

Aptamers are isolated from randomized DNA or RNA libraries through a multi-round
SELEX procedure. Each round of isolation consists of three essential steps: separation of
target-binding strands, polymerase chain reaction (PCR) amplification of the targetbinding strands, and reconstruction of the new library from the isolated sequences.
Strands binding to the target with higher affinity are enriched more than non-binders
during each round. Therefore, after several rounds of SELEX, strands with the highest
target-binding affinity will dominate the library and can be identified by sequencing the
pool. Figure 2-1 shows a schematic outline of the SELEX process.
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2.2.1

Library design

Libraries used for aptamer isolation typically comprise a randomized sequence flanked
by consensus sequences at both ends that serve as primer-binding sites. The library can
be either DNA or RNA; DNA libraries can be directly synthesized, while RNA libraries
are generated by in vitro transcription of the DNA library. The number of nucleotides (N)
in the random region determines the total possible sequences (4N) in the library, as each
position has four possible nucleotides (A, T, C and G for DNA; A, U, C, and G for
RNA). The length of the random region can range from 6 to 200 nt.27 A long random
region has more sequence diversity, which in principle allows for the formation of more
complicated motifs that may benefit aptamer affinity and specificity. However, not all
possible sequences in these libraries can be practically represented during SELEX.28 In
contrast, short random regions form simpler binding motifs but also allow for
representation of every possible sequence. Notably, one recent study showed that the
length of the random region has no significant correlation with the affinity of the isolated
aptamers.27 A shorter aptamer also has advantages such as easier identification of the
target-binding domain, easier sequence engineering to introduce signal-transducing
functionality, and lower production costs. The most widely used small-molecule binding
aptamers for sensor development, which include aptamers for cocaine,21 ATP,29 and
kanamycin,30 are shorter than 40 nt. In addition to the length of the random region, one
can incorporate different secondary structures such as G-quadruplexes,31 stem-loops,32
and TWJs33,34 into the library to isolate more specialized aptamers with various
functionalities. For example, we have recently designed a TWJ-structured library and
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isolated an aptamer with intrinsic binding affinity to the small molecule dye Cy7 for
sensitive detection MDPV using a colorimetric dye-displacement assays.34

Figure 2-2. Common strategies to separate target-binding and non-binding strands. These
strategies include (A) target-immobilized SELEX, (B) library-immobilized SELEX, and (C)
homogeneous SELEX.

2.2.2

Strand separation strategies for SELEX

The success of SELEX greatly depends on the separation of target-binding strands
from non-target-bound library strands. This can be achieved through either heterogeneous
or homogeneous techniques. Heterogeneous (bead-based) SELEX methods have been
widely utilized to isolate hundreds of aptamers for small-molecule targets such as
steroids,33 nucleotides,29,35 and antibiotics,30,36–39 achieving micromolar binding affinities
after 10–20 rounds of selection.40 These methods require immobilization of either the
target or library strands. For target-immobilized SELEX (Figure 2-2A), a small-molecule
target is covalently conjugated on a solid-phase carrier (e.g., magnetic microbeads) via a
linker. When the target-conjugated carrier is incubated with the nucleotide library,
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strands binding to the target strongly adhere to the solid phase and can be collected, while
non-target-binding strands remain in the solution and can be eluted away with the buffer.
Since the target is covalently conjugated onto the beads in target-immobilized methods,
highly-stringent SELEX conditions can be employed to isolate aptamers within a few
rounds.41
However, these methods also have several technical challenges.42,43 Since small
molecules typically have limited functional groups, surface conjugation of these targets
can be challenging. Functional groups occupied by the linker may not be accessible to
aptamer binding, making isolation of high-affinity aptamers difficult. In addition, both
the bead surface and the linker are susceptible to non-specific recognition by library
molecules, reducing separation efficiency and requiring additional negative SELEX
processes to remove these non-specific binders.43 For small molecules that are not
suitable for surface immobilization, library-immobilized SELEX is often used (Figure
2-2B). This method utilizes a short, bead-conjugated complementary DNA (cDNA)
sequence that hybridizes to a specific region of the library strands and thereby
immobilizes them onto the surface. Upon addition of the target, non-binding sequences
remain on the surface, while target-binding strands undergo a conformational change that
detaches them from the cDNA and releases them into solution, so that they can be
collected for further enrichment. Since small-molecule targets are free in solution, nonspecific enrichment of carrier/linker binding sequences can be avoided. However,
because the binding between library and capture strand is non-covalent and prone to
spontaneous dissociation during target elution,44 the separation efficiency of these
methods is low and requires more rounds of selection. Moreover, both target-
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immobilization and library-immobilization create steric hindrance to interactions between
library and target, resulting in the isolation of aptamers with low target-binding affinity.
Alternatively, several homogeneous methods (Figure 2-2C) have been recently
developed to overcome the limitations of heterogeneous SELEX, enabling higher
separation efficiency and allowing for isolation of high-affinity aptamers after just a few
rounds of selection. The first reported homogeneous SELEX technique utilized capillary
electrophoresis separation, exploiting the differential mobility between unbound and
target-bound library molecules under an external electrical field.45,46 However, this
method offers limited utility for small-molecule targets, because the mobility of targetaptamer complexes is very similar to that of unbound oligonucleotides, resulting in poor
separation resolution.47 Alternatively, graphene oxide has been used to remove nontarget-bound molecules during the separation step, as this material binds more strongly to
single-stranded DNA than to folded, target-bound DNA structures.48 This technique has
produced DNA aptamers for three pesticides and two toxins, with KD ranging from 1–100
nM after 5-10 rounds.49–51 However, this technique is not compatible with targets that
have strong π-π interaction with graphene oxide, such as doxorubicin.52 So far, there is no
generally applicable homogeneous SELEX technique for isolating small-moleculebinding aptamers.
2.2.3

Aptamer enrichment by PCR and regeneration of single-stranded libraries

There are a few examples of aptamers isolated through a single-round selection
process53,54 or a multi-round selection process without PCR amplification.55 However,
none of these methods has been successfully applied to small-molecule targets, and
SELEX is almost always a multi-round process. Since target-bound strands usually
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comprise a minimal fraction of the library pool, especially in the earlier rounds, the
separated target-binding strands need to be amplified by PCR to regenerate the new
library for the next round of selection. For RNA-based libraries, in vitro reverse
transcription is required before PCR amplification. During PCR, single-stranded library
strands are converted into double-stranded products, and it is therefore necessary to
remove antisense strands to regenerate the single-stranded new library for the next round
of selection. Methods routinely used for library regeneration include physical
separation,56 enzymatic digestion57,58, and asymmetric PCR59. In the physical separation
method, a biotinylated reverse primer is used during PCR to generate a biotin-labeled
antisense strand. The double-stranded PCR products are then captured by streptavidincoated microbeads and incubated with NaOH, denaturing the double-stranded DNA and
releasing the sense strands into solution. These strands are then collected and used as a
new single-stranded library. Alternatively, modified primers can be used to enable
enzymatic removal of antisense strands from the PCR products. For example, if PCR
amplification is performed using a 5’-phosphorothioate-labeled forward primer, the
antisense strands can be digested using T7 exonuclease, while the sense strands are
protected by the 5’-phosphorothioate label and remain intact.57

Similarly, if PCR

amplification is performed using a 5’-phosphorylated reverse primer, lambda exonuclease
can be used to specifically remove the phosphorylated antisense strands while sparing the
non-modified sense strands.58 As an alternative, asymmetric PCR allows for direct
generation of single-stranded libraries by adding an excess of forward primer relative to
the reverse primer. During PCR, the reverse primer is rapidly depleted so that ultimately,
only the sense strand can be effectively amplified with the forward primer, producing
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single-stranded products.59 These different methods for library regeneration have been
found to vary moderately in terms of cost and efficacy,60 and our work has generally
employed physical separation with streptavidin-coated agarose resin.34,61

Figure 2-3. Common SELEX strategies for control aptamer specificity.

2.2.4

Common selection strategies for control affinity and specificity of aptamers

One of the major advantages of aptamers compared with antibodies is that their
affinity and specificity can be fine-tuned during SELEX by using different selection
strategies. Control of aptamer affinity is usually achieved by manipulating SELEX
stringency. Under low-stringency conditions, even aptamers with low target-binding
affinity can be retained in the enriched pool. However, under highly stringent conditions,
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only aptamers with the highest target affinity can survive.62–64 Common ways of
modulating selection stringency include altering target concentration, target incubation
time, temperature, and buffer ionic strength.27,62,63 High selection stringency results in
higher aptamer affinity. However, high stringency also increases the risk of losing targetbinding sequences, especially during earlier rounds where the copy number of each
sequence is low. Therefore, SELEX is usually performed with relatively lower stringency
in earlier rounds to retain all possible target-binding sequences. The stringency is then
gradually increased in later rounds to enrich high-affinity aptamers.65 Some mathematical
models have been established to guide selection stringency during the SELEX process,
62–64

but in most cases the change in stringency between rounds is highly empirical.61

Some selection strategies have also been developed to control the binding specificity
of the aptamers. One disadvantage of target-immobilized SELEX is the evolution of
bead-binding aptamers. Negative-SELEX strategies can overcome this problem (Figure
2-3, left).66 Here, the library is first incubated with non-modified beads, so that beadbinding strands are adsorbed onto the beads. These beads are then removed, and the
remaining library strands are then incubated with target-immobilized beads for regular
SELEX. A similar strategy, termed counter-SELEX, was developed to prevent isolated
aptamers from binding to possible interferents (Figure 2-3, left). In 1994, using a very
stringent counter-SELEX regime, Polisky et al. isolated a theophylline-binding aptamer
that has a 10,000-fold higher affinity for this target compared to caffeine, which only
differs from the target by a methyl group.25 After incubating theophylline-immobilized
beads with the library, they used a high concentration of caffeine to elute and thereby
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eliminate library strands recognizing this molecule. Multiple rounds of counter-SELEX
can be used to further fine-tune the specificity of the resulting aptamers.
The specificity of aptamers can also be tailored to recognize a whole family of targets
sharing the same core structure. Such ‘class-specific’ aptamers can be used in many
sensing applications, including detection of illicit drugs and their metabolites for forensic
investigations, antibiotics for food safety, or pesticides for environmental monitoring.67–69
In order to generate class-specific aptamers, Sullenger et al. developed a toggle-SELEX
strategy (Figure 2-3, right) in 2001, yielding an aptamer that cross-reacted to both human
and porcine thrombin.26 The initial library was incubated with a mixture of both targets to
enrich all potential aptamers, after which human and porcine thrombin were used as
alternating selection targets every round. Consequently, only library strands that bind to
epitopes present on both targets can be enriched in every round, while aptamers specific
to one species were removed. The final aptamer bound to human and porcine thrombin
with a KD of 2.8 and 0.1 nM, respectively. In comparison, an aptamer isolated using only
porcine thrombin demonstrated >10,000-fold higher specificity for this protein relative to
human thrombin.26 Toggle-SELEX has been employed to isolate several class-specific
aptamers, mostly for protein and cell targets.70–72 In some cases, toggle-SELEX was also
performed with more than two targets to achieve broader binding spectra.71,72 A similar
toggle strategy can also be applied to isolate class-specific aptamers for small-molecule
targets.36,39,73 However, this is more challenging than for protein and cell targets due to
lack of epitopes on small-molecule targets. For example, one study used toggle SELEX
with four different target pairs to isolate class-specific aminoglycoside-binding aptamers.
However, only one out of the 80 aptamers demonstrated cross-reactivity to all eight
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aminoglycoside targets.36 To overcome such limitations, we have recently developed new
parallel-and-serial selection strategies to increase target cross-reactivity and the success
rate of class-specific aptamer isolation.74 As a demonstration, we have isolated a classspecific aptamer that binds to more than 12 synthetic cathinones sharing the same corestructure with nanomolar affinity.

Figure 2-4. Different strategies to develop aptamer-based sensors. Sensors can be developed
from (A) a fully folded aptamer via (B) aptamer truncation, (C) splitting, (D) introducing a
competitive strand, or (E), a dye binding to target-binding domain of the aptamer.

2.3. Aptamer-based sensors for small molecule detection
As target affinity is typically the only selection pressure applied during SELEX,
isolated aptamers usually lack innate signal transducing functionality and cannot be
directly used for biosensing. Many strategies have been developed to introduce different
signal transducing functionalities into aptamers to achieve optical, electrochemical, or
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electrical detection of small-molecule targets (Figure 2-4).75 Most aptamer-based sensors
for small-molecule detection rely on a conformational change of the aptamer upon target
binding—functionality that are typically be introduced into the aptamer via a multi-stage
process of sequence analysis, truncation and chemical modification.75–77 Nevertheless,
several sensor platforms are available that employ fully-folded aptamers without
requiring target-induced conformational change.
2.3.1

Sensors based on target-induced conformational changes

Small-molecule-binding aptamers are usually fully folded upon isolation, with stable
secondary structures (Figure 2-4A), such that target binding does not significantly alter
their structure. The functionality of binding-induced conformational change is therefore
introduced into the aptamer via post-SELEX. An aptamer comprises a target-binding
domain and several scaffold regions. Small-molecule-binding aptamers usually have
small target-binding domains, since the small surface area of the target can interact with a
limited number of nucleotides simultaneously. The nucleotides in the scaffold regions do
not directly interact with the target, but help to stabilize the structure of the aptamer and
thereby ensure proper formation of the target-binding domain. When scaffold regions are
disrupted, the aptamer will lose its secondary structure and become single-stranded.
However, the disrupted sequences may retain their capacity for target recognition and to
reassemble into the original secondary structure in the presence of the target. This targetinduced aptamer conformational change can then be employed for signal transduction.
Aptamer truncation, splitting, and strand-displacement are the three general strategies to
introduce target-induced conformational change functionality.
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2.3.1.1 Sensors based on truncated structure-switching aptamer
The most intuitive way of introducing structure-switching functionality is to truncate
the aptamer (Figure 2-4B). Aptamers usually have double-stranded stems contributing to
the scaffold region. Shortening these stems reduces the melting temperature of the
aptamer, shifting their equilibrium to favor a single-stranded structure that can still be
refolded upon target binding. For example, the well-characterized cocaine-binding aptamer
MNS-4.1 (KD ∼5 μM) is structurally stable and forms a TWJ even before binding

cocaine.78 Stojanovic et al. subsequently truncated one of the three stems to destabilize the
aptamer, and attached a fluorophore-quencher pair to the ends of the truncated stem for signal
reporting.78 The resulting aptamer exists in an equilibrium state consisting of both folded and
unfolded structures in the absence of the target, in which the fluorophore cannot be efficiently
quenched and thus emits strong fluorescence. The aptamer refolds in the presence of cocaine,
bringing the quencher into proximity of the fluorophore and resulting in a signal reduction.
The method demonstrated a limit of detection (LOD) of 10 μM.78 The same aptamer sequence
has also been modified with electroactive methylene blue for electrochemical detection of
cocaine even in the most challenging sample matrix, whole blood.79 So far, many structureswitching aptamers have been engineered by truncation for folding-based sensor
development.80
Traditionally, engineering of structure-switching aptamers with sensitive target
response is a laborious multistep process. First, the secondary structure of the fully-folded
aptamer must be predicted by software such as mfold or NUPACK.81,82 Different
domains of the aptamer are then truncated or mutated to identify the target-binding
domain and scaffold regions. Finally, multiple truncated aptamers with different portions
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of the scaffold regions removed are synthesized and tested for validating structureswitching functionality, and the optimized aptamer is used for downstream sensor
developments.83–85 This process is not only labor-intensive but also greatly relies on trial
and error. For example, Neves et al. identified the target-binding domain and secondary
structure requirements of MNS-4.1 by interrogating 24 truncated/mutated aptamers using
isothermal titration calorimetry (ITC),86 followed by testing the parent aptamer with three
truncated/mutated variants using nuclear magnetic resonance (NMR) to identify the
optimized structure-switching aptamer.87 To expedite the aptamer engineering process,
we have recently developed a one-step nuclease-directed truncation method to generate
structure-switching small-molecule-binding aptamers.88 Specifically, we found that Exo
III digestion of aptamers can be strongly inhibited a few nucleotides prior to their targetbinding domain. The resulting digestion product not only retains substantial targetbinding affinity but also exhibits structure-switching functionality, enabling rapid
development of aptamer-based sensors for small-molecule detection.
Since small-molecule-binding aptamers usually have relatively high dissociation
constants (∼μM KD),40 a substantial scaffold region is required to stabilize the aptamer
structure and maintain target-binding affinity, which promotes problematic background
folding. For example, the optimized structure-switching cocaine-binding aptamer
described above are partially folded in the absence of target, resulting in high background
that greatly limited sensor sensitivity.78,89 However, further truncation of this aptamer
results in the complete loss of target affinity.86
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2.3.1.2 Sensors based on split aptamers
An alternative way to generate target-induced conformational change is to split the
fully folded aptamer into two21 or three90 fragments, which destabilizes the aptamer such
that the fragments are unable to assemble in the absence of target. However, the
fragments retain their capacity for target recognition and can successfully reassemble into
a complex secondary structure in the presence of target (Figure 2-4C).91 As with
truncation, splitting of the aptamer also requires knowledge of its target-binding domain
and scaffold regions. Splitting is often performed at non-binding loop regions of the
aptamer. Recently, Heemstra et al. reported a general approach for engineering smallmolecule-binding DNA split aptamers with TWJ target-binding domains.92 Splitting of
aptamers with other secondary structures can be challenging, especially for those lacking
apparent non-binding loop regions, thus requiring considerable trial-and-error.
Splitting is a more aggressive method that results in reduced background signal
compared with truncated aptamers. However, aptamer splitting also results in notably
reduced target affinity for the same reason.21 Thus, this approach still compromises the
sensitivity of the resulting sensors. To improve sensor sensitivity, Zhang et al. reported an
amplified assay based on an enzyme-linked split aptamer to perform colorimetric cocaine
detection.23 One fragment was conjugated to a plastic surface; in the presence of cocaine, this
fragment formed a complex with the second fragment, which was modified with biotin in
order to bind streptavidin-linked horseradish peroxidase for signal amplification. However,
washing caused the dissociation of a subset of the assembled tripartite complexes, resulting in
a LOD of just 2.8 μM. To address this, Heemstra et al. incorporated a proximity ligation
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strategy into this assay.93 Here, cocaine binding facilitated the assembly of the azide- and
cyclooctyne-modified split fragments, bringing these two chemical groups into close
proximity to form covalent bonds. This prevented dissociation of the assembled target–
aptamer complex during washing and improved the sensor's detection performance. Although
the signal was then amplified by the enzyme, the sensitivity remained limited to 0.1 μM94 due
to the low binding affinity of the split aptamer (KD = ∼200 μM).21 Target affinity can be

improved by engineering split aptamers with longer complementary stems, but the
majority of thermostable split aptamers undergo some degree of pre-assembly in the
absence of target, producing high background signal.95
To overcome this limitation, we have developed a general approach to incorporate
cooperative binding-functionality into split aptamers to achieve more sensitive detection
of small molecules.95,96 The new aptamer construct termed cooperative binding split
aptamer (CBSA) contains two tandem target-binding domains, where the initial targetbinding event stabilizes the structure of the split aptamer and facilitates subsequent
target-binding at the second binding domain. Compared with split aptamers with a single
target-binding domain, CBSAs exhibit higher target affinity and far more responsive
target-induced aptamer assembly, enabling sensitive target detection. For example, we
have developed a CBSA-based fluorescence assay that can detect cocaine with a LOD of
50 nM in 10% saliva within 15 min, which could not be achieved with any conventional
split-aptamer-based sensors.95
2.3.1.3 Sensors based on strand displacement
Both truncated aptamers and split aptamers require sequence engineering to disrupt the
isolated aptamer, but strand-displacement strategies allow for the generation of structure-
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switching aptamers without sequence engineering (Figure 2-4D).97 This strategy employs
a short competitive strand complementary to the aptamer. In the absence of the target, the
competitive strand hybridizes with the aptamer and disrupts its folded structure. The
aptamer undergoes a conformational change upon target binding, refolding into its
original structure and thus dissociating with the competitive strand. This target-induced
structure-switching event can be readily transduced into an optical97 or electrochemical22
signal. For example, Li et al. attached a fluorophore to an ATP-binding aptamer and a
quencher onto the competitive strand. In the absence of the target, the hybridization of
aptamer and the competitive strand brings the fluorophore into proximity with the
quencher, yielding low fluorescence. Upon addition of the target, the competitive strand
is displaced, resulting in a high fluorescent signal.97 Since no sequence engineering is
required in the strand-displacement approach, less knowledge is required about the
aptamer structure. Moreover, library-immobilized SELEX methods have been developed
that make it possible to isolate aptamers with inherent structure-switching
functionality,32,98 which further simplify sensor development. Nevertheless, since
competitive strands have high binding affinity for the aptamer, they inadvertently inhibit
target binding and consequently reduce the sensitivity of strand-displacement assays.
This is particularly problematic for the detection of small-molecule targets, which have
relatively low target-binding affinity. As such, the LOD of strand-displacement assays for
small molecules is usually comparable to or even higher than the KD of the aptamer being
employed.32,33,97,99,100 Moreover, unlike truncated aptamer or split-aptamer-based assays,
strand-displacement assays require a heating-and-cooling process lasting ≥ 30 min to
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ensure complete hybridization between the complementary strand and aptamer to achieve
low background. This greatly hinders the use of these assays for rapid on-site detection.
2.3.2

Sensors that do not require target-induced conformational change

Recently, several methods have been developed that can generate a readout of target
binding without utilizing a structure-switching aptamer. These typically employ a fullyfolded aptamer in combination with a second probe such as a dye molecule, exonuclease,
or even the target itself to report target-binding events. This eliminates the need for
laborious sequence engineering but also yields high sensitivity due to the high targetbinding affinity of fully-folded aptamers. The need for specific signaling probes is the
major drawback of these methods, which has limited their application to only a few
targets. Nevertheless, several new strategies have been developed to improve the
generality of these methods.
2.3.2.1 Dye-displacement assays
Dye-displacement assays34,74,101–104 rely on small-molecule dyes that can initially be
associated with the aptamer-binding domain (Figure 2-4E). The target displaces the dye
from the binding domain, resulting in a change in the absorbance or fluorescence of the
dye. These assays do not require any additional labeling or chemical modification of the
aptamer. Since the aptamers typically bind to these small-molecule targets and dyes with
similar affinities, target-induced dye-displacement is more thermodynamically feasible
than the displacement of a tightly-bound complementary strand in strand-displacement
assays. As a result, dye-displacement assays can achieve a LOD which is 10-fold lower
than the KD of the aptamer being used.34,74,101–104 However, this assay strategy has not
been generalized, as there are currently no sequence engineering strategies or SELEX
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techniques that can directly isolate aptamers with dye-displacement functionality. To
remedy this problem, we recently developed a simple strategy for directly isolating
signal-reporting aptamers that have intrinsic dye-displacement functionality from a TWJ
structured DNA library.34 As a demonstration, we isolated an aptamer against a synthetic
cathinone, 3,4-methylenedioxypyrovalerone (MDPV). The aptamer intrinsically binds the
small-molecule dye Cy7 within its TWJ domain, while MDPV efficiently displaces the
dye, resulting in a change in absorbance within seconds. The assay also showed high
sensitivity, achieving a LOD of 300 nM in 50% urine or saliva.34
2.3.2.2 Aptamer-modified field-effect transistors
Receptor-modified field-effect transistors (FETs) have recently gained attention in the
biosensing field.105 The conductivity of the semiconductor channel in FETs is extremely
sensitive to changes in the local electric field. When the surface of a FET is modified
with a specific bioreceptor such as an aptamer, binding of charged target molecules at the
surface is sufficient to generate an electric signal.105 FET-based sensors can achieve ultrahigh sensitivity, partially because of the nonlinear behavior of the semiconductor
channel. Since the charge on the targets is being employed for signal transduction, highaffinity fully-folded aptamers can be directly employed in the sensor platform. Moreover,
FET offers a broad dynamic range spanning several orders of magnitude, which cannot
be achieved in most sensing platforms.106 For example, Weiss et al. demonstrated
detection of positively-charged dopamine using an aptamer-modified FET with a LOD of
10 pM and a dynamic range from 10 pM to 1 µM.107 Aptamer-modified FETs do have
some significant limitations, however. First, small-molecule targets with no charge have
minimal effect on the semiconductor, and thus cannot be effectively measured.108 Second,

28

semiconductor transconductance is only sensitive to variations in charge density within
the electrical double layer, but the thickness of this layer dramatically decreases as
solution ionic strength increases—dropping below 1 nm in physiological fluids, which
makes target detection challenging in these conditions.109 Recent work has shown the
possibility of remedying both limitations, based on the determination that small-molecule
binding can introduce a ternary structure change in fully-folded aptamers modified onto
the FET surface. This rearrangement of negatively-charged aptamer phosphodiester
backbones near the semiconductor surface can then be detected by FET even if the
binding event itself occurs outside the electrical double layer. Using this strategy,
Andrews et al. demonstrated sensitive detection of both charged and non-charged small
molecules in biological samples.110 The generalizability of this strategy for other smallmolecule-binding aptamers needs to be assessed in the future, however. This will not be
easy due to the need for specialized equipment and techniques for fabrication of aptamermodified FETs, which are not accessible for most labs.
2.3.2.3 Exonuclease-inhibition assay
We have recently discovered that binding of small-molecules to aptamers can strongly
affect their digestion by the exonucleases Exonuclease III (Exo III) and Exonuclease I
(Exo I).88,111 Exo III and Exo I respectively digest double- and single-stranded DNA from
the 3’ terminus. In the absence of target, aptamers can be completely digested by this
nuclease mixture. However, upon binding of the target, digestion by both enzymes is
strongly inhibited at a position 3-4 nucleotides prior to the target-binding domain,
yielding a truncated aptamer. Such drastic differences in digestion profiles can be utilized
to determine the presence of the target using a DNA-binding dye such as SYBR gold or a
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fluorophore-quencher-modified molecular beacon. This exonuclease-based assay allows
for the use of high-affinity fully-folded aptamers without any sequence engineering or
modification, achieving much higher sensitivity compared with sensors based on
structure-switching aptamers. We have demonstrated the generality of this method using
different aptamers with both TWJ and stem-loop secondary structures, with low
nanomolar detection limits in biological matrices.111 Since each aptamer has a unique
sequence, multiplex detection can also be achieved in a single-pot reaction using specific
molecular beacons (Figure 2-5).

Figure 2-5. Working principle of exonuclease-inhibition assay for small molecule detection.111

2.4. Gold nanoparticles (AuNPs) and their use in aptamer-based sensors
AuNPs are gold particles with diameters ranging from 1–100 nm, and are widely used
for biosensor development due to their distinctive optical properties. The color of an
AuNP solution is determined by their localized surface plasmon resonance (LSPR) and
can thus change according to their size, shape, and distance from each other. For
example, 13-nm spherical citrate-capped AuNPs have strong absorbance at 520 nm and
present a red color. Particles with smaller sizes have higher LSPR frequency, resulting in
a blue-shift of their absorbance spectra that produces an orange-red color, whereas larger
particles absorb at longer wavelengths and thus produce a purple color. When AuNPs
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aggregate upon addition of salt, the absorbance peak shifts to 650 nm and the solution
color changes to blue. The color changes that occur upon dissolution, enlargement,
assembly, dissociation, or aggregation of AuNPs have been extensively utilized for signal
transduction in different sensors for the instrument-free, naked-eye detection of various
targets. In addition, nucleic acids can be easily modified onto AuNPs through gold-thiol
chemistry. For these reasons, AuNPs have been widely used as a sensing element for
colorimetric detection of targets including metal ions, small molecules, DNA, and
proteins.112

Figure 2-6. Synthesis AuNPs by citrate reduction.

2.4.1

Synthesis and characterization of citrate-capped AuNPs

Various techniques have been developed for the synthesis of AuNPs with different
sizes and shapes.113–117 The most commonly used technique is the Turkevitch method,
which uses citrate to reduce HAuCl4 into spherical AuNPs in aqueous solution (Figure
2-6).113 HAuCl4 solution is mixed with trisodium citrate; Au3+ ions in the solution are first
reduced to Au+ ions, and then to Au0 species through disproportionation. This Au0
species is thermodynamically unstable and rapidly becomes a nucleation center for other
newly-reduced Au0 species. These nucleation centers therefore slowly grow into welldispersed AuNPs. Excessive citrate anion acts as a capping reagent that adsorbs onto the
surface of the AuNPs and renders them negatively-charged. These AuNPs therefore repel
each other and are stable for a long period of time without aggregation. The size of the
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AuNPs can be easily fine-tuned by adjusting the HAuCl4:citrate ratio, temperature, or
solution pH.113
After synthesis of AuNPs, the size, shape, concentration, and dispersity of the
nanoparticles can be characterized by various methods (Figure 2-7). Given the color
change associated with these particles (Figure 2-7A), one can easily determine their size
and concentration based on UV-vis absorbance (Figure 2-7B). The surface plasmon peak
wavelengths and extinction coefficients for different sizes of AuNP have been well
studied,118 and UV-vis spectrometry offers a rapid, facile, and non-destructive way to
characterize the size and concentration of synthesized AuNPs. The accuracy of this
method is relatively low, however – especially for size determination. This is because the
surface plasmon peak wavelength of AuNPs with sizes ranging from 1 to 100 nm only
varies between 520 and 580 nm,118 and the local environment and different surface
modifications have been known to further affect their UV-vis absorbance.119 UV-vis
spectrometry is also inaccurate for poly-disperse AuNPs due to the overlapping surface
plasmon peaks from particles of different sizes. Dynamic light scattering (DLS) is
another analytical method routinely used to characterize the size and dispersity of AuNP
solutions (Figure 2-7C).119 Nanoparticles in the solution scatter light upon illumination,
and the intensity of scattered light rapidly fluctuates over time due to Brownian motion of
the particles. Smaller particles have faster Brownian motion, which results in more rapid
DLS fluctuation, thus allowing accurate measurement of particle size. DLS measurement
also provides information about particle dispersity, which is important for assessing the
quality of AuNPs.119 Notably, DLS measures the hydrodynamic size of particles, which
includes the protectant (such as citrate) and surface modification (such as DNA) instead
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of just the size of the gold core. This unique feature of DLS allows the study of
bioconjugation processes on AuNPs.120 Finally, transmission electron microscopy (TEM)
is a powerful tool for AuNP characterization (Figure 2-7D). Although it requires much
more expensive instruments and more complicated sample preparation, the size of
individual AuNPs can be accurately determined without the interference of solvent
conditions or surface protectants/modifications. Moreover, TEM also gives direct
information on particle shape that cannot be obtained using other methods.

Figure 2-7. Methods for AuNP characterization. (A) color, (B) UV-vis spectrum, (C) DLS
measurement, and (D) TEM picture of 13 nm AuNPs.

2.4.2

DNA functionalized AuNPs

DNA-modified AuNPs can specifically recognize a variety of targets, including
nucleic acids, proteins, peptides, small molecules, and metal ions.112 Accordingly, such
particles have proven extraordinarily useful for bioimaging, bioseparation, diagnostic
assays, drug targeting, nanotherapeutics, and nanomaterial assembly.10,121,122 DNA can be
conjugated onto AuNPs by several chemistries,123–126 where alkane-thiol adsorption is the
most common approach (Figure 2-8).125,127 In this method, an excessive amount of
thiolated DNA is mixed with AuNPs for several hours to allow gold-thiol interaction. The
DNA surface coverage on AuNPs is controlled by the DNA:AuNP ratio employed for
modification. Next, salt aging is performed, in which the salt concentration of the AuNP-
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DNA solution is gradually increased. Citrate-capped AuNPs without DNA attached are
not stable at elevated ionic strength and aggregate from the solution, while conjugation of
highly negatively charged-DNA allows modified AuNPs to tolerate even 1 M salt
concentrations.128 Finally, the DNA-modified AuNPs are washed with buffer by
ultrafiltration or ultracentrifugation to remove salt and unconjugated DNA. The resulted
DNA-modified AuNPs can then be characterized using different methods and can be
stored refrigerated for several months.
The extent of DNA surface coverage can profoundly influence DNA hybridization
efficiency, enzyme activity, and assay sensitivity employing DNA-modified AuNPs.129–
135

High surface coverage is associated with steric hindrance, electrostatic repulsive

interactions, and elevated surface salt concentration, whereas low surface coverage can
result in nonspecific binding of oligonucleotides to the particle surface. Both scenarios
can greatly reduce DNA hybridization efficiency and enzyme activity for surface-bound
DNA probes,136,137 resulting in low sensitivity of DNA-modified AuNP-based assays.
Therefore, strategies for accurately quantifying the degree of surface coverage are critical
for research applications based on DNA-conjugated particles.
DNA surface coverage on AuNPs under different modification conditions is typically
quantified using thiolated DNA with a fluorophore label. Fluorophore-labeled DNA is
strongly quenched when bound to AuNPs, but this fluorescence is fully recovered once
the DNA is detached from the surface. Therefore, the surface coverage of thiolated-DNAmodified AuNPs can be determined by measuring the fluorescence of oligonucleotides
liberated via ligand displacement with dithiothreitol (DTT), which can effectively bind
AuNPs via two thiol groups.138,139 The standard DTT displacement protocol usually
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requires overnight incubation of DNA-modified AuNPs with high concentrations (∼0.5
M) of DTT at room temperature.128 Although time-consuming, the DTT displacementbased assay is recognized as a reliable “gold standard” for quantifying surface coverage
on AuNPs irrespective of DNA length or sequence. Recently, several label-free methods
utilizing PCR, OliGreen, and unimolecular beacon have been developed to characterize
DNA surface coverage.140–142

Figure 2-8. Synthesis of DNA-modified AuNPs.121
We have recently developed a simple and broadly applicable Exo III digestion assay
based on the cleavage of phosphodiester bonds—a universal feature of DNA-modified
particles—to accurately quantify DNA probe surface coverage on AuNPs and other
commonly used particles of different compositions, conjugation chemistries, and sizes.143
Our assay utilizes particle-conjugated, fluorophore-labeled probes that incorporate two
abasic sites. These probes are hybridized to a cDNA strand, and quantitation is achieved
via cleavage and digestion of surface-bound probe DNA via Exo III’s apurinic
endonucleolytic and exonucleolytic activities. The presence of the two abasic sites in the
probe greatly speeds up the enzymatic reaction without altering the packing density of the
probes on the particles. Probe digestion releases a signal-generating fluorophore and
liberates the intact cDNA strand to start a new cycle of hybridization and digestion until
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all fluorophore tags have been released. After digestion, DNA surface coverage can be
determined accurately based on the complete release of fluorophores. Our method
delivers accurate, rapid, and reproducible quantitation of thiolated DNA on the surface of
gold nanoparticles, and also performs equally well with other conjugation chemistries,
substrates, and particle sizes, and thus offers a broadly useful assay for quantitation of
DNA surface coverage.
2.4.3

Aptamer-based assays employing AuNPs for small molecule detection

Both unmodified and aptamer-modified AuNPs have been widely employed as
colorimetric signal reporters in aptamer-based assays for naked-eye small-molecule
detection.96,144–146 Unmodified citrate-capped AuNPs strongly adsorb single-stranded
DNA through interaction with exposed nitrogenous bases, but have low binding affinity
to double-stranded DNA.147 Meanwhile the binding of negatively-charged singlestranded DNA to AuNPs significantly stabilizes AuNPs against salt-induced
aggregation.148 Basing on this feature, Fan et al. developed a simple split-aptamer-based
assay for rapid visual detection of cocaine (Figure 2-9A).145 A cocaine-binding split DNA
aptamer was incubated with 13-nm citrate-coated AuNPs, followed by addition of the
analyte and a salt solution. In the absence of target, both split aptamer fragments are in a
single-stranded conformation and adsorb onto the AuNPs. The DNA-protected AuNPs
are stable with the addition of salt solution, and thus the sample maintains the red color of
the original AuNP mixture. In the presence of target, however, the split-aptamer
fragments assemble, forming a duplexed complex that detaches from the particle surface.
When a salt solution is added into the sample, the unprotected AuNPs rapidly aggregate
and produce a clearly visible red-to-blue color change. Using this method, cocaine was
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visually detected within 10 min at concentrations as low as 20 µM. Similar methods have
been developed for the detection of other targets such as ATP145 and aminoglycosides36.
Recently, the same method has also been successfully applied to a truncated structureswitching aptamer for detection of cocaine.149 Unfortunately, these assays are not very
specific, as unmodified AuNPs are not stable and can undergo non-specific aggregation
under high salt or target concentration, even in the presence of single-stranded DNA.128

Figure 2-9. Examples of aptamer-based colorimetric assays employing AuNPs for small
molecule detection. (A) Assay based on unmodified AuNPs. (B) Assay based on DNA- modified
AuNPs employing a “assembly-to-dissociation” strategy. (C) Assay based on CBSA- modified
AuNPs employing a “dissociation-to-aggregation” strategy.

On the other hand, DNA-modified AuNPs are stable in high-salt buffers because of
repulsion by the negatively-charged DNA strands tethered to the particle surface.128 They
can also undergo programmable dissociation or aggregation upon specific target-binding,
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yielding a colorimetric readout for sensitive target detection. For example, Li et al.
discovered that adenosine-binding aptamers conjugated onto 13-nm AuNPs with low
surface density collapse onto the surface in the absence of the target, but fold into a rigid
duplexed structure that lifts up from the surface upon target binding. Such a targetinduced conformational change alters the inter-particle steric hindrance and prevents
AuNPs from aggregating under high ionic strength.150 Using this method, adenosine was
detected at concentrations as low as 20 µM. It is also well known that two sets of AuNPs
modified with different DNA probes can assemble into lattice-like nano- and microstructures in the presence of a cross-linking strand that is complementary to both surfacemodified probes, producing a blue color.125,151 This process is reversible at elevated
temperatures when the linker strand dissociates from the surface-modified DNA,
producing a blue-to-red color change. If the cross-linking strand is replaced with a
structure-switching aptamer, AuNP assembly and dissociation can be mediated by target
concentration (Figure 2-9B). Specifically, in the absence of target, the aptamer unfolds
and links two sets of DNA-modified AuNPs together, forming blue aggregates. In the
presence of target, the aptamer folds into a duplexed structure and dissociates from the
surface-immobilized probes, resulting in dissociation of the aggregates and producing a
blue-to-red color change. Using this “assembly-to-dissociation”

method, Lu et al.

demonstrated aptamer-based visual detection of cocaine and adenosine.144
Another commonly-employed strategy known as “dissociation-to-aggregation” utilizes
an target-triggered enzymatic cleavage reaction to remove surface-bound DNA strands,
which destabilizes the AuNPs and causes them to aggregate, producing a red-to-blue
color change (Figure 2-9C).96,152–155 For example, we recently demonstrated the use of
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CBSAs for sensitive colorimetric detection of cocaine based on the aggregation of
AuNPs via enzyme-assisted target recycling (EATR).96,155 We coupled one the two
CBSA fragments to AuNPs while the other remained free in solution. In the absence of
target, the fragments remain separate, and the AuNP-conjugated fragment is resistant to
digestion by Exo III. When the target is present, the CBSA fragments assemble, forming
a substrate that can be cleaved by Exo III. This digestion shears all surface-bound DNA,
resulting in aggregation of AuNPs and a red-to-blue color change. This method allowed
for visual detection of cocaine at concentrations as low as 10 µM within 30 minutes.96
2.5. EATR-based signal amplification
In conventional bioassays, assay sensitivity is limited by the the target affinity of the
bioreceptor, as the signal intensity is proportional to the number of receptor-bound target
molecules.156 To overcome this limit, many amplification approaches have been
developed that enable detection of targets at very low concentrations157,158. EATR159
relies on selective, nuclease-mediated degradation of the probe strand of a target-probe
duplex that only forms in the presence of target. This liberates the target, which is then
‘recycled’ for use in further digestion reactions. In this scenario, each target molecule can
generate multiple signals, achieving much higher sensitivity compared with assays
without amplification. So far, many EATR-based assays have been developed for the
detection of DNA as well as small molecules.96,159,160
2.5.1

EATR assays for DNA detection

EATR was first used with molecular beacon probes for DNA detection (Figure
2-10).158 The molecular beacon probe contains a loop sequence complementary to the
target DNA, with a fluorophore-quencher pair attached to the stem of the beacon as a
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signal-reporting element. When the molecular beacon probe binds the target DNA, it
switches from a stem-loop structure into a probe-target duplex that contains a specific
sequence that can be recognized by a nicking enzyme. This enzyme then catalyzes
cleavage of the beacon probe, liberating the fluorophore and releasing the target, which
can then be recycled to hybridize with other molecular beacon probes. Thus, an
amplifiedfluorescent signal can be generated by a single copy of the target though EATR,
greatly decreasing the LOD. Using this EATR method, termed nicking enzyme signal
amplification (NESA), Xie et al. demonstrated more than 100-fold signal amplification
and achieved a LOD of 6.2 pM for a DNA target.158 Without the assistance of the
enzyme, the assay remained insensitive to target concentrations as high as 2 nM. Given
that DNA can be easily modified with various signaling reporters154,158,161,162 and
different nucleases can be utilized to process target-probe duplexes,158,161,163,164 many
EATR-based assays have been developed for DNA detection with ultra-high
sensitivity.159 For example, Plaxco et al. improved the NESA assay by replacing the
nicking enzyme with a structure-specific nuclease, Exo III. This method does not require
a specific enzyme-recognition sequence in the target, and thus can be generalized for
detection of virtually any sequence.164 More recently, we have successfully demonstrated
EATR on the surface of AuNPs and achieved ultra-sensitive visual detection of DNA
targets.154 The assay utilizes particle-conjugated DNA probes that incorporate two abasic
sites. The single-stranded probe is inert to Exo III, rendering the AuNPs stable in solution
and producing a red color. Target DNA can hybridize to the AuNP-conjugated probes
forming a stable duplex, and these duplexes can then be rapidly digested by Exo III.
Probe digestion releases the target strand to start new cycles of hybridization and
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digestion until all surface-tethered probes are sheared. The AuNPs then aggregate,
yielding a red-to-blue color change. This color change is easily observed by the naked
eye within 15 min, and as little as 2 nM of target can be detected using this method.
Importantly, even a single-base target mismatch adjacent to the abasic sites impairs Exo
III activity on the probe, making this assay suitable for single nucleotide polymorphism
detection.

Figure 2-10. Working principle of an EATR assay for detection of DNA.158

2.5.2

Aptamer-based EATR assays for small-molecular detection

In principle, the target-induced assembly of split aptamers should be compatible with
EATR-mediated signal amplification, since this process largely resembles hybridization
between target and probe strands in DNA-based EATR assays. However, such an
approach has been historically challenging due to the low target affinity and insensitive
target-induced aptamer assembly of small-molecule-binding aptamers. We have recently
overcome these limitations by incorporating highly target-responsive CBSAs into EATRamplified biosensors. Specifically, we have developed an EATR-amplified fluorescence
assay for the detection of dehydroepiandrosterone sulfate (DIS) using a fluorophore-
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quencher-labeled CBSA and Exo III, and have demonstrated that this assay exhibits 100fold enhanced sensitivity relative to the CBSA alone without EATR signal amplification.
Importantly, this assay also proved highly sensitive when used in urine samples, allowing
us to detect DIS at concentrations as low as 1 μM in 50% urine within 30 minutes.
Moreover, using CBSA fragment-modified AuNPs as signal reporters, naked-eye
detection of low micromolar concentrations of cocaine was achieved within 20 minutes.
2.6. Small molecule targets used in this work
2.6.1

Cocaine

Cocaine (Figure 2-11A) is a strong and highly addictive central nervous system
stimulant extracted from the coca plant. Cocaine is currently a schedule II-controlled
substance regulated by the Drug Enforcement Agency, and has been approved for limited
medical uses. Recreational abuse of cocaine can have severe negative health
consequences, such as nausea, hyperthermia, hypertension, cardiac arrest, and even
death.165 Cocaine is the second most abused and third most frequently seized illicit drug
in the United States.166 The National Survey on Drug Use and Health estimated that in
2016, about 1.9 million people aged 12 or older were current users of cocaine.167
2.6.2

DIS

DIS (Figure 2-11B), also known as dehydroepiandrosterone sulfate (DHEA-S) sulfate
is a conjugated metabolite of DHEA, which is the precursor of many other androgens and
estrogens.168 DIS is one of the most abundant steroid hormones in both blood and urine.
DIS itself has no hormonal activity; however, it can be converted into hormonally-active
DHEA by steroid sulfatase. Upon secretion by adrenal cortex into the circulation, DIS is
mostly bound to serum albumin, and thus has a long biological half-life of 14 hours.168
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DIS is eventually excreted into the urine through the kidney. DIS concentration in blood
and urine reflects adrenal gland function. Levels are low during childhood, rapidly
increase during sexual maturation, and peak around the age of 20 to 30 years and
gradually decrease afterward.169 Urinary concentration of DIS in healthy adults typically
ranges from 1–20 μM

170,171

but can climb to the sub-millimolar range in patients with

adrenal dysfunction and adrenal tumors.172
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Figure 2-11. Chemical structure of small molecule targets. Structures of (A) cocaine, (B) DIS,
and (C) core structure of synthetic cathinones are shown. R1-R4 represent substituent sites.

2.6.3

Synthetic cathinones

Synthetic cathinones (Figure 2-11C), known popularly as ‘bath salts’, are a family of
novel psychoactive substances that share the same beta-keto phenethylamine chemical
core structure. They are highly addictive central nervous system stimulants,173 and are
associated with many negative health consequences, such as agitation, seizures, cardiac
arrest, and even death.174,175 Synthetic cathinones are sold on the Internet and in head
shops as “legal” alternatives to amphetamines and ecstasy.19 Evidence from poison
control centers suggests that synthetic cathinones are primarily used by youths and young
adults.176 So far, 14 synthetic cathinones have been scheduled as controlled substances by
the Drug Enforcement Agency.177 However, in attempts to circumvent existing drug laws,
drug designers continually add new substituents to existing synthetic cathinones, giving
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rise to several hundred novel synthetic cathinone derivatives that are potentially even
more potent and dangerous.19 Synthetic cathinones thus pose a major risk to public health
and safety due to their severe and unpredictable toxicity, the difficulty of achieving
effective surveillance, and their increasingly broad availability.

44

CHAPTER 3: A Cooperative-Binding Split Aptamer Assay for Rapid, Specific and
Ultra-Sensitive Fluorescence Detection of Cocaine in Saliva
3.1. Introduction
Aptamers are single-stranded oligonucleotides isolated via in vitro SELEX,1,2 which
can specifically bind to a wide range of targets including proteins, small molecules and
metal ions.3 Aptamers offer several advantages as recognition elements for biosensors
relative to antibodies. First, aptamers can be chemically synthesized with high
reproducibility at relatively low cost.5 Second, the high chemical stability of DNA
aptamers means that they can be used under harsher conditions and stored with a longer
shelf life.5 Finally, it is possible to generate unstructured aptamers that form specific
secondary structures such as three-way junctions33,78 or tertiary folds such as Gquadruplex structures8,29 upon target binding. Such target-induced conformational
changes can be readily exploited for specific target detection in a variety of applications,
including medical diagnostics, environmental monitoring and drug screening.9–11
However, target-induced conformational change is hard to control, especially for
small-molecule-binding aptamers that have relatively high dissociation constants (~μM
KD).40 For example, the well-characterized cocaine-binding aptamer MNS-4.1 (KD ~ 5
μM) is structurally stable and forms a three-way junction even before binding cocaine.101
To achieve an effective target-induced conformational change, the aptamer can be split
into two21 or three90 fragments. This destabilizes the aptamer such that the fragments are
unable to assemble without target, while the fragments retain their capacity for target
recognition and can successfully reassemble into a complex secondary structure in the
presence of target. Such target-induced assembly of the split aptamers can accordingly be
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employed for signal transduction. However, aptamer splitting results in notably reduced
target affinity.21 Thus, this approach still compromises the sensitivity of split aptamerbased sensors, even with various amplification strategies applied.23,93
To overcome the limitation of split aptamers, we have developed a cooperative
binding-based approach to generate split aptamers that retain high target affinity.
Cooperative binding behavior is commonly observed in ligand-binding proteins that are
highly responsive to ligand concentration, such as hemoglobin,178 ion channels179 and
transcription factors.180 Those proteins generally have more than one ligand-binding site,
where binding at one site increases the affinity of the other sites, resulting in a ‘switchlike’ binding curve.181 Breaker et al. initially found that some tandem riboswitches182,183
naturally employ such cooperative binding182 to control gene expression in response to
subtle changes in ligand concentration. This cooperative behavior was further extended
into artificial biosystems such as ribozymes,184 molecular beacons185 and DNA
aptamers186. Specifically, Plaxco et al. introduced the disorder into the parent aptamer to
achieve cooperative binding, and focused on the demonstration of the “switch-like”
response behavior of cooperative binding that occurred when ligand concentration
approaches K1/2 (K1/2 represents the ligand concentration at which half of the binding
domains are occupied). These engineered cooperative DNA aptamers could not employ
for practical sensor platform because the introduction of cooperativity unavoidably
reduced the target-binding affinity of the resulting cooperative aptamer (K1/2 = ~3
mM).186
We have for the first time successfully incorporated two tandem target-binding
domains into a split aptamer (termed cooperative binding split aptamer, CBSA) to

46

achieve more sensitive detection of cocaine, even in complex biological samples. The
initial cocaine-binding event stabilizes the structure of the split aptamer and facilitates
subsequent target-binding at the second binding domain. Our CBSA exhibits higher
target affinity and far more responsive target-induced aptamer assembly compared to the
single-domain parent split aptamer (PSA) from which it was derived. Using a
fluorophore/quencher pair, we have demonstrated that a CBSA-based fluorescence assay
can achieve sensitive and reproducible cocaine detection in biofluid specimens, with a
LOD of 50 nM in 10% saliva within 15 min. Given the simplicity of splitting and
engineering a CBSA from an isolated aptamer and the excellent performance of the
CBSA-based assay in biofluid samples, it should be straightforward to develop other
CBSA-based assays from existing or future aptamers for rapid, sensitive and specific
detection of various targets in clinical or field settings in a simple, low-cost assay format.
3.2. Experimental section
3.2.1

Materials

2-amino-5,6,7-trimethyl-1,8-naphthyridine (ATMND) was purchased from Ryan
Scientific and dissolved in dimethyl sulfoxide (DMSO) as a stock solution (50 μM).
Cocaine

hydrochloride

was

purchased

from

Sigma-Aldrich.

Benzoylecgonine

tetrahydrate, (-)-nicotine, anhydroecgonine methyl ester and cocaethylene were
purchased from Cerilliant Corporation and prepared as 50 mM stock solutions in
deionized water and stored at 4°C. Saliva samples were collected from eight healthy and
drug-free volunteers (four males and four females) and centrifuged at 20,000 rcf for 15
min, with supernatants stored at 4°C before use. The pooled saliva matrices were
prepared by mixing 1 mL of saliva supernatant from each donor. All DNA molecules
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were ordered from Integrated DNA Technologies and purified with HPLC and the
sequences are listed in Table 3-1. DNA was dissolved in PCR grade water and DNA
concentrations were measured with a NanoDrop 2000 (Thermo Scientific).
Table 3-1. Sequence ID and DNA sequences used in Chapter 3.
Sequence ID
Sequence (5’ – 3’)
L-PSA
CTCCTTCAACGAAGTGGGTTCC
S-PSA
GG/iSpC3/ACAAGGAG
L-LSA
CTCCTTCAACGAAGTGGGTTCCTTGTCTC
L-5325
CTCCTTCAACGAAGTGGGTTCCTTCAACGAAGTGGGTCTC
S-5325
GAGACAAGG/iSpC3/ACAAGGAG3’
S-5325-Cy5
/5IAbRQ/ GAGACAAGG/iSpC3/ACAAGGAGT/3Cy5Sp/
L-CBSA-M1
CTCCTTCAACGAAGTGGGTTCCTTCGACGAAGTGGGTCTC
L-CBSA-M2
CTCCTTCGACGAAGTGGGTTCCTTCAACGAAGTGGGTCTC
L-5335
CTCCTTCAACGAAGTGGGTCTCCTTCAACGAAGTGGGTCTC
S-5335
GAGACAAGG/iSpC3/GACAAGGAG
S-5335-Cy5
/5IAbRQ/ GAGACAAGG/iSpC3/GACAAGGAGT/3Cy5Sp/
L-5335-GT
CTCCTTCAATGAAGTGGGTCTCCTTCAACGAAGTGGGTCTC
L-5435
CTCCTTCAACGAAGTGGGTCTTCCTTCAACGAAGTGGGTCTC
S-5435
GAGACAAGGA/iSpC3/GACAAGGAG
L-5445
CTCCTTCAACGAAGTGGGTTCTTCCTTCAACGAAGTGGGTCTC
S-5445
GAGACAAGGA/iSpC3/GAACAAGGAG
38-GC
GGGAGACAAGGAAAATCCTTCAACGAAGTGGGTCTCCC
38-GC-20A
GGGAGACAAGGAAAATCCTACAACGAAGTGGGTCTCCC
38-GC-20C
GGGAGACAAGGAAAATCCTCCAACGAAGTGGGTCTCCC
38-GC-21T
GGGAGACAAGGAAAATCCTTTAACGAAGTGGGTCTCCC
38-GC-22T
GGGAGACAAGGAAAATCCTTCTACGAAGTGGGTCTCCC
38-GC-22G
GGGAGACAAGGAAAATCCTTCGACGAAGTGGGTCTCCC
/5IAbRQ/ represents Iowa Black RQ
b. /iSpC3/ represents internal C3 spacer
c. S-5325 served as short fragment for CBSA-5325, LSA, CBSA-M1 and CBSA-M2
d. /3Cy5Sp/ represents Cy5
e. Mutations are marked in red

3.2.2

Characterization of split aptamer assembly using ATMND

For each ATMND-binding assay, we mixed 10 μL of 10× binding buffer (100 mM
Tris, 1 mM MgCl2, pH 7.4), 85 μL of deionized water, 1 μL of each split aptamer
fragment (final concentration 1 μM), 1 μL ATMND solution (final concentration 200
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nM) and 2 μL of cocaine at different concentrations into wells of a 96-well plate.
Fluorescence intensity was measured using Tecan M1000Pro with excitation at 358 nm
and emission at 405 nm at a 2-minute time interval until the fluorescence intensity was
stable. Each sample was analyzed in triplicate, and the means and standard deviations
were plotted. Quenching was calculated by (FA-F)/FA×100%, where FA is the
fluorescence of 200 nM ATMND in 1× binding buffer alone and F is the fluorescence of
the ATMND-CBSA mixture with or without cocaine. Error bars show standard
deviations obtained from three measurements.
3.2.3

Isothermal titration calorimetry (ITC) experiments

ITC experiments were performed with a MicroCal ITC200 (GE Healthcare). Cocaine
and split aptamers were prepared with 1×binding buffer. The sample cell was initially
loaded with 20 μM of CBSA-5335 or PSA. 4 mM of cocaine titrant was loaded into the
syringe. Each experiment typically consisted of 39 successive 1 μL injections after a 0.4
μL purge injection with spacing of 210 seconds to a final molar ratio of 43:1
(cocaine:aptamer). Split-aptamer experiments were performed at 20 °C. The raw data
were first corrected based on the heat of dilution of cocaine, and then analyzed with the
MicroCal analysis kit integrated into Origin 7 software. The titration curve of PSA was
fitted with a single-site binding model and the titration curve of CBSA-5335 was fitted
with independent-sites and cooperative-sites models with two binding sites.
3.2.4

Fluorophore/quencher-modified

CBSA-5325,

-5335,

or

-5335-GT

for

detection of cocaine
For each fluorophore/quencher-modified CBSA-based assay, we mixed 10 μL of 10×
binding buffer, 83 μL of deionized water, 1 μL of the CBSA long fragment and 1 μL of
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the fluorophore/quencher-modified CBSA short fragment (final concentration 1 μM
each), and 5 μL of cocaine at different concentrations into wells of a 96-well plate. We
measured the fluorescence intensity with a Tecan M1000Pro with excitation at 648 nm
and emission at 668 nm at room temperature after 15 minutes of incubation. Each sample
was analyzed in triplicate, and the means and standard deviations were plotted. The data
were fitted with the Hill equation using Origin 9 software to calculate Hill coefficient
(nH) and cocaine concentration producing half occupancy (K1/2). The signal gain was
calculated by (F-F0)/F0×100%, where F0 is the fluorescence of the CBSA mixture without
cocaine and F is the fluorescence of CBSA mixtures with different concentrations of
cocaine. Error bars show standard deviation of signal gains from three individual
measurements at each cocaine concentration.
3.2.5

Assessing saliva matrix and dilution effects on the CBSA-5335-based

fluorophore/quencher assay
Cocaine was first spiked into the pooled saliva (FIU IRB: IRB-13-0320) to create
artificial samples with concentrations ranging from 0.25 to 500 μM. Each sample was
prepared by mixing 10 μL of 10× binding buffer, 1 μL of CBSA long fragment and 1 μL
of fluorophore/quencher-modified CBSA short fragment (final concentration 1 μM each)
into wells of a 96-well plate. 10 or 50 μL of sample for each cocaine concentration was
added into the well to analyze the 10% or 50% saliva matrices and deionized water was
added to bring each well’s volume to 100 μL. Fluorescence intensity with excitation at
648 nm and emission from 655-850 nm was scanned with a Tecan M1000Pro at room
temperature after 15 minutes of incubation. Each sample was analyzed in triplicate, and
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the mean and standard deviation of the signal gain at different cocaine concentrations
were plotted.
3.2.6

Determining the sensitivity and dynamic range of CBSA-5335-based

fluorophore/quencher assay in saliva
For cocaine detection in 10% saliva, we combined 5 μL of cocaine in solutions of
concentrations ranging from 0.001 to 10 μM with 10 μL of pooled saliva, 10 μL of 10×
binding buffer, 1 μL of CBSA long fragment, 1 μL of fluorophore/quencher-modified
CBSA short fragment (final concentration 1 μM each), and 73 μL of deionized water into
wells of a 96-well plate. Fluorescence intensity with excitation at 648 nm and emission at
668 nm was measured with Tecan M1000Pro at room temperature after 15 minutes of
incubation. Each sample was analyzed in triplicate, and the mean and standard deviation
of the signal gain at different cocaine concentrations were plotted. A control calibration
curve in buffer was also generated with cocaine concentrations ranging from 0.001 to 10
μM as described above. The signal gain was calculated by (F-F0)/F0×100%, where F0 is
the fluorescence without cocaine and F is the fluorescence with different concentrations
of cocaine. Error bars show standard deviations from three measurements. The
measurable LOD was determined using the lowest non-zero calibrator concentration
according to the Scientific Working Group for Forensic Toxicology Standard Practices
for Method Validation in Forensic Toxicology.187 In all cases, the calibrators (cocaine
standard concentration) were analyzed over three runs, and the lowest concentration
achieving mean signal gain higher than 3.3 times the standard deviation was defined as
the measurable LOD.
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3.2.7

Determining

the

target

specificity

of

CBSA-5335-based

fluorophore/quencher assay in saliva
The CBSA-5335 fluorophore/quencher assay was performed as described above with
cocaine, cocaethylene, benzoylecgonine, anhydroecgonine methyl ester or nicotine at
concentrations of 5 or 50 μM in 10% saliva. Each sample was analyzed in triplicate and
the mean and standard deviation of the signal gain at different cocaine concentrations
were plotted. The cross-reactivity of each analyte at each concentration was calculated as
a percentage based on SigANA/SigCOC × 100%, where SigANA is the signal gain achieved
by a given interferent and SigCOC is the signal gain achieved by cocaine at the same
concentration.
3.2.8

Determining

the

precision

and

bias

of

CBSA-5335-based

fluorophore/quencher assay in saliva
The CBSA-5335 fluorophore/quencher assay was performed as described above in
10% diluted saliva matrices collected from eight different donors, 10% diluted pooled
saliva matrices and binding buffer. We performed six measurements of samples
containing final cocaine concentrations of 0, 1, 5 and 10 μM, and plotted the mean and
standard deviation of the signal gain at different cocaine concentrations. The bias of each
cocaine concentration was calculated as (Meansam - Meanpool)/ Meanpool × 100%, where
Meansam is the mean signal gain obtained in 10% saliva matrices collected from different
donors, and Meanpool is the mean signal gain obtained in the 10% pooled saliva matrix.
The precision within samples or between runs at different cocaine concentrations was
calculated by performing a one-way ANOVA test with the measurement number (6) as
the grouping variable. Within-sample precision at each cocaine level was calculated
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as

, where MSwg is the within-group mean square obtained

from the ANOVA table, and Meansam is the mean of signal gains obtained in 10% saliva
matrices collected from different donors. Between-run precision at each cocaine level
was calculated as

, where MSbg is the between-

group mean square obtained from the ANOVA table, and n is the total number of
measurements (n = 6).
3.3. Results and discussion
3.3.1

Design of the cocaine-binding CBSA
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Figure 3-1. The design of our cocaine-binding CBSA. Two split aptamer pairs were derived from
38-GC. Stem 1 of one split aptamer (A) was merged with stem 2 of the other split aptamer (B) to
form an engineered CBSA (C) comprising a short fragment (SF) and a long fragment (LF).

Cooperative target binding of split aptamers requires the incorporation of at least two
binding domains into a single pair of fragments. We previously reported a cocainebinding aptamer (38-GC)102 that exhibits 2.5-fold higher cocaine affinity than the MNS4.1 aptamer from which it was derived. 38-GC contains a three-way junction with the
target-binding domain located at its center, surrounded by three double-stranded stems
(stems 1, 2 and 3) and two loops (GAA and AAA loops). We have determined that stem
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3 is essential for cocaine binding, while both stem 1 and stem 2 contribute to the stability
of the three-way junction structure that forms upon target binding.102 We derived two
different pairs of split aptamer fragments from 38-GC (Figure 3-1, A and B), in which
stem 3 remained intact but the 3’-end of stems 1 and 2 were truncated and the AAA loop
of stem 2 was eliminated. We subsequently produced a construct from these two sets of
split aptamers, in which stem 1 from one set was linked to stem 2 from the second set
(Figure 3-1C). The resulting CBSA consists of a short fragment (SF) and a long
fragment (LF).
3.3.2

Characterizing cocaine-induced CBSA assembly

We anticipated that the CBSA fragments would remain separated in the absence of
target, but would form two tandem cocaine-binding domains when fully assembled with
cocaine. To confirm effective target-induced CBSA assembly, we developed a binding
assay based on the fluorescent molecule ATMND. It has been reported that ATMND can
strongly bind to a thymine situated opposite a C3 spacer abasic site (AP site) within a
DNA duplex (KD = 111 nM) via three-point hydrogen bonding.188 Although ATMND
fluoresces brightly when free in solution, this fluorescence is greatly quenched when
ATMND is bound to a DNA duplex in this fashion.189 We therefore replaced the
adenosine (at position 10 from 5’) between the two binding domains of the short
fragment with a C3 spacer to form an AP site with a thymine in the opposite position
within the long fragment upon cocaine binding (Figure 3-2A). In the absence of cocaine,
the long and short fragments remain separated, with strong fluorescence produced by the
free ATMND molecules (Figure 3-2B, left). Upon addition of cocaine, the CBSA
fragments undergo cooperative target-induced assembly and form a duplexed AP site that
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binds ATMND and quenches its fluorescence (Figure 3-2B, right). The resulting CBSA5325/cocaine complex contains four base-paired segments (Figure 3-2A, right; segments
labeled A–D) and a dinucleotide bulge formed within each three-way junction.86
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Figure 3-2. ATMND as a fluorescence reporter of target-induced CBSA assembly. (A) We
modified the core CBSA sequence (left) by replacing the adenosine (at position 10 from 5’)
between the two binding domains of the short fragment with a C3 spacer abasic site (marked as
X) to yield the final CBSA construct (middle). Upon binding cocaine, the CBSA undergoes
target-induced assembly, forming a dinucleotide bulge within each three-way junction (right).
The cocaine-CBSA-5325 complex features four complementary double-stranded regions (A–D)
and a duplexed AP site. (B) In the absence of cocaine, LF and SF remain separated and the
unbound ATMND in solution generates a strong fluorescent signal. Cocaine induces CBSA
assembly, forming the duplexed AP site that binds ATMND and thereby quenches its
fluorescence. (C) Time-course of ATMND quenching by cocaine-induced split aptamer
assembly. (D) Sequence of the parent split aptamer (PSA) with incorporated AP site.
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3.3.3

Importance of dual-binding domain of CBSA for target-induced assembly

We subsequently confirmed the cocaine-induced assembly of CBSA experimentally.
When we mixed 1 μM each of the long and short fragments with 200 nM ATMND in 1×
binding buffer (10 mM Tris-HCl, 100 μM MgCl2, pH 7.4 ), we observed 10%
background quenching (Figure 3-2C, before cocaine addition). This quenching is most
likely attributable to low levels of non-specific quench and non-target assembly of the
CBSA. Upon addition of 250 μM cocaine, 72% of the ATMND fluorescence was
quenched within 15 min, indicating rapid target-induced CBSA assembly (Figure 3-2C,
after cocaine addition). We also tested the performance of the AP-incorporating parent
split aptamer (PSA) from which the CBSA was initially derived (Figure 3-2D, PSA),
which features only a single cocaine-binding domain, in our ATMND-binding assay. In
the absence of cocaine, the PSA quenched 6% of ATMND fluorescence (Figure 3-2C,
before cocaine addition), and no measureable signal change was observed upon addition
of 250 μM cocaine (Figure 3-2C, after cocaine addition). This indicates that no cocaineinduced assembly is taking place, presumably because the shortening of stem 1 to four
base-pairs with an abasic site in the middle results in poor thermodynamic stability of the
cocaine-PSA complex at room temperature. We therefore conclude that the quenching
observed most likely arises through nonspecific interactions between PSA and ATMND.
Aptamer binding affinity78,190 and DNA hybridization efficiency191 are both strongly
affected by magnesium concentration. We therefore used our ATMND-binding assay to
optimize cocaine-induced CBSA assembly by varying the Mg2+ concentration from 0 to
1000 μM, and observed that maximum cocaine-induced ATMND quenching occurred in
the presence of 100 μM Mg2+ (Figure 3-3A). In the absence of cocaine, we observed 9%
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quenching without Mg2+, which we attributed to nonspecific CBSA assembly (Figure
3-3A, no cocaine). The presence of cocaine only generated an additional 7% quenching
due to the absence of the Mg2+ counterion, resulting in strong repulsion between the
CBSA fragments (Figure 3-3A, cocaine). At high concentration of Mg2+ (1000 μM),
extensive CBSA assembly occurred in the absence of cocaine, producing 38% ATMND
quenching, while also reducing the binding affinity of CBSA to cocaine, which only
produced an additional 17% quenching upon addition of 250 μM cocaine (Figure 3-3A).
A

B

Figure 3-3. Optimization of Mg2+ and ATMND concentrations for our CBSA-based ATMNDbinding assay. (A) ATMND (200 nM) quenching by target-induced CBSA assembly upon
addition of 250 μM cocaine in the presence of 0-1000 μM Mg2+ in 1× binding buffer. Quenching
was calculated by (FA-F)/FA×100%, where FA is the fluorescence of 200 nM ATMND in 1×
binding buffer alone and F is the fluorescence of the ATMND-CBSA mixture with 250 μM
cocaine (red curve) or without cocaine (black curve), respectively. (B) Quenching analysis with
ATMND concentrations ranging from 50-1000 nM in 1× binding buffer containing 100 μM Mg2+.
Quenching was calculated by (F0-F)/F0×100%, where F0 and F are the fluorescence of the
ATMND-CBSA in the absence and presence of cocaine, respectively.

We also varied the ATMND concentration from 50 to 1000 nM, and found that 200
nM ATMND produced low background and high target-induced signal change (Figure
3-3B). Under these optimized conditions (200 nM ATMND and 100 μM Mg2+), we
examined the extent of target-induced CBSA assembly at different cocaine
concentrations. We found a strong correlation between ATMND quenching from CBSA
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assembly and cocaine concentration in the range of 0 to 250 μM (Figure 3-4). We
characterized the binding affinity of the assembled-CBSA for ATMND by titrating
different concentrations (0-20 μM) of CBSA into 200 nM ATMND in the presence of 1
mM cocaine (Figure 3-5). The calculated KD was 365 nM, which is consistent with the
reported value for ATMND binding to AP sites.188 We subsequently demonstrated that
the presence of two binding sites makes CBSA-5325 far more responsive to the presence
of cocaine than split aptamers containing a single binding domain. We produced a long
split aptamer (LSA) from CBSA, in which we replaced one of the binding domains with
fully complementary sequences (Figure 3-6A, LSA). The LSA fragments quenched 75%
of ATMND fluorescence in the absence of cocaine. Addition of 250 μM cocaine only
induced an additional 10% signal change, indicating that most LSA fragments were
stably pre-assembled even without target (Figure 3-6B). In contrast, CBSA-5325
generated a large signal change (72%) upon addition of 250 μM cocaine because of its
dual target binding domains, with far weaker background signal (9%) without cocaine.

Figure 3-4. ATMND-reported calibration curve for CBSA-5325 at varying cocaine
concentrations. Error bars show standard deviations from three measurements. Quenching was
calculated by (F0-F)/F0×100%, where F0 and F are the fluorescence of the ATMND-CBSA in the
absence and presence of cocaine, respectively.
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Figure 3-5. ATMND binding affinity for cocaine-assembled CBSA-5325. ATMND (200 nM)
fluorescence was quenched with increasing concentrations of CBSA-5325 in the presence of 1
mM cocaine. Inset: Scatchard plot of the fluorescence data. The KD was determined based on the
negative reciprocal of the slope.
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generated multiple derivatives of CBSA-5325, including split aptamers with a single binding
pocket (LSA) and a pair of point-mutants (CBSA-M1 and CBSA-M2) with sequence alterations
that disrupt either of the two binding domains (pink circle). (B) ATMND quenching in the
presence or absence of 250 μM cocaine. Quenching was calculated by (FA-F)/FA×100%, where
FA is the fluorescence of 200 nM ATMND in 1× binding buffer alone and F is the fluorescence of
the ATMND-CBSA mixture with 250 μM cocaine or without cocaine, respectively.
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Specific target binding at both domains is required for target-CBSA assembly. We
tested the binding affinity of 38-GC and several point-mutated derivatives using ITC
(Figure 3-7). We found that replacing an adenosine at position 22 with guanine
completely impaired cocaine binding (Figure 3-7, 38-GC-22G). Based on this finding, we
created two CBSA mutants (CBSA-M1 and CBSA-M2) in which either of the two
binding domains was disrupted by this single-nucleotide mutation, leaving only a single
binding domain capable of binding cocaine (Figure 3-6A). CBSA-M1 and CBSA-M2
were mutated at the 3’- and 5’-binding domain of the long fragment, respectively. We
tested these mutants using the same ATMND-binding assay, and found that neither
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CBSA-M1 nor CBSA-M2 was capable of cocaine-induced aptamer assembly, with no
significant ATMND quenching observed upon addition of cocaine (Figure 3-6B). These
results confirmed that both target-binding domains of the CBSA were required for targetinduced aptamer assembly, and thus provide strong support for a cooperative-bindingbased assembly mechanism.
3.3.4

Confirmation of cooperative target binding of CBSA and fabricating an

ultra-sensitive CBSA-based fluorophore/quencher assay
We hypothesized that the binding affinity of the CBSA might be enhanced by further
stabilizing the target/aptamer complex with additional base-pairs, based on prior findings
that longer complementary stems surrounding the three-way junction increased the
aptamer’s target-binding affinity.87 Thus, we increased the total number of base-pairs
between the two binding domains of CBSA-5325 by adding an additional one, two or
three base-pairs to generate CBSA-5335, -5435 and -5445 (Figure 3-8A) and examined
the extent of target-induced CBSA assembly at different cocaine concentrations (0 - 50
µM). Our results demonstrated that the number of additional base-pairs greatly affects
both binding affinity and target-induced assembly. In the absence of cocaine, the
quenching of ATMND fluorescence increased as the number of base-pairs between the
two CBSA binding domains increased from 5- to 8-bp (Figure 3-8B). This is probably
due to the increased thermo-stability of CBSA assembly, even without target. Upon
addition of cocaine, we found a strong correlation between ATMND quenching from
CBSA assembly and cocaine concentration in the range of 0 to 50 μM (Figure 3-8C).
Compared to CBSA-5325, quenching saturation occurred at lower target concentrations
for the other CBSAs, in keeping with the assumption that the CBSA binding affinity can
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be enhanced with additional base-pairs. However, considerable background assembly
was observed for CBSA-5435 and CBSA-5445 in the absence of cocaine, reducing their
target-induced signal gain. We thus found that CBSA-5335 is most responsive and
exhibited the most extensive target-induced CBSA assembly, and we therefore used this
construct for subsequent sensor development.
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Figure 3-9. Effect of target-binding affinity (K1/2) on CBSA cooperativity. (A) The working
principle of the CBSA-based fluorophore/quencher assay. (B) Calibration curves for the assay at
cocaine concentrations ranging from 0 to 2500 μM (left). Right panel shows a linear response at
0-10 μM. Reactions were performed with 1μM CBSA long fragment, 1 μM
fluorophore/quencher-modified CBSA short fragment, and different concentrations of cocaine in
10 mM Tris-HCl, 0.1 mM MgCl2 (pH 7.4) at room temperature.

Figure 3-10. Spectra of CBSA-5335-based fluorescent detection of cocaine in 1× binding buffer.
In the absence of cocaine, we observed negligible emission from 655 to 850 nm when excited at
648 nm. The fluorescence peak at 668 nm increased with increasing cocaine concentration.
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We then produced fluorophore/quencher-modified derivatives of CBSA-5325 and
CBSA-5335 to achieve sensitive detection of cocaine. The short fragment was modified
with an IowaBlack RQ quencher at its 5’ terminus and a Cy5 fluorophore at its 3’
terminus. In the absence of cocaine, the two CBSA fragments remain separate, and the
flexibility of the unbound short fragment routinely brings the fluorophore into close
proximity with the quencher, resulting in very low fluorescence (Figure 3-9A, left). In the
presence of cocaine, the two fragments assemble to form a rigid target/aptamer structure
that separates the fluorophore/quencher pair, producing increased fluorescence (Figure
3-9A, right). We used these two fluorophore/quencher-modified CBSAs to generate
calibration curves for cocaine concentrations ranging from 0-1000 μM (Figure 3-9B;
spectra of CBSA-5335 shown in Figure 3-10) and used the Hill equation (Equation 3-1)
to fit the binding curve to calculate K1/2 and Hill coefficient (nH):186,192
(Equation 3-1)

We determined a K1/2 of 106 μM with an nH of 1.1 for CBSA-5325 and a K1/2 of 36
μM with an nH of 1.5 for CBSA-5335 (where K1/2 represents the cocaine concentration at
which half of the binding domains are occupied and nH describes the order of binding
cooperativity).192 An nH of 1.5 clearly indicates higher cooperativity between the two
binding domains of CBSA-5335. We found that the measurable LOD was 500 nM (4.5 ±
0.8%) and 50 nM (4.3 ± 0.9%) for CBSA-5325 and CBSA-5335, respectively (Figure
3-9B). Clearly, the target-binding affinity of CBSA can be affected by the cooperativity
of the two binding domains. Note that CBSA-5335 has the highest cocaine affinity of any
split aptamer described to date, and the LOD of CBSA-5335 is more than 200-fold lower
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than that of a previously-described single-domain, split aptamer-based cocaine assay
using a similar sensing platform (LOD = 10 μM).21
A

CBSA-5335

B

PSA

Figure 3-11. Characterization of cocaine binding affinity of CBSA-5335 and PSA using ITC.
Top panels present raw data showing the heat generated from each titration of cocaine for (A)
CBSA-5335 (black broken line represented independent-sites model and red solid line
represented cooperative-sites model) and (B) PSA. Bottom panels show the integrated heat of
each titration after correcting for dilution heat of the titrant.

We subsequently used ITC to characterize the binding mechanism and affinity of
CBSA-5335 for its target at both sites. Recognizing that the KD of the aptamers was in
the μM range, we set up a titration with a high cocaine:aptamer ratio to obtain accurate
KD values for each binding scenario (the adjacent binding pocket empty, or occupied by
cocaine), where KD represents the ligand concentration at which half of the receptor sites
are occupied at equilibrium.193 The resulting two-phase titration curve confirmed the
interaction of cocaine with the two binding domains of CBSA-5335 (Figure 3-11A). The
binding stoichiometry between cocaine and CBSA was manually set as two, because
previous studies have demonstrated that one cocaine-binding aptamer binds a single
molecule of cocaine.102 ITC data of CBSA-5335 were then fitted with both independent-

65

sites and cooperative-sites models194 with two binding sites (Figure 3-11A, black broken
line represented independent-sites model and red solid line represented cooperative-sites
model). We observed better fitting using the cooperative-sites model, and determined that
the KD for the initial and secondary cocaine-binding events were 116 and 36 μM,
respectively (Figure 3-11A). Based on these KDs, we calculated a K1/2 of 65 μM and a nH
of 1.3 for CBSA-5335,195 which is comparable with the results obtained via the CBSA5335-based fluorophore/quencher assay (K1/2 = 36 μM and nH =1.5). Notably, the low
K1/2 of CBSA-5335 represents a 56-fold higher target binding affinity relative to its
single-domain PSA (KD = 2 mM, Figure 3-11B).
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Figure 3-12. Effect of the intrinsic affinity of the PSA on CBSA target-binding affinity (K1/2).
(A) We generated CBSA-5335-GT by replacing a G-C base-pair (highlighted) in the 5’ binding
domain of CBSA-5335 with a G-T wobble pair. (B) Calibration curves for the assay at cocaine
concentrations ranging from 0 to 1000 μM after a 15-minunte incubation (left), with a linear
response at 0-10 μM (right). Experiments were performed with 1μM CBSA long fragment, 1 μM
fluorophore/quencher-modified CBSA short fragment, and different concentrations of cocaine in
10 mM Tris-HCl, 0.1 mM MgCl2 (pH 7.4) at room temperature.
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We believed that the target-binding affinity of CBSA could be affected by the intrinsic
binding affinity of its parent split aptamer. To address this point, we replaced a G-C pair
in the 5’ binding domain of CBSA-5335 with a wobble G-T pair to form CBSA-5335GT. This alteration in stem 3 of the cocaine-binding aptamer reduces its binding affinity
to cocaine102 (Figure 3-12A), but we expected the resulting CBSA to still retain its
cooperativity. Indeed, our fluorescence results demonstrated that both CBSAs have
identical cooperativity (nH = 1.5) (Figure 3-12B). However, since the intrinsic affinity of
38-GC is 4-fold higher than the parent split aptamer variant used for CBSA-5335-GT,
CBSA-5335 yields a lower K1/2 (33 µM) and better sensitivity (LOD = 50 nM in buffer)
than CBSA-5335-GT (K1/2 = 125 µM and LOD = 500 nM in buffer) (Figure 3-12B).
3.3.5

Validation of the CBSA-5335-based fluorophore/quencher assay for cocaine

detection in saliva samples
We subsequently confirmed that our CBSA-5335-based fluorophore/quencher assay is
capable of equally sensitive cocaine detection in saliva samples. The excitation
wavelength for Cy5 (648 nm) does not induce auto-fluorescence in the saliva matrix, and
thus produces minimal background fluorescence (Figure 3-13). Additionally, the high
quenching efficiency of the IowaBlack RQ quencher196 allowed robust detection of
cocaine at very low concentrations. To ensure that our CBSA-5335-based
fluorophore/quencher assay can be reliably used in real-world (i.e., clinical or field)
settings, we evaluated the assay’s performance according to Scientific Working Group
for Forensic Toxicology Standard Practices.187 To this end, we performed detailed
experiments to investigate matrix effects, reaction time, limit of detection, interference
effects and bias and precision in saliva samples.
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Figure 3-13. Fluorescent detection of cocaine in saliva with our fluorophore/quencher modified
CBSA-5335. 10% saliva (blue) exhibited no emission from 655 to 850 nm when excited at 648
nm. CBSA-5335 alone (black) yielded only slight fluorescence background when excited at 648
nm, but we observed a significant increase in fluorescence at 668 nm with the addition of 50 μM
cocaine (red).
A

B

Figure 3-14. Successful detection of cocaine in saliva samples with fluorophore/quenchermodified CBSA-5335. (A) Dilution effects on cocaine detection in saliva. Saliva samples spiked
with cocaine were tested with CBSA-5335 at 50% or 10% dilutions. Calibration curves were
constructed based on signal gain at each concentration of cocaine in the pre-dilution sampler. (B)
Time course of CBSA-5335 in the presence of 1, 5 and 10 μM cocaine in 10% pooled samples.

To test the matrix effects on assay performance, we mixed eight different saliva
samples collected from healthy and drug-free donors of diverse gender and ethnic
backgrounds as a pooled matrix. The pooled matrix was then spiked with different
concentrations of cocaine (0 to 500 µM) and diluted with binding buffer 1:1 (50%) or 1:9
(10%) before being applied to the CBSA-5335-based fluorophore/quencher assay. Our
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results showed that the 10% dilution resulted in a higher signal gain with a broader
dynamic range (0-100 µM in the initial saliva sample) compared to the 50% dilution (025 µM in the initial sample) (Figure 3-14A). Additionally, the 10% dilution compensates
for variations (such as salt concentration and pH) in individual saliva samples, and we
therefore used 10% dilutions for subsequent experiments.
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Figure 3-15. High sensitivity and specificity of our CBSA-5335-based fluorophore/quencher
assay for cocaine detection in saliva. (A) Calibration curve for the assay in buffer and 10% saliva.
(B) Signal gains from the CBSA assay in the presence of 50 μM (left) and 5 μM (right) cocaine
(COC) or potential interferents including cocaethylene (EC), benzoylecgonine (BZE),
anhydroecgonine methyl ester (MEG) and nicotine (NIC) in 10% saliva. Inset shows the
interferent structures. Error bars show standard deviation of signal gain from three measurements
at each concentration.

Figure 3-16.Calibration curve of our CBSA-5335-based fluorophore/quencher assay in 1×
binding buffer and 10% saliva at cocaine concentrations ranging from 0 to 10 μM. The signal
gain was calculated by (F-F0)/F0×100%, where F0 is the fluorescence without cocaine and F is the
fluorescence with different concentrations of cocaine. Error bars show standard deviation of
signal gain from three measurements at each concentration.
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We also monitored the time course of our CBSA-5335-based fluorophore/quencher
assay in 10% pooled saliva matrix. We found that the fluorescence signal greatly
increased with the increase of reaction time upon the addition of 1, 5 or 10 μM cocaine
and 85% of the maximum signal was obtained after 15 minutes (Figure 3-14B). Clearly,
the fast reaction time of our assay is suitable for on-site detection due to the rapid
assembly of cocaine-CBSA complex in saliva samples.
CBSA-5335-based

fluorophore/quencher

assay

also

demonstrates

excellent

performance on target detection in complex samples. Studies have shown that cocaine
concentrations are generally higher in saliva than serum within the first few hours of
administration,197,198 and the European Union’s Driving Under the Influence of Drugs,
Alcohol and Medicines (DRUID) program identified 510 nM as the recommended cut-off
sensitivity for road-side screening of cocaine in undiluted saliva.197 To determine the
sensitivity of our assay, we generated a calibration curve in 10% saliva samples,
obtaining a linear range from 0 to 10 µM and a measurable LOD of 50 nM (signal gain
3.3±0.8%, Figure 3-15A and Figure 3-16). This suggests that, accounting for the ten-fold
sample dilution, our assay can meet the recommendations established by DRUID for onsite detection of cocaine, with a detectable LOD equivalent to 500 nM in undiluted saliva.
In contrast, split aptamers containing a single binding domain have previously achieved
LODs of 30 nM in 0.5% saliva,199 5 μM200 and 3.8 μM201 in 25% saliva. Two factors
contribute to the high sensitivity of our CBSA assay. First, the low thermo-stability of the
split aptamer greatly suppresses non-specific assembly of the CBSA fragments. Second,
the cooperative binding from the two target-binding domains significantly increases the
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CBSA’s affinity, resulting in a 56-fold reduction in KD (36 μM) relative to its singledomain PSA (2 mM).
We then investigated the specificity of the CBSA-5335-based fluorophore/quencher
assay for cocaine versus structurally-similar and -dissimilar interferents in saliva.
Benzoylecgonine (BZE), anhydroecgonine methyl ester (MEG), and cocaethylene (EC)
are major structurally-similar metabolites of cocaine that are secreted into oral fluids.202
We tested our CBSA-5335-based assay with high concentrations of these metabolites as
well as nicotine (NIC), since tobacco is widely used among cocaine users. We found that
our CBSA assay showed excellent cocaine specificity: our results demonstrated no
measurable signal from 50 μM of BZE, MEG, or NIC and only 19% and 3% crossreactivity to 50 μM and 5 μM EC, respectively, in 10% saliva (Figure 3-15B). The results
are consistent with previously reported assays21,93 based on single-domain cocainebinding split aptamers, demonstrating that CBSA retains excellent specificity for its
target molecule in saliva. Finally, we tested the bias and precision of our CBSA assay by
spiking cocaine at low, medium, and high concentrations into 10% saliva samples (final
concentration of 1, 5 or 10 μM) from eight different individuals (Figure 3-17A). Using
the pooled saliva as a standard, the average bias of signal gain obtained in these
individual samples was 12.7%, -0.4% and -5.8% for 1, 5 and 10 μM cocaine,
respectively. At 1, 5 and 10 μM, the coefficients of variation (CV) within samples were
7.1%, 5.2% and 9.0%, respectively, and the CV between runs were 7.3%, 5.1% and
8.5%, respectively (Figure 3-17B). Thus, the bias and CV were consistently below the
acceptable cut-off (20%) for drug-screening methods,187 further demonstrating the
immediate feasibility of our CBSA-based assay for on-site drug screening.
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Figure 3-17. Bias and precision of the CBSA-5335-based fluorophore/quencher assay. (A) Signal
gain obtained from various cocaine concentrations in buffer, 10% saliva collected from different
donors (Sample I-VIII) and 10% pooled saliva. Signal gain was calculated by (F-F0)/F0×100%,
where F0 is the fluorescence of the CBSA without cocaine and F is the fluorescence of the CBSA
with cocaine. Error bars show standard deviations from six measurements. (B) Bias at each
cocaine concentration was calculated from the mean signal gain obtained with samples I-VIII and
the pooled sample. Within-sample and between-run precision at each cocaine concentration was
calculated by one-way ANOVA.

3.4. Conclusions
We have demonstrated greatly improved split-aptamer-based sensing of cocaine in
both buffer and saliva with a CBSA that incorporates two tandem target-binding domains
into a single split aptamer. The CBSA fragments remain separate in the absence of target
but specifically assemble upon addition of cocaine, and show high sensitivity to target
concentration as a result of increased binding affinity caused by cooperative binding
behavior. We achieved rapid, one-step detection of cocaine by simply mixing our CBSA
components, which consist of a fluorophore/quencher-modified short fragment and an
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unmodified long fragment, with a cocaine-containing sample at room temperature. A
measurable LOD of 50 nM in buffer was achieved within 15 minutes without any signal
amplification. The sensor’s performance was also very robust in saliva, achieving a LOD
of 50 nM cocaine in 10% diluted saliva. Our assay also demonstrates very high target
specificity, as evidenced by acceptably low cross-reactivity to common interferents,
strong reproducibility, as well as a cost of $1.28 per test, confirming the potential value
of our CBSA-based assay for on-site detection of cocaine.
Our CBSA-based assay can be generalized in terms of both targets and sensor
platforms. Stojanovic et al. recently isolated new aptamers for four different steroids via
heterogeneous SELEX using partially randomized DNA libraries with a pre-designed,
three-way-junction binding domain.33 We believe that such a selection strategy could
similarly be applied for the isolation of aptamers for other drugs of abuse as well as
clinically relevant targets such as small-molecule biomarkers, toxins and therapeutics.
Based on Heemstra’s general approach to split three-way-junction structured aptamers92
and the simplicity of engineering a CBSA from a split aptamer, it should be
straightforward to develop other CBSA-based assays from the isolated aptamers for
which the target-binding domain has been identified. Since many optical and
electrochemical sensing strategies have been developed that employ target-induced split
aptamer assembly,94,160,203–205 it should be feasible to integrate our CBSA into these
platforms. We also foresee the potential to improve the performance of our CBSA-based
assay by employing signal amplification techniques160,204–207 that could further enhance
its sensitivity.
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CHAPTER 4: Rapid and Sensitive Detection of Small-Molecule Targets Using
Cooperative Binding Split Aptamers and Enzyme-Assisted Target Recycling
4.1. Introduction
The biosensor field is on a continuous quest for ever-greater sensitivity. In
conventional bioassays, where the signal is directly proportional to the target
concentration, the sensitivity is determined by the intrinsic target affinity of the
bioreceptor being used for detection.156 In this scenario, it would be difficult to generate a
measurable signal at target concentrations more than 100-fold lower than the KD of the
bioreceptor. Accordingly, many amplification approaches have been developed in which
one binding event can generate multiple signals,157,158 allowing detection of targets at
very low concentrations. Enzyme-assisted target recycling (EATR) has proven to be an
especially effective way to amplify signals generated from target-binding events.159 This
approach relies on selective, nuclease-mediated degradation of the probe strand of a
target-probe duplex that only forms in the presence of target; this liberates the target,
which is ‘recycled’ for use in additional digestion reactions. For example, EATR has
been used with molecular beacon probes for DNA detection.158 The molecular beacon
probe contains a loop sequence complementary to the target DNA, with a fluorophorequencher pair attached to the stem of the beacon as a signal-reporting element. When the
molecular beacon probe binds the target DNA, it switches from a stem-loop structure into
a probe-target duplex that contains a structural164 or sequence158 recognition site for a
nuclease. This enzyme then catalyzes the digestion or cleavage of the beacon probe,
liberating the fluorophore and releasing the target, which can then hybridize with another
molecular beacon probe. Thus, a substantial fluorescent signal can be generated by a

74

single copy of the target though EATR, greatly decreasing the limit of detection.158,164
Given that DNA can be easily modified with various signaling reporters154,158,161,162 and
that different nucleases can be utilized to process the target-probe duplex,158,161,163,164
many EATR-based assays have been developed for DNA detection with ultra-high
sensitivity.159
Aptamers are nucleic acid-based bio-recognition elements that are isolated in vitro
through SELEX processes.1 Aptamers can bind to a wide variety of targets, including
proteins, metal ions, small molecules, and even whole cells,3 and aptamer-based
biosensors have been developed for environmental monitoring, drug detection, and
medical diagnostics.9–11 Aptamer-based sensors have many advantages compared to other
state-of-the-art methods for the detection of small-molecule targets. Instrumental
methods, such as gas or liquid chromatography/mass spectrometry, are sensitive and
specific. However, these methods require laborious sample preparation and instruments
that are cumbersome and sophisticated, limiting their use for on-site and high-throughput
detection.12 Antibody-based immunoassays, such as ELISA, are highly sensitive and
offer high target specificity. However, the in vivo processes for antibody generation are
tedious, costly, and challenging for non-immunogenic small molecules.16 On the other
hand, aptamers can be isolated rapidly with controllable affinity and specificity, and are
produced without batch-to-batch variation.16 Many strategies have been employed into
aptamer-based assays to achieve target detection in an instrument-free manner.208 In
particular, aptamers can be split into two or three fragments that remain separate in the
absence of target but assemble upon target binding,21,90 and such split-aptamer based
sensors have gained popularity as a potential strategy for effective signal reporting.91 In
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principle, the target-induced assembly of split aptamers should be compatible with
EATR-mediated signal amplification. Ideally, the split fragments should be highly
responsive to target-induced assembly and only the target-aptamer complex should be
specifically recognized and digested by the enzyme. However, it is difficult to achieve
sensitive target-induced aptamer assembly with conventional split aptamers with a single
binding-domain. Small-molecule-binding split aptamers usually have equilibrium
dissociation constants (KD) in the high micromolar range, such that no measurable targetinduced aptamer assembly can be observed even with a high concentration of targets.92,95
Although target affinity can be improved by engineering split aptamers with longer
complementary stems, the majority of thermo-stable split aptamers undergo some degree
of pre-assembly in the absence of target,95 producing high background signal. Second, in
contrast to DNA-based EATR assays, in which target-binding always converts a stemloop probe structure into a probe-target duplex, aptamer-target binding often gives rise to
complex tertiary structures that are non-ideal substrates for nucleases. For example,
three-way junctions and G-quadruplexes have been shown to inhibit exonuclease I,209
flap endonuclease I,210 and polymerases.211 Additionally, target binding within the
aptamer can interfere with enzyme binding and activity; for example, some smallmolecule DNA-intercalating agents and DNA adducts can inhibit nucleases, especially
exonucleases.210,212,213
To overcome these limitations, we have developed a strategy for generating CBSAs
for use in EATR-amplified biosensors. CBSAs are engineered from parent split aptamers
with a single target-binding domain, and consist of a short fragment and a long fragment
that contain two target-binding domains. The first binding event partially stabilizes the
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CBSA structure such that the second binding event can occur. This cooperative assembly
can reduce the concentration change required to assemble the CBSA several-fold,
resulting in far greater specificity and sensitivity relative to the parent split aptamer.95,186
For example, our group has previously demonstrated the successful engineering of a
highly target-responsive CBSA for cocaine, which enables specific, ultra-sensitive, onestep fluorescence detection of cocaine within 15 minutes in 10% saliva.95 Here, we have
developed a CBSA-based EATR-amplified fluorescence assay for the detection of
dehydroisoandrosterone-3-sulfate (DIS) in urine samples. We modified our short
fragment to incorporate a C3 spacer abasic site;214 when the CBSA assembles, the
resulting duplex at the abasic site is recognized and cleaved by exonuclease III (Exo III).
This results in recycling of the long fragment and DIS molecules for further rounds of
digestion, while releasing a fluorescent signal for each digestion event. We demonstrated
that this assay exhibits 100-fold enhanced sensitivity relative to the CBSA alone without
EATR signal amplification. Importantly, this assay also proved highly sensitive when
used in urine samples, allowing us to detect DIS in 50% urine within 30 minutes at
concentrations as low as 1 μM. To demonstrate the generality of our approach for the
detection of other small-molecule targets, we also developed an assay that utilizes EATRmediated aggregation of CBSA fragment-modified gold nanoparticles (AuNPs) for
colorimetric detection of cocaine. This assay was able to successfully achieve naked-eye
detection of low micromolar concentrations of cocaine within 20 minutes. We believe
that our approach should offer a general strategy for the development of other CBSAbased, EATR-amplified assays for the rapid, sensitive, and specific detection of various
small-molecule targets in complex samples in both clinical and field settings.
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4.2. Experimental section
4.2.1

Materials

Table 4-1. The sequences of the oligonucleotide strands employed in Chapter 4.
Sequence ID
COC-LF
COC-SF
COC-SF-5’A
COC-SF-3’A
COC-SF-T
SH-COC-SF-1X
SH-COC-SF-2X
DIS-LF
DIS-SF
FQ-DIS-SF
DIS-LF-536
FQ-DIS-SF-536
DIS-LF-36
FQ-DIS-SF-36

Sequence (5’ – 3’)
CTCCTTCAACGAAGTGGGTCTCCTTCAACGAAGTGGGTCT
CAAAAA
GAGACAAGG/iSpC3/GACAAGGAG
AAAAAGAGACAAGG/iSpC3/GACAAGGAG
GAGACAAGG/iSpC3/GACAAGGAGAAAAA
AAAAAGAGACAAGGTGACAAGGAG
HS-(CH2)6-TTTTTTGAGACAAGG/iSpC3/GACAAGGAG
HS-(CH2)6-/TTTTTTGAGACAAGG/iSpC3/GACAAGGAGTTTTT
TGAGACAAGG/iSpC3/GACAAGGAG
GTCCGCATACGAAGTTGTCTTCCGCATACGAAGTTGTCCAAAAA
GGACGTGGA/iSpC3/GACGTGGACAAAAA
/5IAbRQ/GGACGTGGA/iSpC3/GACG TGGAC/iCy5/AAAAA
GTCCGCATACGAAGTTGTCTTCCGCAAAAA
/5IAbRQ/GTGGA/iSpC3/GACGTGGAC/iCy5/AAAAA
GTCCGCATACGAAGTTGTCAAAAA
/5IAbRQ/GACGTGGAC/iCy5/AAAAA

a. /iSpC3/ represents internal C3 spacer modification
b. /5IAbRQ/ represents Iowa Black RQ quencher modification
c. /iCy5/ represents Cy5 fluorophore modification

All DNA strands used in this work were synthesized by Integrated DNA Technologies
and purified with HPLC. DNA was dissolved in PCR grade water and DNA
concentrations were measured with a NanoDrop 2000 (Thermo Scientific). The
sequences

of

the

oligonucleotide

Tris(hydroxymethyl)aminomethane

(Tris),

strands

are

hydrochloric

listed
acid,

in

Table

sodium

4-1.

chloride,

magnesium chloride, bovine serine albumin (BSA), 1,4-dithiothreitol (DTT), gold (III)
chloride trihydrate, cocaine hydrochloride, and DIS were purchased from Sigma-Aldrich.
Exo III was purchased from New England Biolabs. OliGreen and SYBR gold were
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purchased from Thermo Fisher Scientific. Urine samples used in this work were collected
from healthy and consenting adult donors.
4.2.2

Isothermal titration calorimetry (ITC)

ITC experiment was performed with a MicroCal ITC200 (Malvern). 0.2 mM DIS was
titrated into 10 µM DISS.1-AT, with both diluted in DIS binding buffer (10 mM TrisHCl, 0.5 mM MgCl2, pH 7.4). The experiment consisted of 19 successive 2 μL injections
after a 0.4 μL purge injection with spacing of 180 seconds at 23 °C. The injection heat
was analyzed with the MicroCal analysis kit integrated into Origin 7 software, and the
titration curve was fitted with a single-site binding model.
4.2.3

Determining binding affinity of DIS-CBSA-4536, DIS-SA-536 and DIS-SA-36

The binding affinities of the split aptamers were determined fluorescently as reported
previously95 with some modifications. 1 μL of 100 μM DIS long fragment (DIS-LF, DISLF-536 or DIS-LF-36), 1 μL of 100 μM respective fluorophore/quencher-modified DIS
short fragment (FQ-DIS-SF, FQ-DIS-SF-536 or FQ-DIS-SF-36), and 93 μL of DIS
binding buffer were mixed with 5 μL of solution containing various concentrations of
DIS. 80 μL of each sample was then transferred into wells of a 96-well plate. After a 30minute incubation at room temperature, the fluorescence was measured using a TECAN
M1000 Pro (λex/em = 648/668 nm). Each sample was analyzed in triplicate, and the
means and standard deviations were plotted. The data were fitted with the Hill equation
using OriginLab 9 to calculate Hill coefficient (nH) and K1/2 (DIS concentration
producing half occupancy) of each split aptamer.
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4.2.4

Exo III digestion and gel electrophoresis analysis

All digestion experiments were performed as followed unless specified otherwise. 1
µL each of 50 µM short and long CBSA fragments were added into 43 µL of reaction
buffer to yield a final DIS and cocaine concentrations of 250 µM and 500 µM,
respectively. The buffer composition varied for each aptamer/target composition, with
final concentrations for each reaction as follows: DIS (10 mM Tris, 0.5 mM MgCl2, 0.1
mg/mL BSA, pH 7.4) and cocaine (10 mM Tris, 0.1 mM MgCl2, 0.1 mg/mL BSA, pH
7.4). After incubation at 23 °C for 30 minutes, 5 µL of 0.01 U/μL Exo III was added.
After 5, 10, 15, 30 and 60 minutes of digestion, 5 µL of each sample was collected and
immediately mixed with 10 µL of loading buffer (71.25% formamide, 10% glycerol,
0.125% SDS, 25 mM EDTA, and 0.15% (w/v) xylene cyanol) to inactivate Exo III.
Control samples were prepared similarly, but with 5 µL reaction buffer instead of Exo III.
The digestion products were characterized via denaturing polyacrylamide gel
electrophoresis (PAGE), with 3 µL of each sample loaded into each well. Separation was
carried out at 20 V/cm for 3 hours in 0.5× TBE running buffer. The gel was stained with
1× SYBR Gold for 25 minutes and imaged using a ChemiDoc MP imaging system (BioRad). The percent of digestion was calculated based on band intensity relative to the
control sample.
4.2.5

CBSA-based, EATR-amplified fluorescence assay for detection of DIS

2 μL of 100 μM DIS-LF or DIS-LF-536, 1 μL of 100 μM FQ-DIS-SF or FQ-DIS-SF536, and 92 μL of DIS binding buffer (10 mM Tris-HCl, 0.5 mM MgCl2, pH 7.4) or 50%
urine diluted with the binding buffer were mixed with 5 μL of solution containing various
concentrations of DIS in the wells of a 96-well plate. The fluorescence of each sample
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was first measured (λex/em = 648/668 nm) after a 30-minute incubation at room
temperature. Then, 5 μL of 0.2 U/μL Exo III was added into each well to initiate EATR.
After a 30-minute digestion at room temperature, the fluorescence of each sample was
measured again. The signal gain was calculated by (F-F0)/F0 ×100%, where F0 is the
fluorescence of the split aptamer mixtures without DIS and F is the fluorescence of split
aptamer mixtures with different concentrations of DIS. Error bars were calculated from
standard deviation of signal gains from three individual measurements at each DIS
concentration.
4.2.6

Synthesis of gold nanoparticles (AuNPs) modified with cocaine-binding

CBSA short fragment
The modification of the thiolated short fragment onto 13-nm AuNPs was performed
using a previously published protocol,143 at a 300:1 molar ratio of thiolated short
fragment:AuNP. The modified AuNPs were then treated with DTT to regulate surface
coverage. Specifically, 50 μL of 5 nM modified AuNPs were mixed with 20 μL of
solution containing different concentrations of DTT in 10 mM Tris-HCl (pH 7.4). After a
30-minute incubation, the solution was centrifuged at 28,000× rcf for 10 minutes. The
supernatant was discarded to remove the excess DTT and displaced DNA strands, and the
precipitated AuNPs were resuspended in 10 mM Tris-HCl (pH 7.4). This step was
repeated twice. Finally, the modified AuNPs were resuspended in 5 μL of the same buffer
to obtain a particle concentration of 50 nM.
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4.2.7

Quantitation of the surface coverage of CBSA short fragments on AuNPs via

DTT displacement
We measured surface coverage of the modified AuNPs using a standard DTT
displacement assay.141 The AuNPs were diluted to a final volume of 55 µL in Tris buffer
(10 mM Tris-HCl, pH 7.4). 50 µL of AuNP solution was loaded into a well of a 384-well
plate and the absorbance was measured using a TECAN M1000 Pro. The concentration
of AuNPs was calculated using Beer’s law (ε=2.7× 108 mol-1·cm-1). 50 µL of the
modified AuNP solution was collected and mixed with 50 µL of 1.0 M DTT solution.
After an overnight incubation at room temperature, the solution was centrifuged at
25,000× rcf for 10 minutes to remove the AuNP precipitate. 20 µL of the supernatant was
then mixed with 80 µL of 0.625× OliGreen solution to obtain a 0.5× Oligreen
concentration. 100 µL of supernatant-Oligreen mixture was loaded into a well of a 384well microplate and fluorescence was measured using a TECAN M1000 Pro (λex/em =
500/525 nm). DTT-displaced oligonucleotides were quantified using an established
calibration curve derived from CBSA short fragments that had been subjected to the same
DTT treatment.
4.2.8

CBSA-based, colorimetric EATR assay for detection of cocaine

2.5 μL of short-fragment-modified AuNPs (50 nM), 1 μL of 2.5 μM long fragment
(COC-LF), 2 μL of a solution with different cocaine concentrations or different cutting
agents with final concentration of 50 μM, and 15.5 μL reaction buffer (final
concentrations: 10 mM Tris-HCl, 100 mM NaCl, 0.75 mM MgCl2, 0.1 mg/mL BSA, pH
7.4) were mixed in wells of a 384-well plate. After 30 minutes, 4 μL of 1.25 U/μL Exo III
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was added into each well. Absorbance spectra from 400–800 nm were recorded every 5
minutes, with pictures taken by Nikon D800 after 20 minutes of Exo III digestion.
4.3. Results and discussion
4.3.1

Engineering of DIS-binding CBSA

Stojanovic and colleagues recently isolated aptamers for various steroids, including
DIS, using a library-immobilized SELEX approach.33 DIS is one of the most abundant
steroid hormones in urine. The concentration of DIS in healthy adults typically ranges
from 1–20 µM,170,171 but can climb to the sub-millimolar range in patients with adrenal
tumors.172 The isolated DIS-binding aptamer (DISS.1-AT) demonstrated a KD of 0.44 μM
(Figure 4-1), and we used DISS.1-AT as a starting point for our CBSA engineering
strategy that we have described previously.95 First, we generated parent split aptamers by
removing the poly(T)3 loop region from DISS.1-AT and reducing the number of base
pairs in stem 1 (Figure 4-2A). We then fabricated a DIS-binding CBSA by fusing two
sets of these parent split aptamers as shown in Figure 4-2B. The engineered CBSA
consists of a short fragment and a long fragment. To facilitate EATR, we replaced the
adenosine at position 9 from the 5’ end of the short fragment with a C3 spacer abasic site
(labeled as X in Figure 4-2C). In the presence of DIS, these two fragments assemble to
form DIS-CBSA-4536 complex (Figure 4-2D), where the C3 spacer abasic site is
opposite a thymine within the long fragment. Exo III can cleave the short fragment at this
duplexed abasic site using its apurinic endonuclease activity,214 releasing the intact long
fragment and DIS molecules.
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Figure 4-1. Characterization of DIS binding affinity of DISS.1-AT using ITC. Top panel presents
raw data showing the heat generated from each titration of DIS for DISS.1-AT. Bottom panel
shows the integrated heat of each titration after correcting for dilution heat of the titrant.
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Figure 4-2. Design of DIS-binding CBSA. (A) The single-stranded DIS binding aptamer
(DISS.1-AT) was truncated at Stem 1 and Stem 2 to generate the parent split aptamers. (B) Two
sets of parent split aptamers were (C) merged and modified to incorporate (D) a C3 spacer abasic
site (denoted by X) that resides opposite a thymine nucleotide when the CBSA duplex is
assembled. A fluorophore (Cy5) and a quencher (Iowa Black RQ) were respectively modified at
the 3’ and 5’ terminus of the short CBSA fragment. A poly(A)5 overhang was added on the 3’
termini of each CBSA fragment to prevent non-specific Exo III digestion.
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4.3.2

Design of a CBSA-based EATR-amplified fluorescence assay

To confirm binding cooperativity of DIS-CBSA-4536, we modified the short fragment
with a Cy5 fluorophore and an Iowa Black RQ quencher at the 3’ and 5’ terminus,
respectively (FQ-DIS-SF) (Figure 4-2D). In the absence of the target, both FQ-DIS-SF
and the corresponding long fragment (DIS-LF) remain separate, and the fluorophore is
quenched due to its close proximity with the quencher (Figure 4-3A). Upon the addition
of DIS, the two fragments assemble to form a rigid CBSA-target complex, separating the
fluorophore from the quencher and resulting in elevated fluorescence (Figure 4-3B). By
titrating various DIS concentrations, we determined a Hill coefficient (nH)192 of 1.6 for
DIS-CBSA-4536 (Figure 4-4A), indicating considerable positive cooperativity. This
implies that a transition of CBSA assembly from 10% to 90% requires only a 16-fold
increase in target concentration, compared to its parent split aptamers which require an
81-fold increase.186 NUPACK analysis81 of the DIS-binding CBSA sequences
demonstrated that both fragments are predominantly unassembled (99%) in the absence
of target under our experimental conditions but DIS-SF exists primarily as a duplexed
structure. Therefore, binding of the first target to DIS-CBSA-4536 should open up the
DIS-SF duplex, facilitating binding of a second DIS molecule to the CBSA. This results
in a high level of cooperativity. A K1/2192 of 491 μM was obtained, where K1/2 represents
the DIS concentration at which half of the binding domains are occupied (Figure 4-4A).
To demonstrate the highly sensitive target-induced assembly of the CBSA, we designed
two sets of DIS-binding split aptamers with a single binding domain. Specifically, we
extended Stem 1 of the DIS-binding parent split aptamer (termed DIS-SA-36) (Figure
4-2B, right and Figure 4-4B) by one abasic site and five base pairs to form a split aptamer
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with a longer stem (termed DIS-SA-536) (Figure 4-4C). The long fragments were
unmodified while the short fragments were modified with a Cy5 fluorophore and an Iowa
Black RQ quencher at the 3’ and 5’ terminus, respectively. We performed binding
experiments with these two split aptamers along with the CBSA. DIS-CBSA-4536
demonstrated no background assembly in the absence of the target, and progressive
target-induced assembly with increasing concentrations of DIS. DIS-SA-536 also showed
target-induced assembly with a moderately higher target affinity, but had high
background assembly in the absence of DIS (Figure 4-4A). As expected, no cooperativity
was observed (nH = 1.05) with this single-binding pocket split aptamer. The parent split
aptamer, DIS-SA-36, was unable to assemble regardless of the presence or absence of
target due to its thermal instability.
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Figure 4-3. Working principle of our CBSA-based, EATR-amplified fluorescence assay. (A) FQDIS-SF contains a fluorophore-quencher pair, and remains dark in the absence of target. (B) In
the presence of target, the CBSA assembles, (C) creating a duplex that can be recognized and
cleaved by Exo III at the abasic site (denoted by X). (D) The complex then disassembles,
releasing the intact long fragment and target for additional rounds of complex formation and
digestion. The fluorophore is also released and produces a signal, which (E) becomes amplified
over the course of many rounds of EATR.
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Figure 4-4. Characterization of target-induced assembly of DIS-CBSA-4536, DIS-SA-36 and
DIS-SA-536 using a fluorophore-quencher assay. (A) Binding curve of these three split aptamers
with DIS ranging from 0 to 5000 μM. Binding affinity (K1/2) and cooperativity (nH) was
characterized by fitting with the Hill Equation. The error bars represent the standard deviation of
three measurements. Structures of (B) DIS-SA-36 and (C) DIS-SA-536 are given.

The affinity of DIS-CBSA-4536 was too low for direct detection of DIS at
physiological levels.170,171 Nevertheless, the highly target-responsive feature of the CBSA
enables us to demonstrate its compatibility with EATR-mediated signal amplification.
We selected Exo III for this reaction because of its potent apurinic endonuclease activity,
along with the fact that this enzyme is inexpensive and highly active at room temperature
in a sequence-insensitive manner.215,216 When the CBSA-DIS complex assembles in the
presence of DIS, Exo III is able to recognize the duplexed structure and specifically
cleaves it at the abasic site (Figure 4-3C). This cleavage results in disassembly of the
CBSA-target complex, releasing the long fragment, DIS molecules, and the fluorophore,
which now fluoresces due to its separation from the quencher. The released long
fragment and target are then free to assemble with another FQ-DIS-SF (Figure 4-3D),
starting the cycle anew. The end result is that a very small amount of target can be
recycled for multiple rounds of assembly and cleavage, generating a substantially
amplified fluorescence signal (Figure 4-3E).
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Figure 4-5. Time-course of Exo III-mediated cleavage of DIS-CBSA-4536. (A) PAGE analysis
of digestion products from DIS-CBSA-4536. Reactions consisted of 1 µM DIS-SF, 1 µM DIS-LF
and 0.004 U/µL Exo III with or without 500 µM DIS after 5, 10, 15, 30, 60 and 120 minutes of
digestion. Cleavage of short (B) and long (C) fragments was quantified by (Int0-Int)/Int0 × 100%,
where Int is the band intensity after the addition of Exo III and Int0 is the band intensity before the
addition of Exo III.

4.3.3

Exo III efficiently mediates EATR of DIS-CBSA-4536 in solution

We then set out to demonstrate efficient Exo III digestion of abasic-site-modified
DIS-SF. In order to prevent nonspecific digestion215 of the CBSA, we added a poly(A)5
overhang at the 3’ terminus of both fragments. We then performed a time-course of
digestion with Exo III using DIS-CBSA-4536 in the presence or absence of DIS. The
digestion products were collected after 5, 10, 15, 30, 60 and 120 minutes and analyzed by
polyacrylamide gel electrophoresis (PAGE) (Figure 4-5A). The concentration of retained
short fragments was calculated relative to a control sample that was untreated with Exo
III. We observed that Exo III cleavage of DIS-SF was rapid and specific, with 59%
cleavage in the presence of 500 µM DIS after 30 minutes. In contrast, only 9% of DIS-SF
was cleaved in the absence of the target (Figure 4-5B). After 120 minutes, DIS-SF was
almost completely cleaved (95%) in the DIS sample, compared to only 15% cleavage in
the absence of the target (Figure 4-5B). These results confirmed that the apurinic
endonuclease activity of Exo III could specifically cleave the CBSA even when it is
bound to the DIS target. Notably, we observed moderate non-specific digestion of DIS-
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LF by Exo III, resulting in partial removal of its poly(A)5 protection (Figure 4-5A).215
The total concentration of DIS-LF and its products, calculated from the intensity of all
bands larger than 39 nt, remained constant after a 120-minute digestion (Figure 4-5C).
Since all digested products contained the intact recognition segments of the CBSA, we
believe that EATR efficiency was not affected. We then demonstrated recycling of target
and long fragment by performing an Exo III cleavage reaction with 1 μM DIS-LF and 4
μM DIS-SF in the presence of DIS. PAGE analysis confirmed that Exo III achieved
efficient and specific cleavage of the short fragment, with 99% of DIS-SF cleaved after
240 minutes (Figure 4-6A). In contrast, only 11% of DIS-SF was cleaved in the absence
of DIS (SI, Figure 4-6B). We observed that less than 15% of DIS-LF was digested
regardless of the presence or absence of target (Figure 4-6C). Since the short fragment
was almost completely cleaved despite being present at a concentration greatly exceeding
that of the long fragment, it is clear that Exo III-mediated recycling of the long fragment
and target was taking place.

Figure 4-6. Digestion time-course of DIS-CBSA-4536 with excess DIS-SF. (A) PAGE analysis
of digestion products from 4 μM DIS-SF and 1 μM DIS-LF in the presence of 0.1 U/μL Exo III
with or without 500 μM DIS after 10, 30, 60, 120 and 240 min of digestion. Digestion of DIS-SF
(B) and DIS-LF (C) was quantified by (Int0-Int)/Int0 × 100%, where Int is the band intensity after
addition of Exo III and Int0 is the band intensity before addition of Exo III.
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A

B

Figure 4-7. CBSA-based EATR-amplified fluorescence assay for sensitive detection of DIS. (A)
Fluorescence time-course measurements after adding 0.01 U/µL of Exo III to our CBSA in the
presence of different concentrations of DIS (0, 0.5, 1, 2, 5, 10, 20, 50, 100 and 200 µM). (B)
Calibration curves before (black) and 30 minutes after (red) EATR signal amplification. The inset
shows the calibration curve at low DIS concentrations. The signal gain was calculated from the
fluorescence intensity of the samples. Error bars represent the standard deviation of three
measurements. Limit of detection is determined using the lowest non-zero calibrator
concentration.187
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DIS-CBSA-4536

DIS-SA-536

Figure 4-8. Demonstration of EATR-amplified signal in a fluorophore-quencher assay. Time
course digestion of (A) DIS-SA-536 and (B) DIS-CBSA-4536 with 0, 0.5, 1, 2, 5, 10, 20, 50, 100,
and 200 μM DIS. (C) Calibration curves of the fluorophore-quencher assay obtained with both
split aptamers before and after 30 minutes of EATR amplification.

4.3.4

Sensitive DIS Detection in biofluid samples using CBSA-based EATR-

amplified fluorescence assay
Having demonstrated the feasibility of our CBSA-based EATR-amplified approach,
we performed the fluorescence assay described in Figure 4-3 to detect DIS. As expected,
when we incubated 1 µM FQ-DIS-SF with 2 µM DIS-LF and different concentrations of
DIS for 30 minutes, we did not observe a significant DIS-induced fluorescence change
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even with 100 µM DIS (Figure 4-7, A and B, 0 min), as target binding of the CBSA was
too weak to efficiently assemble the CBSA-target complex. However, after adding 0.01
U/µL of Exo III, we saw a steady and concentration-dependent increase in fluorescence
(Figure 4-7A). The initial rate at which fluorescence increased was proportional to the
DIS concentration, and we found that concentrations as low as 1 μM could be detected
after 30 minutes of cleavage (Figure 4-7B, inset). It should be noted that the fluorescence
of the samples without DIS also increased to some extent due to the nonspecific digestion
of FQ-DIS-SF (Figure 4-7A, 0 μM). These results clearly demonstrated that the
sensitivity of our CBSA binding assay was enhanced 100-fold by implementing EATR,
producing a measurable limit of detection that is more than 500-fold lower than the K1/2
of the CBSA. As a control experiment, we also performed our EATR-amplified
fluorescence assay using DIS-SA-536. Although DIS-SA-536 underwent target-induced
assembly and was efficiently cleaved by Exo III, we observed no target-induced signal
amplification after a 30-minute digestion because of the high levels of DIS-independent
background assembly (Figure 4-8, A and C). In contrast, DIS-CBSA-4536 exhibited clear
target-induced signal amplification (Figure 4-8, B and C), with rapid assembly occurring
at very low concentrations of target and minimal background assembly in the absence of
target. Importantly, our assay performed equally well in urine samples. Different
concentrations of DIS were spiked into 50% diluted urine and tested with our CBSA
fluorescence assay. After a 30-minute enzyme digestion, we obtained a calibration curve
with a linear range from 0 to 100 μM (Figure 4-9A), which covers the urinary DIS
concentration range in normal adults (1-50 μM). In addition, we found that
concentrations as low as 1 µM DIS spiked in 50% urine could be distinguished from the
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background signal (Figure 4-9B). Our results clearly demonstrated the robustness and
sensitivity of our CBSA-based EATR fluorescence assay even in complex samples.
A

B

Figure 4-9. CBSA-based EATR-amplified fluorescence assay for sensitive detection of DIS in
50% urine. (A) Calibration curve after a 30-min enzyme digestion with a linear range between 0
and 100 μM DIS (inset). (B) Calibration curve at lower DIS concentrations. The signal gain was
calculated from the fluorescence intensity of the samples. Error bars represent the standard
deviation of three measurements.

4.3.5

Design of the CBSA-based colorimetric assay employing EATR-mediated

AuNP aggregation
Due to the highly responsive target-induced assembly feature of CBSAs, we believe
that a similar EATR-amplified strategy can be readily adopted into different sensing
platforms using other small-molecule-binding CBSAs. For example, the EATR-amplified
assay described above is instrument-dependent, making it unsuitable for instrument-free
applications. However, the same strategy can be also used to achieve rapid colorimetric
detection of small-molecule targets in an instrument-free fashion. As a demonstration, we
used the cocaine-binding CBSA previously developed by our group, COC-CBSA-5335,
which has an nH of 1.5 and a K1/2 of 36 μM,95 to develop an assay with a visual readout
that is potentially suitable for field use. Specifically, we immobilized the short fragment
of this CBSA (COC-SF) onto AuNPs, and then added the free long fragment (COC-LF)
in solution (Figure 4-10A). In the presence of cocaine, the fragments assemble to form
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CBSA-cocaine complexes on the particle surface (Figure 4-10B). Exo III specifically
recognizes the duplexed C3 spacer abasic site between the two binding domains and
cleaves the AuNP-conjugated short fragment (Figure 4-10C), releasing the intact long
fragment and cocaine for another round of target assembly and Exo III cleavage (Figure
4-10D). Once all of the short fragments have been cleaved from the particle surface
(Figure 4-10E), the AuNPs lose their stability under the employed buffer conditions and
rapidly aggregate, producing a visible red-to-blue color change (Figure 4-10F). The
CBSA fragments cannot assemble in the absence of cocaine, precluding Exo III
digestion, and the intact short fragments prevent AuNP aggregation such that the solution
remains red.
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Figure 4-10. A colorimetric CBSA-based EATR-amplified assay for naked-eye detection of
cocaine. (A) AuNPs are coupled to the short fragment (COC-SF), creating steric repulsion
between AuNPs that produces a visible red color. Upon addition of long fragment (COC-LF) and
cocaine, (B) the CBSA assembles, and the resulting duplexed abasic site can then (C) be digested
by Exo III. (D) This cleaves off COC-SF while recycling COC-LF and cocaine for another round
of assembly and digestion, until (E) all short fragments have been sheared from the AuNP. (F)
These sheared AuNPs can now aggregate, producing a visible red-to-blue color change.
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Figure 4-11. Cocaine-binding CBSA with a poly(A)5-protected long fragment and different
derivatives of the short fragment. Arrows indicate suitable digestion sites for Exo III.

4.3.6

EATR of CBSA mediated by AP endonuclease of Exo III instead of its 3’-5’

exonuclease activity
We first investigated the contribution of Exo III’s 3’-5’ exonuclease activity to the
digestion of CBSA-cocaine complexes relative to its endonucleolytic activity by
engineering three derivatives of COC-SF. The first derivative (COC-SF-5’A) included a
poly(A)5 extension at the 5’ end that allows digestion of both the abasic site and the 3’
terminus (Figure 4-11A). For the second derivative, the poly(A)5 protection was added at
the 3’ instead of 5’ end (COC-SF-3’A), allowing cleavage only at the abasic site (Figure
4-11B). For the third derivative (COC-SF-T), we replaced the abasic site with a thymine,
allowing digestion only from the 3’ terminus (Figure 4-11C). We also added a poly(A)5
extension at the 5’ end of COC-SF-T to match the length of COC-SF-3’A. We performed
Exo III digestion of a mixture of COC-LF with a 3’ poly(A)5 modification combined with
each of the three different short fragment derivatives in the presence or absence of 250
µM cocaine, and characterized the digestion products using PAGE. For the COC-SF-5’A,
we observed that 61% and 5% of the short fragment was cleaved with and without 250
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μM cocaine, respectively, after a five-minute enzyme reaction (Figure 4-12). After 60
minutes, the amount of cleaved COC-SF-5’A increased to 97% and 21%, respectively.
We obtained a similar digestion profile for COC-SF-3’A, where Exo III cleavage occurs
only at the abasic site. 61% and 8% of the COC-SF-3’A were respectively cleaved with
and without addition of cocaine after five minutes of digestion, which increased to 95%
and 17%, respectively, after 60 minutes (Figure 4-13). These results demonstrated that
the apurinic endonuclease activity of Exo III is efficient enough to mediate the digestion
of CBSA-cocaine complexes. Our control experiment with COC-SF-T demonstrated that
Exo III was able to remove only one nucleotide from the short fragment. Only 5% of the
COC-SF-T was digested both with and without cocaine after a five-minute Exo III
reaction, and only 15% of the COC-SF-T was digested in the presence of cocaine versus
20% without cocaine after 60 minutes (Figure 4-14). It is clear that the CBSA-cocaine
complex inhibits the 3’-to-5’ exonuclease activity of Exo III. Thus, we concluded that the
abasic site is sufficient to enable robust EATR signal amplification, and poly(A)5
protection at the 3’ end of the short fragment is unnecessary.

Figure 4-12. Time-course of CBSA digestion with COC-SF-5’A. (A) PAGE analysis of digestion
products of CBSA consisting of 1 μM COC-SF-5’A and 1 μM poly(A)5 protected COC-LF after
treatment with 0.01 U/μL Exo III in the presence or absence of 250 μM cocaine for 5, 10, 15, 30
or 60 min of digestion. Digestion of (B) COC-SF-5’A and (C) COC-LF-5’A was quantified by
(Int0-Int)/Int0 × 100%, where Int is the band intensity after addition of Exo III and Int0 is the band
intensity before addition of Exo III.
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Figure 4-13. Time-course of CBSA digestion with COC-SF-3’A. (A) PAGE analysis of digestion
products of CBSA consisting of 1 μM COC-SF-3’A and 1 μM poly(A)5 protected COC-LF after
treatment with 0.01 U/μL Exo III in the presence or absence of 250 μM cocaine for 5, 10, 15, 30
or 60 min of digestion. Digestion of (B) COC-SF-3’A and (C) COC-LF-5’A was quantified by
(Int0-Int)/Int0 × 100%, where Int is the band intensity after addition of Exo III and Int0 is the band
intensity before addition of Exo III.

Figure 4-14. Time-course of CBSA digestion with COC-SF-T. (A) PAGE analysis of digestion
products of CBSA consisting of 1 μM COC-SF-T and 1 μM poly(A)5 protected COC-LF after
treatment with 0.01 U/μL Exo III in the presence or absence of 250 μM cocaine for 5, 10, 15, 30
or 60 min of digestion. Digestion of (B) COC-SF-T and (C) COC-LF-5’A was quantified by
(Int0-Int)/Int0 × 100%, where Int is the band intensity after addition of Exo III and Int0 is the band
intensity before addition of Exo III.

Figure 4-15. Time-course of Exo III digestion of cocaine-binding CBSA. (A) Digestion of a
mixture of 1 μM COC-LF and 8 μM COC-SF by 0.1 U/μL Exo III in the presence or absence of
250 μM cocaine after 5, 10, 15, 30, or 60 minutes of digestion. (B) Digestion was quantified by
(Int0-Int)/Int0 × 100%, where Int is the band intensity after addition of Exo III and Int0 is the band
intensity before addition of Exo III.
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We then demonstrated that we could perform EATR with our cocaine-binding CBSA
in solution. We performed a time-course of Exo III digestion using poly(A)5 protected
COC-LF and unprotected COC-SF, with a 1:8 ratio of COC-LF:COC-SF, either with or
without 250 μM cocaine. PAGE analysis of the digestion products showed rapid and
specific Exo III digestion, with more than 60% of the short fragment cleaved in the
presence of cocaine after only 10 minutes (Figure 4-15). In contrast, less than 5% of the
short fragment was cleaved in the absence of cocaine. After a 30-minute reaction, COCSF was almost completely digested (92%) in the presence of cocaine, while only 14%
was digested in the absence of cocaine, demonstrating the specificity of EATR
amplification in solution.
4.3.7

DNA surface coverage and the length of COC-SF affect EATR-mediated

AuNP aggregation
We employed our CBSA-based EATR-amplified assay to achieve naked-eye detection
of cocaine. We conjugated a thiolated version of COC-SF (Table 4-1, SH-COC-SF-1X)
onto AuNPs as described previously.143 Since DNA surface coverage has a critical
influence on EATR-mediated AuNP aggregation, we developed a simple strategy for
generating AuNPs displaying different quantities of short fragment. We did this by
incubating short fragment-saturated AuNPs with various micromolar concentrations of
DTT to displace different quantities of immobilized short fragment from the particle
surface. We then measured the surface coverage resulting from treatment with various
DTT concentrations by mixing each of these batches of AuNPs with an equal volume of
1.0 M DTT128 and incubating overnight to remove all remaining DNA strands from the
particle surface. We subsequently quantified these by centrifuging the samples and
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measured the DNA concentration in the collected supernatant with OliGreen, a DNA
binding dye.141 A calibration curve (Figure 4-16A) determined that treatment with DTT
concentrations of 0, 100, 200, 300, and 400 µM produced AuNPs that respectively
displayed 102±1, 41±1, 34±1, 25±1, and 22±1strands/particle (Figure 4-16B). This
demonstrates that DTT treatment can effectively regulate DNA surface coverage on
AuNPs in a concentration-dependent manner. AuNPs treated with 500 μM DTT yielded a
surface coverage of 20±1strands/particle; the resulting particles were unstable, and
spontaneously aggregated in the reaction buffer (data not shown). Thus, these AuNPs
were omitted from following experiments.

A

B

Figure 4-16. Characterizing surface coverage of SH-COC-SF-1X-modified AuNPs treated with
different concentrations of DTT. (A) A standard calibration curve established with known
concentrations of SH-COC-SF-1X was used to calculate the DNA surface coverage of the DTTtreated AuNPs. (B) Surface coverage decreased with increasing amounts of DTT employed
during the treatment procedure. Error bars show standard deviations obtained from three
measurements.
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Figure 4-17. Effect of SH-COC-SF-1X surface coverage. Time-dependence of Exo III digestion
of AuNPs displaying SH-COC-SF-1X at (A) 102±1, (B) 41±1, (C) 34±1, (D) 25±1, or (E) 22±1
strands/particle in the absence or presence of 250 μM cocaine are shown. The detection window,
during which the drug-containing sample is blue while the drug-free sample remains red, is
marked as a vertical line. (F) Summary of detection time and detection window obtained using
AuNPs with different surface coverages. 25 strands/particle was identified as the optimal surface
coverage.

We then assessed how differing levels of surface coverage affect CBSA-cocaine
assembly, exonuclease cleavage, and AuNP aggregation. Since the CBSA will be
assembled on the particle, Exo III will have minimal accessibility to the 3’ end of the
long fragment. We incubated our various batches of 5 nM SH-COC-SF-1X-modified
AuNPs with 100 nM unprotected COC-LF in the presence or absence of 250 µM cocaine
for 30 minutes, and then added 0.2 U/µL Exo III. We tracked the signal response by
performing time-dependent measurements of UV-vis absorbance. Well-dispersed AuNPs
have an absorbance peak at 520 nm; as AuNPs start to aggregate, this peak decreases and
a new peak appears at 650 nm.217 Therefore, we used the ratio of A650/A520 to evaluate
EATR-mediated AuNP aggregation. When the value of A650/A520 is below 0.4, the
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AuNPs are well separated and the solution appears red. When the value of A650/A520 is
0.6, the AuNPs begin to aggregate and the solution appears purple. A value of A650/A520 ≥
0.8 indicates complete aggregation, and the solution appears dark blue. We found that
SH-COC-SF-1X-modified

AuNPs

with

relatively

low

surface

coverage

(25

strands/particle) demonstrated much faster aggregation than AuNPs with high surface
coverage (102 strands/particle) (Figure 4-17). We observed no aggregation for these 102
strands/particle AuNPs, even 70 minutes after the addition of Exo III (Figure 4-17A).
Likewise, we did not observe a visible color change at a surface density of 41
strands/particle (Figure 4-17B). However, further reductions in surface coverage
produced a clear increase in the rate of AuNP aggregation, and AuNPs with surface
coverages of 34, 25 and 22 strands/particle produced a dark blue color (A650/A520 ≥ 0.8)
within 72, 52, and 38 minutes of Exo III digestion, respectively. This indicates both
specific CBSA-cocaine assembly and successful EATR amplification. In the meantime,
the AuNPs remained well-dispersed at all levels of surface coverage and all target-free
samples remained red (A650/A520 = 0.4) (Figure 4-17, C-E). Notably, both target- and
non-target-mediated Exo III digestion and AuNP aggregation are more pronounced for
AuNPs with lower surface coverages. We identified 25 strands/particle as the optimal
level of surface coverage for our assay due to the existence of detection window during
which the drug-containing sample is blue while the drug-free sample remains red (Figure
4-17F). Although the ratio between COC-LF and AuNP-conjugated SH-COC-SF-1X
under this optimal surface coverage was close to 1:1, we believe that Exo III-mediated
recycling of LF and target was taking place on the particle surface since DNA
hybridization efficiency on AuNPs is usually below 20%.129,136 We believe that our DTT-
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based strategy for regulating DNA surface coverage plays multiple roles in facilitating
exonuclease digestion of AuNP-conjugated short fragments for rapid cocaine detection.
First, it prevents non-specific binding of DNA bases218 by occupying vacant areas on the
particle surface with DTT, lifting the covalently-bound aptamer fragments into an upright
orientation that increases CBSA-target assembly and enzyme accessibility.219 Second, it
adjusts the surface density by replacing some of the chemically-bound aptamer
fragments. This significantly reduces the steric and electrostatic repulsion caused by
neighboring DNA strands, enabling optimized CBSA-cocaine complex assembly.220
Finally, by reducing DNA surface coverage, the treatment decreases local salt
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concentration at the surface,133 which prevents the salt-induced inhibition of Exo III.216
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Figure 4-18. Alternative version of our colorimetric cocaine sensor using SH-COC-SF-2Xmodified AuNPs.
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B

Figure 4-19. Surface coverage of SH-COC-SF-2X-modified AuNPs treated with
different concentrations of DTT. (A) A calibration curve established with known
concentrations of SH-COC-SF-2X was used to calculate the DNA surface coverage of the
DTT-treated AuNPs. (B) The surface coverage decreased with increasing amounts of
DTT employed during the treatment procedure. Error bars show standard deviations
obtained from three measurements.
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Figure 4-20. Effect of SH-COC-SF-2X surface coverage. Time-dependence of Exo III digestion
of AuNPs displaying SH-COC-SF-2X at (A) 83±2, (B) 23±1, (C) 20±1, (D) 18±1, or (E) 16±1
strands/particle in the absence or presence of 250 μM cocaine are shown. The detection window,
during which the drug-containing sample is blue while the drug-free sample remains red, is
marked as a shaded box. (F) Summary of detection time and detection window obtained using
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AuNPs with different surface coverages. 20 strands/particle was identified as the optimal surface
coverage.

We predicted that a longer version of COC-SF should further increase the stability of
our modified AuNPs by suppressing nonspecific digestion-mediated aggregation. Thus,
we designed a new construct (Table 4-1, SH-COC-SF-2X) comprising of two tandem
abasic-site-incorporated short fragment repeats with a (T)6 linker. Our reasoning was that
the assay’s specificity should be enhanced by this change, since Exo III will have to
cleave both abasic sites in order to trigger cocaine recycling and AuNP aggregation
(Figure 4-18). We modified 13-nm AuNPs with SH-COC-SF-2X, used our DTT
regulation strategy to adjust the surface coverage of AuNPs, and tested the effects of
DNA surface coverage on EATR performance. A calibration curve (Figure 4-19A)
determined that treatment with DTT concentrations of 0, 200, 300, 400, and 500 µM
produced AuNPs that respectively displayed 83±2, 23±1, 20±1, 18±1, and 16±1 strands
per particle (Figure 4-19B). As expected, increasing concentrations of DTT produced
AuNPs with lower levels of surface coverage (Figure 4-19). Compared to SH-COC-SF1X modified-AuNPs, SH-COC-SF-2X modified-AuNPs are stable even with surface
coverages as low as 16 strands/particle. This is most likely due to the increased number
of negatively charged DNA-phosphate groups located on the AuNP surface, providing
more repulsion among particles. Lower-coverage AuNPs underwent EATR-mediated
AuNP aggregation at a much faster rate than those with saturating coverage (Figure 4-20,
A-E). The surface coverage of 20±1 strands/particle was selected for a combination of
short reaction time and long detection window (Figure 4-20F).
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4.3.8

Visual detection of cocaine using CBSA-based EATR-amplified colorimetric

assay
Finally, we compared the assay’s performance with SH-COC-SF-1X versus SH-COCSF-2X at optimized surface coverage. SH-COC-SF-2X-modified AuNPs aggregated
more rapidly than those modified with SH-COC-SF-1X (Figure 4-21). We then used SHCOC-SF-2X-modified AuNPs to test the sensitivity of our assay. The particles remained
stable in the reaction buffer, and the color of the sample was not affected by cocaine
concentrations of up to 500 µM in the absence of Exo III (Figure 4-22A, 0 min). Upon
addition of Exo III, samples containing cocaine demonstrated different levels of particle
aggregration, resulting in a distinctive color readout that shifted from light purple, dark
purple, to dark blue at increasing drug concentrations over the course of 20 minutes
(Figure 4-22A, 20 min), with A650/A520 varying from 0.39 (0.2–1 µM) to 0.90 (500 µM).
The color of the cocaine-free sample remained unchanged. We could observe a clear blue
color in samples containg as little as 10 µM cocaine with the naked eye after 20 minutes
(Figure 4-22A). Using UV-vis spectroscopy measurements, we obtained a measurable
limit of detection of 2 µM (Figure 4-22B). We determined the target-specificty of the
CBSA-based EATR-amplified colorimetric assay by challenging it with cocaine along
with common cutting agents observed in street samples221 such as lidocaine, caffeine,
levamisole, and benzocaine at a concentration of 50 μM. We observed a red-to-blue color
change only in the cocaine sample within 20 minutes (Figure 4-23). These results show
that our EATR colormietric assay can be used for the specific and sensitive naked-eye
detection of cocaine in seized samples.
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Figure 4-21. Comparison of different SF in the CBSA-based EATR-amplified colorimetric assay.
Time-dependence of Exo III digestion of AuNPs modified with SH-COC-SF-1X (25
strands/particle, black) or SH-COC-SF-2X (20 strands/particle, red) in the absence (open circles
and squares) or presence (solid circles and squares) of 250 μM cocaine are shown.

Figure 4-22. CBSA assay for cocaine detection with SH-COC-SF-2X-conjugated AuNPs. (A)
After 20 minutes, samples containing cocaine at concentrations ≥ 10 µM produced a clearly
visible red to blue color change. Cocaine-free samples without cocaine remained red. (B)
Calibration curve of our colorimetic CBSA-based cocaine assay; inset shows the calibration curve
at low cocaine concentrations.
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Figure 4-23. Specificity of the EATR-amplified CBSA-based colorimetric assay for 50 μM
cocaine versus various interferents. A red-to-blue color change was observed in the cocaine
sample, whereas lidocaine, caffeine, levamisole, and benzocaine samples remained red after 20
minutes of digestion.

4.4. Conclusions
We have demonstrated a general and simple approach for developing a variety of
CBSA-based EATR-amplified assays for the sensitive detection of small-molecule
targets. The 3’-5’ exonuclease activity of Exo III has been used extensively in DNAbased EATR assays,159 but our results demonstrated that Exo III’s 3’-5’ exonuclease
activity is greatly inhibited by the tertiary structure of target-CBSA complexes. To
achieve rapid CBSA-based EATR, we therefore incorporated a C3 spacer abasic site
between the two target-binding domains on our CBSA short fragment, creating a
recognition site for Exo III’s apurinic endonuclease activity. We have previously
demonstrated that the apurinic endonuclease activity of Exo III can effectively enable
EATR-mediated AuNP aggregation for rapid and sensitive detection of single-base
mismatched DNA.154 Here, we showed that Exo III’s apurinic endonuclease activity
could mediate CBSA-based EATR in solution as well as on particle surface. We thus
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believe that the highly active and robust apurinic endonuclease activity of Exo III should
allow many DNA-based EATR sensor platforms to be applied to our CBSA-based EATR
assays for detection of various small-molecule targets.
As an initial demonstration, we engineered a DIS-binding CBSA with a duplexed C3
spacer abasic site incorporated between the two target-binding domains. This allowed us
to exploit EATR signal amplification, which enhanced the sensitivity of our CBSA-based
fluorescence assay by 100-fold relative to an unamplified assay. The detection limit of
our CBSA-based EATR-amplified fluorescence assay is 100 and 50 times lower than
previously reported DIS assays based on a split aptamer92 and a structure-switching
aptamer,222 respectively. This assay also allowed us to detect DIS at concentrations as
low as 1 μM in 50% urine within 30 minutes. We then demonstrated that this strategy
could be adopted for rapid colorimetric detection of cocaine, based on EATR-mediated
aggregation of AuNPs—a useful strategy for instrument-free detection. This assay
enabled us to achieve rapid, naked-eye detection of cocaine at low micromolar
concentrations within 20 minutes and is more sensitive, robust, or simple compared to
previously reported methods for the visual detection of cocaine (Table 4-2).
Recent work has described SELEX approaches for isolating small molecule-binding
aptamers with a three-way junction structure using a partially-structured library.33 These
aptamers can be readily engineered into CBSAs using the strategy demonstrated in this
work and, as also shown here, these CBSAs can then be readily adapted for use in EATRamplified assays. Based on the generality of our CBSA engineering procedure and
excellent performance of EATR assays in complex samples, we believe that the strategy
described here will accelerate the development of sensitive and accurate sensors for
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detecting small-molecule targets in fields including environmental monitoring, food
safety, law enforcement, medical diagnostics, and public health.
Table 4-2. Comparison of assays for the visual detection of cocaine.

Detection strategy

Visual
Detection
limit

CBSA-based EATR-amplified
10 µM
assay
Dissociation of aptamerhybridized DNA-conjugated 500 µM
AuNP-assemblies
Dye-displacement assay

500 µM

Aggregation of split aptamer50 µM
protected unmodified AuNPs
AuNP and conjugated
50 μM
polyelectrolyte
Target-induced dissociation of
2 µM
aptamer-linked hydrogels

Detection
Time

Existing problems

Ref

20 min

Requires enzyme reaction

This
work

1 min

Preparation of AuNP
assemblies is laborious

144

Overnight

Long reaction time
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3 min
2 min
10 min
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Unmodified AuNPs are
unstable
Unmodified AuNPs are
unstable
Enzyme-embedded hydrogel
is hard to preserve

145

146

207

CHAPTER 5: In Vitro Isolation of Small-Molecule-Binding Aptamers with Intrinsic
Dye-Displacement Functionality
5.1. Introduction
Aptamers are nucleic acid-based molecules that can be isolated in vitro through
SELEX techniques to bind various targets with high specificity and affinity.1,5 They are
increasingly being used as recognition elements in biosensing platforms due to their low
cost of production, ease of modification, chemical stability, and long shelf life.5,76,77 The
generation of a sensor readout typically requires an aptamer to undergo some manner of
binding-induced change, and most aptamer-based sensors utilize structure-switching
aptamers that undergo a major conformational rearrangement upon target binding.
However, most aptamers do not innately undergo a measurable binding-induced
conformational change, and the development of a structure-switching aptamer typically
entails a multi-stage process of sequence analysis and chemical modification.75–77
SELEX methods have been developed that make it possible to isolate aptamers with
inherent structure-switching functionality. For example, Ellington98 and Li32 have utilized
a ‘strand-displacement’ strategy to directly isolate structure-switching aptamers. Their
approach begins with the hybridization of library molecules with an immobilized
complementary strand. Library strands that bind to the target undergo a conformational
change, dissociate from the complementary strand, and are collected in the supernatant.
After several rounds of isolation and enrichment, these aptamers are sequenced,
chemically modified with a fluorophore, and can then be directly employed in stranddisplacement assays with a quencher-modified complementary strand. This approach
eliminates the need for sequence engineering, but there is an inherent conflict between
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the requirements for aptamer isolation and sensor development. This is because the
isolation of high-affinity aptamers requires strong hybridization of the complementary
strand with the library molecules in order to create an energetic barrier for stringent
selection. Nevertheless, since competitive strands have high binding affinity for the
aptamer, they inadvertently inhibit target binding and consequently yielding low assay
sensitivity.32,33,97,99,100 Moreover, strand-displacement assays typically require a lengthy
heating-and-cooling process to hybridize the complementary strand with the aptamer,
which greatly hinders the use of these assays for rapid on-site detection. Nonetheless, the
strand-displacement assay is presently the only generally applicable method for
developing aptamer-based small-molecule sensors directly from isolated aptamers
without further engineering.
Dye-displacement strategies offer an appealing alternative in this regard.101–104 In such
assays, a small-molecule dye competes with the target to bind with the aptamer.
Displacement of the dye from the aptamer’s target-binding domain results in a change of
the dye absorbance or fluorescence. Such assays not only require no chemical
modification of the aptamer but also yield high sensitivity, since displacement of a smallmolecule dye is more thermodynamically feasible compare to a tightly-bound
complementary strand. However, this assay strategy has not been generalized, as there is
currently no technology to generate aptamers with dye-displacement functionality.
Herein, we for the first time have developed a new library-immobilized SELEX
strategy for the isolation of small-molecule-binding aptamers with inherent dyedisplacement functionality. The isolated aptamers can rapidly report binding events
through target-induced dye-displacement, which can then be employed in a generalized
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sensor platform for the detection of small-molecule targets. Previous research has
demonstrated that diethylthiatricarbocyanine (Cy7) can bind to a cocaine-binding
aptamer via its three-way junction (TWJ) binding domain,101 and we have now
demonstrated that such Cy7 binding is a general and sequence-independent feature of
DNA TWJ structures. This interaction produces a distinctive change in absorbance at 670
nm and 760 nm, which allowed us to isolate aptamers that undergo target bindinginduced dye-displacement from a TWJ-containing structured library. These aptamers can
then be directly employed to optically report the presence of their respective target
through displacement of Cy7. As a demonstration, we isolated an aptamer for 3,4methylenedioxypyrovalerone (MDPV), a synthetic cathinone designer drug. The isolated
aptamer retains a TWJ-structured binding domain and has a KD of 6.1 µM. The addition
of MDPV displaced Cy7 from the TWJ domain, resulting in a change in the absorbance
of the dye. Using this label-free assay, we were able to detect MDPV at a concentration
as low as 300 nM – 20-fold lower than the KD of the aptamer – within seconds. Our Cy7displacement assay was more sensitive and rapid than an equivalent strand-displacement
fluorescence assay, which used a fluorophore-modified version of the same aptamer
along with a quencher-modified complementary strand. Importantly, our isolated aptamer
is also cross-reactive to other synthetic cathinones, which represent a diverse emerging
class of drugs of abuse, while remaining non-responsive to other structurally-similar noncathinone molecules and commonly-used cutting agents. Our method should be generally
applicable as a means to enable the rapid and sensitive detection of a variety of smallmolecule targets that bind to three-way junction–derived receptors.
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5.2. Experimental section
5.2.1

Materials

Table 5-1. The sequences of DNA oligonucleotides employed in Chapter 5.
Sequence ID
DISS.1
DOGS.1
TWJ pool

Sequence (5’ – 3’)
CTCGGGACGTGGATTTTCCGCATACGAAGTTGTCCCGAG
TCGGGACGTGGATTTTCCACAAACCAGAATGGTGTCCCGA
CTTACGACNNNGGCATTTTGCCNNNNAACGAAGTTNNNGTCGTAAG
CGAGCATAGGCAGAACTTACGACNNNGGNATTTTNCCNNNNANCG
Library
AAGNTNNNGTCGTAAGAGCGAGTCATTC
S1 stem-loop CTTACGACTTTGTCGTAAG
S2 stem-loop GGCATTTTGCC
S3 stem-loop AACGAAGTT
cDNA-bio
TTTTTGTCGTAAGTTCTGCCATTTT/Bio/
FP
GCAGCATAGGCAGAACTTAC
RP
GAATGACTCGCTCTTACGAC
RP-bio
/Bio/GAATGACTCGCTCTTACGAC
MA
CTTACGACTCAGGCATTTTGCCGGGTAACGAAGTTACTGTCGTAAG
CAGAACTTACGACTCAGGCATTTTGCCGGGTAACGAAGTTACTGTC
MA-L
GTAAG
/5Cy5/GGCAGAACTTACGACTCAGGCATTTTGCCGGGTAACGAAGTT
MA-F
ACTGTCGTAAG
cDNA
GTCGTAAGTTCTGCC
cDNA-Q
GTCGTAAGTTCTGCC/3IAbRQsp/
d. N represents random base
e. /Bio/ represents biotin modification
f. /5Cy5/ represents Cy5 fluorophore modification
g. /3IAbRQsp/ represents Iowa Black RQ quencher modification

All oligonucleotides were ordered from Integrated DNA Technologies (IDT), purified
with HPLC, and dissolved in PCR quality water (Invitrogen). DNA concentrations were
measured using a NanoDrop 2000 spectrophotometer (Thermo Scientific). Cy7,
dehydroisoandrosterone-3-sulfate (DIS) sodium salt dihydrate, deoxycorticosterone-21
glucoside (DOG) and all other chemicals were purchased from Sigma-Aldrich unless
otherwise noted. Drug standards, including MDPV, mephedrone, methylone, naphyrone,
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and pentylone were purchased from Cayman Chemicals. Tween 20 and formamide were
purchased from Fisher Scientific. Streptavidin-coated agarose resin (1−3 mg biotinylated
BSA/ml resin), One Shot Chemically Competent E. coli, and SYBR Gold were purchased
from Thermo Scientific. 500 μL micro-gravity columns were purchased from BioRad.
5.2.2

SELEX procedure

The isolation of MDPV-binding aptamers follows a previously-reported SELEX
method33 with some modifications. Briefly, during each round of SELEX, 100 pmole of
either the TWJ-containing library or the enriched pool from a given round was mixed
with 500 pmole of biotinylated complementary strand (cDNA-bio) in 250 μL selection
buffer (10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, pH 7.4). The mixture was heated
at 95 °C for 5 min, slowly cooled to room temperature over 30 min, and then loaded into
a micro-gravity column containing 250 μL of streptavidin-coated agarose resin for library
immobilization. Unconjugated library and complementary strands were removed by
flowing 250 μL of selection buffer through the library-immobilized column at least 10
times. Target-bound aptamers were then eluted at room temperature with 250 μL of
selection buffer containing either 100 μM (Rounds 1-5) or 50 μM (Rounds 6-10) MDPV.
Each elution was completed in two minutes. The elution was repeated two more times to
increase the yield. The combined eluted aptamers were concentrated using a 3K
molecular weight cut-off spin filter (Millipore) and mixed with 1 μM forward primer
(Table 5-1, FP) and 1 μM biotinylated reverse primer (Table 5-1, RP-bio) in 1 mL GoTaq
Hot Start Master Mix (Promega). Polymerase chain reaction (PCR) was then performed
using a BioRad C1000 thermal cycler. Amplification conditions were as follows: 1 cycle
of 95 °C for 2 min; 13 cycles of 95 °C for 15 s, 58 °C for 30 s, and 72 °C for 45 s; and 1
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cycle of 72 °C for 2 min. The double-stranded PCR product was immobilized on a microgravity column containing 200 μL of streptavidin-coated agarose resin. The column was
washed five times with 200 μL of 10 mM Tris-HCl buffer (pH 7.4) containing 20 mM
NaCl to remove unconjugated strands, and then incubated with 300 μL of 0.2 M NaOH
for 10 min. Finally, the eluent was collected and neutralized with 0.2 M HCl in a 1.5 mL
microcentrifugation tube and concentrated using a 3K molecular weight cut-off spin
filter. The enriched pool was used for the next round of SELEX after measuring its
concentration with a NanoDrop 2000.
Counter-SELEX

was

performed

against

methamphetamine

(Rounds

4-5),

amphetamine (Rounds 6-7) and dopamine (Rounds 8-10). Specifically, the libraryimmobilized column was washed 10 times with 250 μL of 100 μM counter-SELEX target
in selection buffer, followed by 20 times with 250 μL of selection buffer prior to target
elution.
5.2.3

Cloning and sequencing

After 10 rounds of SELEX, the final enriched pool was PCR amplified with unlabeled
forward and reverse primers (Table 5-1, FP and RP) under the conditions described
above, with a prolonged 30-min extension step at 72 °C to add an A-tail. The PCR
product was cloned into E. coli using the TOPO TA cloning kit (Invitrogen). 50 colonies
were randomly picked and sequenced at the Florida International University DNA Core
Facility. Multiple sequence alignments were carried out using BioEdit software, and the
sequence logo was generated using WebLogo.223
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5.2.4

Characterization of target displacement of Cy7 from TWJ-structured

aptamers
5 µL of DISS.1 aptamer or DOGS.1 aptamer (1) (final concentration: 7 μM), 5 µL of
Cy7 (final concentration: 3 μM), 5 µL of DIS or DOG (final concentration: 0 or 250 μM),
and 35 µL selection buffer (1) (20 mM Tris-HCl, 10 mM MgCl2, 1 M NaCl, 0.01%
Tween 20, 1% DMSO, pH 7.4) were mixed in wells of a 384-well plate. UV-vis spectra
were immediately recorded from 450–900 nm using a Tecan Infinite M1000 PRO at
room temperature.
5.2.5

Characterization of binding of Cy7 to TWJ pool

5 µL of different concentrations of TWJ pool, 5 µL of 20 µM Cy7, and 40 µL of
reaction buffer (final concentration 10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl,
0.01% Tween 20, and 1% DMSO, pH 7.4) were mixed in wells of a 384-well plate. UVvis spectra were immediately recorded from 450 nm to 900 nm at room temperature. The
absorbance value at 760 nm was plotted against the concentration of added TWJ pool.
The KD was estimated by non-linear fitting using the Langmuir equation.
5.2.6

Continuous variation experiment (Job plot)

10 µM Cy7 and 10 µM TWJ pool were separately prepared in reaction buffer.
Different ratios of Cy7 and TWJ pool were then mixed, with the concentration of both
species totaling 10 µM. 50 µL of each mixture was loaded into a 384-well plate, and UVvis spectra were immediately recorded from 450–900 nm at room temperature. The
absorbance at 760 nm was plotted versus the mole fraction of Cy7.
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5.2.7

Development of a target elution assay to assess pool affinity and target

specificity
After each round of SELEX, 50 pmole of the enriched pool was mixed with 250
pmole of biotinylated complementary strand (Table 5-1, cDNA-bio) in 125 μL binding
buffer (10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, 0.01% Tween 20%, pH 7.4). The
mixture was heated to 95 °C for 5 min, slowly cooled down to room temperature over 30
min, and loaded into a micro-gravity column containing 125 μL of streptavidin-coated
agarose resin for library immobilization. The library-immobilized resin was collected into
a microcentrifugation tube and washed five times with 625 µL binding buffer on an endto-end rotator to remove unconjugated library and complementary stands. After washing,
the library-conjugated resin was re-suspended in 150 μL binding buffer and aliquoted
into six PCR tubes (20 μL each). 50 μL binding buffer containing different amounts of
MDPV was added to these tubes to reach final target concentrations of 0, 10, 50, 100,
250, and 500 μM. After a 60-min incubation on an end-over-end rotator, the agarose resin
was precipitated by centrifugation. 3 μL of supernatant was collected and mixed with 6
µL of gel loading buffer (75% formamide, 10% glycerol, 0.125% SDS, 10 mM EDTA,
and 0.15% (w/v) xylene cyanol). 5 µL of each collected sample was then loaded into the
wells of a 15% denaturing polyacrylamide gel. A control sample (40 nM initial random
library) was also loaded into the gel to evaluate the concentration of target-eluted library
in each sample. Separation was carried out at 20 V/cm for 1 hour in 0.5× TBE running
buffer. The gel was stained with 1× SYBR Gold solution for 25 min and imaged using a
ChemiDoc MP Image System (Bio-Rad). The percentages of elution were calculated
from the concentration of target-eluted library and the initial amount of library used in
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immobilization, which were then plotted versus the concentration of MDPV. KD of the
library pool was estimated with non-linear curve fitting using the Langmuir equation. The
target specificity for the enriched pool was tested using the method described above, by
eluting library-immobilized agarose resin with binding buffer, 500 μM MDPV, 500 μM
methamphetamine, 500 μM amphetamine and 500 μM dopamine.
5.2.8

Isothermal titration calorimetry (ITC)

All ITC experiments were performed at 23 °C in reaction buffer with a MicroCal
iTC200 instrument (Malvern). The sample cell contained 20 µM MA, 20 µM MA-L, 20
µM Cy7-MA complex (1:1), 20 µM Cy7:MA-L complex (1:1), or 20 µM cDNA:MA-L
complex (1:1). The syringe contained 1 mM MDPV in reaction buffer. Each experiment
consisted of 19 successive 2 μL injections after a 0.4 μL purge injection with spacing of
180 seconds to a final molar ratio of 11:1 (MDPV:Aptamer). The raw data were first
corrected based on the heat of dilution of target, and then analyzed with the MicroCal
analysis kit integrated into Origin 7 software with a single-site binding model.
5.2.9

Strand-displacement fluorescence assay for detection of MDPV

First, the molar ratio between the fluorophore-labeled aptamer strand (Table 5-1, MAF) and the quencher-labeled complementary strand (Table 5-1, cDNA-Q) was optimized.
Specifically, 8 µL of MA-F (final concentration 50 nM) and 8 µL of different
concentrations of cDNA-Q were mixed with reaction buffer to a total volume of 80 µL.
The samples were then heated at 95 °C for 5 min and slowly cooled down to room
temperature over 30 min. 75 µL of samples were loaded into a 384-well plate, and the
fluorescence spectra were recorded from 655–850 nm with excitation at 648 nm at room
temperature. To perform the strand-displacement fluorescence assay, reaction buffer
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containing 50 nM MA-F and 50 nM cDNA-Q (final concentration) was heated at 95 °C
for 5 min and slowly cooled down to room temperature over 30 min. 8 µL of different
concentrations of MDPV were then mixed with 72 µL of the cDNA-Q:MA-F complex in
the wells of a 384-well plate. After 10 min of incubation, fluorescence spectra were
recorded from 655–850 nm with excitation at 648 nm at room temperature. The signal
gain was calculated by (F−F0)/F0, where F0 and F are the fluorescence intensity at 668 nm
without and with MDPV, respectively.
5.2.10 Cy7 displacement assay for detection of MDPV
5 µL of MDPV-binding aptamer (Table 5-1, MA) (final concentration: 7 μM), 5 µL of
Cy7 (final concentration = 3 μM), 5 µL of varying concentrations of MDPV, and 35 µL
of reaction buffer (10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, 0.01% Tween 20, 1%
DMSO, pH 7.4) were mixed in wells of a 384-well plate. UV-vis spectra were
immediately recorded from 450–900 nm using a Tecan Infinite M1000 PRO at room
temperature. Signal gain was calculated by (R–R0)/R0, where R0 and R are the 670/760
nm absorbance ratio without and with MDPV, respectively. The same assay was
performed with 50 µM and 250 µM of naphyrone, methylone, pentylone and mephedrone
to evaluate the cross-reactivity of the assay. Additionally, we tested the specificity of the
assay using 50 µM and 250 µM of interfering agents such as amphetamine,
methamphetamine, dopamine, lidocaine, benzocaine, and caffeine.
5.3. Results and discussion
5.3.1

Binding mechanism of Cy7 to TWJs

Stojanovic et al. have previously reported that Cy7 (Figure 5-1A) specifically binds to
the TWJ-structured binding domain of a cocaine-binding aptamer via hydrophobic
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interactions.101 Cocaine displaces Cy7 from the TWJ, resulting in a significant reduction
in the absorbance of the dye at 760 nm. We demonstrated the generality of this Cy7displacement mechanism using another two reported TWJ-structured aptamers which
bind to DIS and DOG.33 Cy7 was immediately displaced from both aptamers upon the
addition of their respective targets, yielding a significant decrease in the absorbance of
the dye at 760 nm (Figure 5-2). Based on these results, we hypothesized that Cy7 binds to
our TWJs in a sequence-independent manner, a principle that could guide the SELEXbased isolation of new small-molecule binding aptamers with intrinsic Cy7-displacement
functionality.
To confirm our hypothesis, we chemically synthesized a 46-nt TWJ-structured DNA
library, in which each strand contains three fully complementary stems (S1, S2, and S3)
and 10 randomized nucleotides within the junction itself (Figure 5-1A and Table 5-1,
TWJ pool). After mixing 2 μM Cy7 with 10 μM TWJ pool, we observed an increase in
the absorbance of the dye at 760 nm and 670 nm, which respectively corresponds to
binding of the Cy7 monomer and dimer (Figure 5-1B).224,225 To assess the binding of Cy7
to various domains within the TWJ pool, we synthesized the isolated S1 stem with an
added terminal TTT loop (termed the S1 stem-loop), the S2 stem-loop, and the S3 stemloop (Table 5-1 and Figure 5-3A) and characterized the binding of Cy7 to each of them.
We observed that none of the stem-loops bound to the monomer (Figure 5-3B), and the
dimer only bound to the S1 stem-loop—most likely within its minor groove.225 When we
incubated Cy7 with a 1:1:1 mixture of the three isolated stem-loops, only dimer binding
was observed (Figure 5-1B). These results clearly indicated that the Cy7 monomer can
only bind to the fully-assembled TWJ domain of the aptamer.
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Figure 5-1. Cy7 binding to a TWJ-containing structured DNA pool in a sequence-independent
manner. (A) Chemical structure of Cy7 and the sequence of the randomized TWJ pool. (B) When
combined with the TWJ pool, the absorbance of Cy7 monomer (760 nm) and dimer (670 nm) is
enhanced. In contrast, when combined with a 1:1:1 mixture of isolated S1, S2, and S3 stem-loops,
only the absorbance of the dimer is enhanced. (C) Binding stoichiometry of Cy7 monomer to the
TWJ pool as characterized by a Job plot.
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Figure 5-2. Generality of target-induced displacement of Cy7 from aptamers with a TWJstructured binding domain. (A) Structure of DIS and DOG and their respective aptamers, DISS.1
and DOGS.1. Both aptamers contain a TWJ-structured binding domain. Absorbance spectra for a
mixture of 3 μM Cy7 and 7 μM (B) DISS.1 or (C) DOGS.1 in the absence (black line) or
presence (red line) of 250 μM DIS or DOGS, respectively. The greatly reduced Cy7 absorbance
at 760 nm indicates successful displacement of Cy7 from the aptamer TWJ domain.

120

A

B

T

G
T TG
C CN N N N A C A
T A
A
CG
G A
G
T T
S2 N
N S3
N
N
NC GN

S1

A
G
C
A
T
T
C
5'

T
C
G
T
A
A
G
3'

TWJ pool

Isolated stem-loops
T
C
A
G
C
A
T
T
C
5'

T

T
G
T
C
G
T
A
A
G
3'

S2 stem-loop

S1 stem-loop

T
T
T
A T
C G
G C
G C
5' 3'

A
G A
C G
A T
A T
5' 3'

S3 stem-loop

Figure 5-3. Characterization of Cy7 binding to the isolated stems from the TWJ pool. (A)
Sequences of the TWJ pool and isolated S1, S2, and S3 stem-loops. (B) Binding of Cy7 to each
isolated stem-loop. When 2 μM Cy7 was combined with 10 μM S1 stem-loop, only the
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KD= 6.4 ± 0.8 µM

Figure 5-4. Characterization of Cy7 binding to the TWJ pool. (A) Titration of increasing amounts
of the TWJ pool (2–10 μM) into 2 μM Cy7 resulted in enhanced absorbance of Cy7 at 760 nm,
indicating interaction between the TWJ pool and the Cy7 monomer. The dashed line represents
the spectrum of Cy7 alone. (B) Cy7 binding affinity for the TWJ pool was estimated from
absorbance at 760 nm in the absence and presence of different concentrations of TWJ pool.

We then obtained the binding affinity of Cy7 monomer for the TWJ pool by titrating
different concentrations of the pool into 2 μM Cy7. As the concentration of the TWJ pool
increased, we observed an increase in absorbance at 760 nm and a slight decrease in
absorbance at 670 nm (Figure 5-4A). This provided further evidence that the TWJ
domain preferentially binds to the Cy7 monomer. The decreased absorbance of the Cy7
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dimer at higher DNA concentrations implies an equilibrium shift from dimer to monomer
that favors Cy7 binding to the TWJ pool. Based on the absorbance at 760 nm, we
obtained a KD of 6.4 ± 0.8 μM (Figure 5-4B). We further characterized the binding
stoichiometry of the Cy7 monomer to the TWJ pool using a Job plot
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. We measured

the absorbance at 760 nm at various Cy7:DNA ratios, with a constant total concentration
of 5 μM. The maximum absorbance was observed at a mole fraction (XCy7) of 0.5,
indicating that the TWJ pool binds to Cy7 in a 1:1 ratio. Since the Cy7 monomer
exclusively binds to the TWJ domain, each randomized TWJ in the pool should bind to a
single Cy7 monomer (Figure 5-1C). These results confirmed our initial hypothesis that
the binding of Cy7 to TWJs is sequence-independent and indicated that it should
therefore be feasible to isolate new small-molecule-binding aptamers with intrinsic dyedisplacement functionality from TWJ-structured libraries.
5.3.2

Library design and isolation process

We designed a structured library in which we extended both termini of the TWJ pool
by 12 nucleotides, creating partial PCR primer binding sites (Figure 5-5 and Table 5-1,
library). We have previously demonstrated that changes in the sequence adjacent to the
TWJ binding domain greatly affected the affinity of a cocaine-binding aptamer

86,102

.

With this in mind, we randomized one base-pair in stems 2 and 3 to further enhance the
potential target-binding affinity of our aptamer. The resulting library is designed to
primarily form TWJ-structured target-binding domains. Although there is a small
possibility of isolating non-TWJ-structured aptamers in the final enriched pool, these
sequences can be identified and removed after sequencing. It should be noted that the
randomness of this library (414 sequences) is considerably lower than many reported
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SELEX libraries.31,32,100 However, this should not be of concern, as small-molecule
targets can only interact with a limited number of nucleotides within an aptamer’s
binding domain. In fact, several small-molecule-binding aptamers have been successfully
isolated using a TWJ-structured library representing no more than 48 different sequences
33

. Increasing the number of random nucleotides in the TWJ binding domain could also

lead to the isolation of aptamers with non-TWJ structures, which lack dye-displacement
functionality.
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Figure 5-5. Isolation of TWJ-structured aptamers for a Cy7-displacement small-molecule
detection assay. A TWJ-containing structured DNA library is immobilized onto a streptavidincoated bead surface using a biotinylated cDNA strand (left). Target-binding strands are eluted due
to a conformational change in the aptamer (right).

We then used this TWJ-containing library along with a previously reported libraryimmobilized SELEX strategy33 to isolate aptamers for MDPV, an emerging drug of abuse
in the synthetic cathinone family. Since there is currently no reliable presumptive test for
any synthetic cathinone, the development of such an assay would be highly valuable. We
performed SELEX in a low ionic strength buffer (10 mM Tris-HCl, 20 mM NaCl, 0.5
mM MgCl2, pH 7.4), as an excessive amount of ions can induce non-specific
hydrophobic interactions227 between the target and the TWJ binding domain, which
disfavors the isolation of highly target-specific aptamers. We immobilized our library
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onto streptavidin-coated agarose beads through hybridization to a biotinylated
complementary DNA (cDNA) strand (Table 5-1, cDNA-bio) that disrupts the TWJ
structure (Figure 5-5A, left). In the presence of MDPV, library molecules that recognized
this target underwent a conformational change and refolded into a TWJ structure, thereby
detaching themselves from the biotinylated cDNA (Figure 5-5A, right). These aptamers
were collected, PCR amplified, and used for the next round of selection. To further
improve aptamer specificity, we sequentially performed counter-SELEX at various
rounds against three molecules that are structurally similar to MDPV: amphetamine,
methamphetamine, and dopamine.

Figure 5-6. Estimation of target affinity and specificity of the enriched pools during SELEX
using a target elution assay. (A) Target elution profile of the initial library and enriched pools
after selection rounds 3, 5, 7, and 10 was analyzed by PAGE. Lanes 1-6 represent samples of the
initial library and enriched pools eluted with 0, 10, 50, 100, 250, and 500 μM MDPV. Control
samples (lane 7) containing 40 nM synthesized library were used to measure the concentration of
eluted strands and percent elution of each sample. (B) The MDPV binding affinity of the library
and enriched pools were calculated based on the percent elution of each sample. (C) The target
specificity of the enriched pool after 10 rounds of SELEX was also assessed by the target elution
assay. Inset shows the enriched pool eluted with binding buffer (lane 1), 500 μM MDPV (lane 2),
500 μM methamphetamine (lane 3), 500 μM amphetamine (lane 4), and 500 μM dopamine
(lane5).

After each round of SELEX, we estimated the target affinity and specificity of the
enriched pool with a target elution assay. After 10 rounds of selection, the enriched pool
achieved saturated target affinity and low cross-reactivity to the counter-SELEX targets
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(Figure 5-6). The isolated aptamers were then cloned and sequenced. We observed that
all sequences retained the TWJ structure present in the original library. The 10 random
nucleotides (Figure 5-7, positions 9–11, 23–26, 36–38) in the TWJ binding domain
exhibited a high level of consensus, with 41 out of 50 clones sharing an identical
sequence at these sites. The four random nucleotide positions within the stems were more
varied (Figure 5-7, positions 14, 20, 28 and 34), but predominantly retained standard
Watson-Crick base-pairing. We selected the most highly-represented sequence and
truncated the 12-nucleotide partial primer-binding sites at both termini to generate the
MDPV-binding aptamer MA (Table 5-1).

Figure 5-7. Sequence logo for 50 clones isolated after 10 rounds of SELEX, showing the relative
frequency of every nucleotide at each position. Nucleotides at pre-determined positions are
marked grey, while positions with randomized nucleotides are color-coded to show the
distribution of different nucleotides. Higher frequency nucleotides appear in a larger font-size.

5.3.3

Aptamer characterization and development of the label-free Cy7-

displacement assay
We determined the binding affinity of MA using ITC, titrating 1 mM MDPV into a 20
μM solution of the aptamer. We found that MA binds MDPV with a KD of 6.1± 0.2 μM
(Figure 5-8A). Binding is driven by a negative enthalpy change (∆H = -11.0 ± 0.2 kcal
mol-1) but with a moderate entropy cost (∆S = -13.1 ± 0.2 cal mol-1K-1) due to the fact
that MDPV is constrained within the TWJ binding domain. Based on our prior findings,
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we anticipated that Cy7 would also bind to the TWJ domain of MA but could be
displaced by MDPV. This was confirmed by performing an ITC experiment in which we
titrated 1 mM MDPV into 20 μM Cy7-MA complex (1:1). The presence of Cy7 did not
significantly reduce the MDPV-binding affinity of MA (KD = 7.0 ± 0.7 μM) (Figure
5-8B). However, the binding heat (∆H = -6.3 ± 0.2 kcal/mol) was notably lower than in
the absence of Cy7 (∆H = -11.0 ± 0.2 kcal mol-1), indicating that a certain amount of
energy was required for target-induced displacement of the dye. Additionally, the higher
binding entropy obtained with Cy7 (∆S = 0.5 ± 0.7 cal mol-1K-1) suggested positive
entropy associated with the MDPV-mediated release of the dye from the aptamer. These
results indicate that both Cy7 and MDPV can bind to the TWJ-structured binding
domain, and that MDPV can efficiently displace Cy7.
A

B

KD= 6.1 ± 0.2 µM
∆H= -11.0 ± 0.1 kcal mol-1
∆S= -13.1 ± 0.2 cal mol-1K-1

KD= 7.0 ± 0.7 µM
∆H= -6.3 ± 0.2 kcal mol-1
∆S= 0.5 ± 0.7 cal mol-1K-1

Figure 5-8. Binding affinity of MDPV to MA and MA-Cy7 complex. ITC characterization of
MA binding to MDPV in the (A) absence or (B) presence of Cy7 are shown. The top panels
display raw data, showing the heat generated from each titration of MDPV. The bottom panels
show the integrated heat of each titration after correcting for dilution heat of the titrant.

We then employed MA in a label-free colorimetric assay for the detection of MDPV,
where target-induced displacement of Cy7 from the aptamer TWJ binding domain
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produces a change in dye absorbance (Figure 5-9A). Specifically, we added different
concentrations of MDPV (0.1–640 μM) to a solution containing Cy7-MA complexes, and
then immediately began recording the absorption spectra. Within seconds, we observed a
progressive reduction of absorbance at 760 nm and enhancement of absorbance at 670
nm (Figure 5-9B). Using the absorbance ratio at 670/760 nm as an indicator, we obtained
a linear range from 0–40 μM, with a low detection limit of 300 nM (Figure 5-9C).
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Figure 5-9. Detection of MDPV with a label-free Cy7-displacement colorimetric assay. (A) Cy7
binds within the TWJ domain of MA (left). MDPV displaces Cy7 from the binding domain
(right) to generate a change in the absorbance spectra of Cy7. (B) UV-vis spectra of 3 μM Cy7
premixed with 7 μM MA in the presence of varying concentrations of MDPV (0, 0.16, 0.31, 0.63,
1.25, 2.5, 5, 10, 20, 40, 80, 160, 320, 640 µM). The increasing concentrations (shown as
blackred curves) resulted in decreased absorbance at 760 nm and increased absorbance at 670
nm. (C) A calibration curve based on the absorbance ratio at 670/760 nm. Inset shows assay
performance at a low concentration range. Error bars show standard deviation from three
measurements at each concentration.
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Figure 5-10. High cross-reactivity of MA to synthetic cathinone drugs and high specificity
against other structurally–similar or –dissimilar interfering agents. (A) Chemical core structure
and structures of synthetic cathinones. (B) Signal gain measurements from the Cy7-displacement
assay with 50 μM MDPV, other synthetic cathinones, or interfering agents (structures shown in
panel C). Error bars show standard deviations from three measurements of each compound.

Figure 5-11. Cross-reactivity and specificity of our Cy7-displacement assay with 250 μM
MDPV, other synthetic cathinones, or structurally-similar non-cathinone compounds and
common cutting agents. Signal gain was calculated by (R–R0)/R0, where R and R0 are the
absorbance ratio at 670/760 nm with and without target/interfering agent, respectively. Error bars
show standard deviation from three measurements of each compound tested.
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Notably, MA was highly cross-reactive to other synthetic cathinones (methylone,
pentylone, naphyrone and mephedrone) that share the same beta-keto phenethylamine
core structure as MDPV but with different side-chains (Figure 5-10A). We tested MA
cross-reactivity to these four synthetic cathinones at concentrations of 50 μM and 250 μM
in the Cy7-displacement assay. We observed cross-reactivity greater than 65% and 80%
for all four molecules at both concentrations (Figure 5-10B and Figure 5-11). This
suggests that MA specifically recognizes the core structure of synthetic cathinones rather
than their side chain substituents. Interestingly, naphyrone showed exceptionally high
cross-reactivity compared to other synthetic cathinones, possibly due to the
hydrophobicity of its naphthalene moiety. The high cross-reactivity of MA is desirable
for onsite detection of the synthetic cathinone family, a class of designer drugs for which
new derivatives are continually being developed. In contrast, MA was not responsive to
non-synthetic cathinone interfering agents. No specific signal was observed from any of
our three counter-SELEX targets (Figure 5-10C) in our Cy7-displacement assay at
concentrations of 50 μM (Figure 5-10B) or 250 μM (Figure 5-11), despite their structural
similarity to MDPV. We further tested the specificity of the assay against lidocaine,
benzocaine, and caffeine, which are cutting agents commonly found in seized substances
(Figure 5-10C), and likewise observed little cross-reactivity at either concentration
(Figure 5-10B and Figure 5-11). It should be noted that the counter-SELEX targets and
cutting agents either do not contain all the moieties present in MDPV (a phenyl ring, a
ketone, and an amine group), or have all of these moieties but arranged in different
positions. These results indicate that MA recognizes targets based on multiple specific
interactions in a certain arrangement. We found that MA was somewhat cross-reactive to
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the structurally dissimilar compounds cocaine, DIS, and DOG at a concentration of 50
μM, with cross-reactivities of 50%, 18%, and 40% respectively relative to MDPV (Figure
5-12) in the Cy7-displacement assay. We believe this cross-reactivity occurs because
counter-SELEX was not performed against these particular compounds, but it should be
feasible to eliminate this unintended cross-reactivity with well-designed counter-SELEX
procedures against additional structurally dissimilar compounds.
2.0

SIgnal Gain

1.5
60

1.0

30

0.5
0.0

Cross-Reactivity (%)

90

G
D
O

D
IS

ne
C
oc
ai

M

D
PV

0

Figure 5-12. Cross-reactivity of our Cy7-displacement assay with 50 μM MDPV, cocaine, DIS
and DOG. Error bars show standard deviation from three measurements of each compound.

5.3.4

Comparison of Cy7-displacement and strand-displacement assays

Finally, we compared the sensitivity of our Cy7-displacement colorimetric assay with a
strand-displacement fluorescence assay (Figure 5-13) based on the same MDPV-binding
aptamer. We generated a fluorophore-modified version of MA (Table 5-1, MA-F) and a
quencher-modified complementary strand (Table 5-1, cDNA-Q). In the absence of
MDPV, MA-F forms a 15-bp duplex with cDNA-Q that situates the fluorophore in close
proximity to the quencher (Figure 5-13A). The fluorescence of 50 nM MA-F was almost
completely quenched in the presence of 50 nM cDNA-Q (Figure 5-14A). We
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subsequently titrated different concentrations of cDNA-Q into 50 nM MA-F and obtained
a KD of 0.5 ± 0.2 nM (Figure 5-14A, inset). In the presence of MDPV, the target induced
a conformational change in MA-F, forming a TWJ structure that resulted in dissociation
of cDNA-Q, generating a measurable fluorescence signal (Figure 5-13B). We observed
less than 50% fluorescence recovery upon adding various concentrations of MDPV up to
640 μM (Figure 5-14B). We obtained a linear range of 0–20 µM, with a detection limit of
2.5 μM (Figure 5-14C), eight-fold poorer than the Cy7-displacement assay. This is
primarily because cDNA-Q has a much higher affinity for the aptamer than Cy7, which
makes target-induced displacement of the complementary strand less energetically
favorable. To further illustrate this point, we synthesized unmodified versions of MA-F
and cDNA-Q (Table 5-1, MA-L and cDNA) and performed ITC experiments in which we
titrated 1 mM MDPV into 20 μM of MA-L either with or without 20 μM cDNA. We
found that MA-L has an affinity for MDPV almost identical to that of MA (Figure 5-15A,
KD = 6.2 μM) in the absence of cDNA. However, in the presence of 20 μM cDNA, no
MDPV binding was observed (Figure 5-15B), confirming that MDPV could not
efficiently displace the cDNA from the aptamer. It should be noted that stranddisplacement efficiency was lower in the ITC experiment due to the higher concentration
of aptamer-cDNA complex employed (20 µM), which greatly reduces the level of
dissociation of this complex. As a control, we titrated 1 mM MDPV into 20 µM Cy7MA-L (1:1), and found that the presence of Cy7 does not attenuate MDPV binding by
MA-L (Figure 5-15C, KD = 7.0 μM). These results clearly demonstrate that the Cy7displacement assay is more sensitive than an equivalent strand-displacement assay for the
detection of small-molecule targets.
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Figure 5-13. Working principle of a conventional strand-displacement fluorescence assay. (A) In
the absence of MDPV, MA-F forms a 15-bp duplex with cDNA-Q, which situates the fluorophore
in close proximity to the quencher, thus quenching fluorescence. (B) MDPV induces a targetinduced conformational change in MA-F, forming a TWJ structure that results in dissociation of
cDNA-Q, generating a measurable fluorescence signal.
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Figure 5-14. Strand-displacement fluorescence assay based on the MA aptamer. (A)
Fluorescence spectra obtained from titration of cDNA-Q into a solution of MA-F at different
molar ratios (0–2×). Inset shows binding affinity of cDNA-Q to MA-F as estimated from the
fluorescence intensity at 668 nm in the absence and presence of different concentrations of
cDNA-Q. (B) Fluorescence spectra obtained from titration of different concentrations of MDPV
into 50 nM MA-F and 50 nM cDNA-Q. (C) Calibration curves for the strand-displacement
fluorescence assay. Inset shows assay performance at a low concentration range. Error bars show
standard deviation from three measurements at each concentration.
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Figure 5-15. Affinity of MDPV to MA-L, cDNA-MA-L complex, and Cy7-MA-L complex.
MDPV binding affinity to (A) MA-L alone, (B) cDNA-MA-L complex (1:1), and (C) Cy7-MA-L
complex (1:1) are characterized by ITC. The top panels display raw data showing the heat
generated from each titration of MDPV. The bottom panels show the integrated heat of each
titration after correcting for dilution heat of the titrant.

5.4. Conclusions
In this report, we describe a general approach for the isolation of small-moleculebinding aptamers with intrinsic dye-displacement functionality that can be directly
implemented in a label-free colorimetric assay. We first determined that Cy7 can bind to
a randomized TWJ-structured DNA library pool in a sequence-independent manner. We
then used a TWJ-structured library to isolate a DNA aptamer against MDPV, an
emerging designer drug, and directly employed the isolated aptamer in a Cy7displacement colorimetric assay without any further engineering. The assay showed high
target sensitivity, detecting MDPV at concentrations as low as 300 nM, 20-fold lower
than the KD of the aptamer, within seconds at room temperature. Our aptamer showed
high specificity in terms of discriminating against structurally-similar non-synthetic
cathinone compounds such as amphetamine, methamphetamine, and dopamine as well as
common cutting agents such as lidocaine, benzocaine, and caffeine. At the same time, the
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isolated aptamer was highly cross-reactive to other synthetic cathinones such as
naphyrone, methylone, pentylone, and mephedrone, indicating that it could offer a
broadly applicable yet specific assay for this particular class of designer drugs, based on
recognition of shared core structural features.
Our determination that Cy7 can generally bind our DNA TWJs in a sequenceindependent manner means that such dye-displacement assays can be generalized for the
detection of other small-molecule targets using existing or future isolated TWJ-structured
aptamers. Since we have previously demonstrated that the fluorescent dye ATMND can
bind to the TWJ domain of a cocaine-binding aptamer,102 we anticipate that other
hydrophobic small-molecule dyes may also serve as signal reporters in such dyedisplacement assays. Our assay is simple, rapid, sensitive, and cost efficient, as it can be
performed by simply mixing the sample, Cy7, and unmodified aptamer. The Cy7
absorbance read-out can be quantified in seconds by a microplate-reader or portable
photometer, allowing for high-throughput or on-site detection, respectively. Importantly,
the absorbance of Cy7 at 670 nm and 760 nm exhibits minimal overlap with other small
molecules 228 or sample matrices,229 potentially allowing for interference-free detection in
complex specimens. Finally, our assay is eight-fold more sensitive than an equivalent
strand-displacement fluorescence assay, because Cy7 is more efficiently displaced by
small-molecule targets than a hybridized cDNA strand. Therefore, we believe that our
SELEX strategy using our TWJ-structured library could offer a broad foundation for the
development of sensitive and simple Cy7-displacement colorimetric assays for the
detection of a wide variety of small-molecule targets.
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CHAPTER 6: In Vitro Isolation of Class-Specific Oligonucleotide-Based SmallMolecule Receptors
6.1. Introduction
It is highly advantageous to be able to sensitively detect multiple different members of
a particular molecular family or class in many analytical contexts—for example,
detecting illicit drugs and their metabolites for forensic investigations, antibiotics for food
safety, or pesticides for environmental monitoring.67–69 Cross-reactive assays that can
broadly detect small molecules based on a shared molecular framework offer a more
efficient and cost-effective solution to this problem than the tandem use of multiple
highly specific assays that each detects an individual analyte. Antibody-based
immunoassays have dominated the field of small-molecule detection,230 and while assays
have been developed for a wide variety of individual targets, the development of classspecific immunoassays has proven difficult.231,232 This is in part because the process of
antibody generation, which is performed in vivo, provides no control over the targetbinding affinity and spectrum of the resulting antibody. Nucleic-acid-based affinity
reagents known as aptamers hold much promise in circumventing many of the
shortcomings associated with antibodies.76 Aptamers are isolated through SELEX to bind
targets of interest with high affinity and specificity. Unlike antibodies, aptamers can be
isolated relatively quickly and chemically synthesized in an inexpensive manner with no
batch-to-batch variation. Moreover, aptamers are thermostable and have shelf lives of a
few years at room temperature.15
Theoretically, since SELEX is an in vitro process, the selection strategy and
conditions can be precisely controlled to isolate class-specific aptamers that can broadly
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bind to small molecules sharing the same core structure. However, little work has been
done to demonstrate the capability of SELEX to achieve such a goal. Aptamers isolated
for a given small-molecule target often have innate cross-reactivity to analogs of that
molecule, but the target-binding spectra of these aptamers are often either insufficient
and/or unpredictable. For example, one heavily studied cocaine-binding aptamer21 can
also bind to metabolites such as norcocaine and cocaethylene, but does not respond to the
major metabolite benzoylecgonine, which only differs from cocaine by a single methyl
group.88,233 Toggle-SELEX was developed as a solution to isolate cross-reactive
aptamers.26 In this strategy, a library pool is challenged with two different targets sharing
the same core structure, which are alternated every round to select for an aptamer that can
cross-react to both targets—and ideally, target analogs sharing the same core structure.
This method has led to the isolation of cross-reactive aptamers for a few structurallyrelated small molecules.36,39,73 However, these aptamers typically exhibit only limited
cross-reactivity,39,73 and the overall success rate of such approaches has been low.36 For
example, Derbyshire et al. successfully isolated an aptamer that can bind to eight
aminoglycoside antibiotics using Toggle-SELEX. Out of four independent selections
with four different target pairs, and only one yielded the final aptamer.36 The limitations
of Toggle-SELEX could be attributed to two reasons. First, in previously reported
approaches, only a fraction of possible substituent positions was varied between the two
targets, yielding aptamers with narrow target-binding spectra. Second, since only a small
portion of the aptamers in the initial pool are cross-reactive compared to those that bind
to at least one target, those cross-reactive aptamers could be lost during Toggle-SELEX.
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To overcome these problems, we have developed a new ‘parallel-and-serial’ selection
strategy for SELEX to isolate class-specific aptamers for small molecule families. Our
strategy has three steps that are crucial for its success. First, a set of structurally-related
targets are selected to define the core structure that is to be recognized by the isolated
aptamer. The use of these targets creates selection pressure for aptamers that recognize
generic molecular features common to all targets while remaining insensitive to
peripheral substituents. Accordingly, it is important to choose as many targets as needed
to represent variations at all desired substituent sites while preserving the core molecular
framework of the target family. Next, these various targets are employed in a parallel
selection process, in which multiple aptamer pools are enriched using each individual
target. As a result, cross-reactive aptamers recognizing the shared core structure are
enriched in all of the resulting pools after a few rounds of selection. When all these
parallel pools are combined, the population of such aptamers should be relatively high.
Finally, this combined pool is subjected to serial selection with each target sequentially, a
process that ultimately retains only those aptamers that bind to the core structure shared
by these targets. Importantly, this selection strategy is supplemented with a well-designed
counter-SELEX procedure25 to further define the targeted core structure and to prevent
the aptamer from binding to structurally-similar non-target molecules.
As a demonstration of this strategy, we isolated a class-specific aptamer for synthetic
cathinones, a large family of dangerous designer drugs173 that are associated with many
severe psychological and physiological health consequences.174,175 The isolated aptamer
demonstrated low nanomolar binding affinity to 12 synthetic cathinones while having no
response to 11 structurally-similar non-cathinone molecules. Analysis of the aptamer
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isolation process via high throughput sequencing revealed that cross-reactive sequences
were enriched during parallel selection, and that exponential enrichment of such aptamers
occurred during serial selection. The target-binding spectrum of the aptamer was further
evaluated via a dye-displacement sensing platform. Impressively, the aptamer enabled
instantaneous colorimetric detection of several synthetic cathinones at nanomolar
concentrations in biological samples, rivaling the performance of any currently-available
immunoassays which can only detect a few members of this family. To our knowledge,
this is the first demonstration of using a rationally-designed strategy to isolate highaffinity aptamers that are truly class-specific, having both broad target-binding spectrum
as well as excellent specificity. Such success shows that the customizable nature of
SELEX makes it well-suited for sourcing receptors with specific, yet broad molecular
recognition capabilities, and that the approach described herein can be generally
employed to directly isolate class-specific aptamers for any small-molecule family.
6.2. Experimental section
6.2.1

Materials

All DNA oligonucleotides were purchased from Integrated DNA Technologies
(HPLC-purified) and dissolved in PCR water. The names and sequences of the DNA
oligonucleotides are listed in

Table 6-1. The concentrations of dissolved DNA were measured using a NanoDrop
2000 spectrophotometer (Thermo Fisher Scientific). Synthetic cathinone standands (all
hydrochloride salts and racemic unless specified), including 3,4-methylenedioxy-αpyrrolidinobutiophenone (MDPBP), 3,4-methylenedioxypyrovalerone (MDPV), 3-
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fluoromethcathinone

(3-FMC),

4-fluoromethcathinone

(4-FMC),

4-methyl-

αpyrrolidinobutiophenone (MePBP), 4'-methyl-α-pyrrolidinohexiophenone (MPHP), 4methylmethcathinone (4-MMC), alpha-pyrrolidinopentiophenone (α-PVP), butylone,
cathinone, ethylone, methcathinone, methedrone, methylone, naphyrone, pentylone,
pyrovalerone, and pure enantiomers (-)-MDPV and (+)-MDPV were purchased from
Cayman Chemicals. Acetaminophen, (±)-amphetamine hemisulfate, benzocaine, caffeine,
cocaine HCl, diethylthiatricarbocyanine iodide (Cy7), (-)-ephedrine HCl, lidocaine HCl,
(+)-methamphetamine HCl, procaine HCl, promazine HCl, (+)-pseudoephedrine HCl,
sucrose and all other chemicals were purchased from Sigma-Aldrich unless otherwise
noted. Tween 20, formamide, SYBR Gold, streptavidin-coated agarose resin (capacity:
1-3 mg biotinylated BSA/ml resin), One Shot Chemically Competent E. coli, TOPO TA
cloning kit, PureLink Quick Plasmid Miniprep Kit, and ExoSAP-IT Express PCR
Purification Kit were purchased from ThermoFisher Scientific. 500 μL micro-gravity
columns were purchased from Bio-Rad. GoTaq Hot Start Colorless Master Mix was
purchased from Promega. 3 kDa cut-off spin filters were purchased from Millipore.
Table 6-1. Sequences of DNA oligonucleotides employed in Chapter 6.
Sequence ID

Sequence (5’ – 3’)
CGAGCATAGGCAGAACTTACGAC(N30)
DNA Library
GTCGTAAGAGCGAGTCATTC
cDNA-bio
TTTTTGTCGTAAGTTCTGCCATTTT/Bio/
FP
CGAGCATAGGCAGAACTTAC
RP-bio
/Bio/GAATGACTCGCTCTTACGAC
RP
GAATGACTCGCTCTTACGAC
SCA2.1
CTTACGACCTTAAGTGGGGTTCGGGTGGAGTTTATGGGGTCGTAAG
N represents random base; /Bio/ represents biotin modification
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6.2.2

SELEX strategy

The isolation of aptamers was carried out via a parallel-and-serial selection strategy.
The whole aptamer isolation process consisted of five (ethylone and butylone) or nine (αPVP) rounds of parallel selection and two cycles of serial selection. Detailed information
regarding the conditions for each round of selection are listed in Table 6-2. Since each
sequence has a low copy number at the beginning of SELEX, high target concentrations
were used during the first few rounds to ensure retention of all possible target binders.
Moreover, counter-target concentrations were initially kept low to remove high-affinity
interferent binders while avoiding loss of target binders. In later rounds of SELEX,
selection stringency was increased by decreasing the target concentration and increasing
the counter-target concentration; this would yield aptamers with high target affinity and
specificity. The counter-SELEX protocol was rationally designed to encompass known
and commonly-observed interferents found in seized drug samples, including cutting
agents (e.g., caffeine and acetaminophen), adulterants (e.g., procaine, lidocaine, and
promazine), other illicit drugs (e.g., cocaine and methamphetamine), or structurallyrelated non-cathinone molecules (e.g., amphetamine, pseudoephedrine and ephedrine) to
ensure that the isolated aptamer did not bind to them.
6.2.3

Parallel selection

Parallel selection began with three initial pools consisting of 1 nmole DNA library
(Table 6-1) for each of the three different selection targets (α-PVP, ethylone, butylone).
From Round P2 to P9, ~ 300 pmole of enriched library pool for each target from the
previous round were employed in the subsequent round. Positive selection was performed
with progressively decreasing target concentrations (Round P1: 1 mM, Rounds P2–P3:
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500 µM, Rounds P4–P5: 250 µM for α-PVP, ethylone and butylone; Rounds P6–P9: 100
µM for α-PVP only) to increase selection stringency for the enrichment of strong binders.
For every round after the first, counter-selection was performed prior to positive selection
in order to eliminate non-specific binders. The number of counter-targets and their
concentrations were progressively increased during the selection process to increase
selection stringency. Specifically, from Rounds P2–P5 for the ethylone and butylone
pools and Rounds P2–P8 for the α-PVP pool, we used the following counter-selection
strategy: 100 µM cocaine for Round P2, a mixture of 100 µM cocaine and 100 µM
procaine for Round P3, and a mixture of 100 µM cocaine, 100 µM procaine, and 100 µM
lidocaine for Rounds P4–P8. For Round P9 for the α-PVP pool, 300 µM each of cocaine,
procaine, and lidocaine was employed consecutively for counter selection (Table 6-2).
6.2.4

Serial selection

We combined 100 pmole each from the P5 parallel pools for ethylone and butylone
and the P9 parallel pool for α-PVP to generate the initial pool for serial selection. Two
cycles of serial selection (Cycle 1 comprising Rounds S1–S3, Cycle 2 comprising
Rounds S4–S6) were performed to specifically isolate cross-reactive aptamers. For each
cycle, positive selection was performed by alternating the selection target (Rounds S1 &
S4: butylone, Rounds S2 & S5: ethylone, and Rounds S3 & S6: α-PVP). Target
concentration was maintained at 100 µM for each round of serial selection for maximum
stringency. In the first cycle of serial selection, counter-SELEX was performed prior to
each round of positive selection by consecutively challenging the pool with 500 µM each
of cocaine, procaine, and lidocaine, while in the second cycle of serial selection, counterSELEX was performed by sequentially challenging with a mixture of 500 µM each of
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ephedrine, pseudoephedrine, acetaminophen, methamphetamine, amphetamine; then with
a mixture of 1 mM each of cocaine, procaine, and lidocaine; and finally with 500 µM
promazine (Table 6-2).
Table 6-2. Detailed information regarding the conditions for each round of SELEX.
Round
#

P6
P7
P8

Pool size
(pmole)
1000
1000
1000
358
346
368
321
362
345
319
367
292
300
300
300
300
300
300

P9

300

S1
S2
S3
S4
S5

300*
300
300
300
300

S6

300

P1

Parallel selection

P2

P3

P4

Serial selection

P5

Counter-targets
N/A

COC (100 µM)

Mixture of COC & PRC (100 µM each)

Mixture of COC, PRC, & LDC (100 µM each)

Mixture of COC, PRC, & LDC (100 µM each)
Mixture of COC, PRC, & LDC (100 µM each)
Mixture of COC, PRC, & LDC (100 µM each)
Mixture of COC, PRC, & LDC (100 µM each)
COC
PRC
LDC
(300 µM)
(300 µM)
(300 µM)
COC
(500 µM)

PRC
(500 µM)

LDC
(500 µM)

Mixture of EPH,
PSE, ACM,
METH, & AMP
(500µM each)

Mixture of COC,
PRC, & LDC
(1000 µM each)

Promazine
(500µM)

Targets
(µM)
Butylone (1000)
Ethylone (1000)
α-PVP (1000)
Butylone (500)
Ethylone (500)
α-PVP (500)
Butylone (500)
Ethylone (500)
α-PVP (500)
Butylone (250)
Ethylone (250)
α-PVP (250)
Butylone (250)
Ethylone (250)
α-PVP (250)
α-PVP (100)
α-PVP (100)
α-PVP (100)
α-PVP (100)
Butylone (100)
Ethylone (100)
α-PVP (100)
Butylone (100)
Ethylone (100)
α-PVP (100)

Consists of 100 pmole each of pool enriched with butylone (Round P5), ethylone (Round P5)
and α-PVP (Round P9).
Acetaminophen (ACM), amphetamine (AMP), cocaine (COC), ephedrine (EPH), lidocaine (LDC),
methamphetamine (METH), procaine (PRC), pseudoephedrine (PSE).
*
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6.2.5

SELEX procedure

The isolation of aptamers was carried out following a previously-reported libraryimmobilized SELEX protocol.61 The initial single-stranded DNA library used for SELEX
consisted of approximately 6×1014 oligonucleotides. Each library strand is stem-loop
structured and 73 nucleotides in length, with a randomized 30 nucleotide loop flanked in
turn by a pair of 8-nt stem-forming sequences and two primer-binding regions (Table
6-1, DNA library). For each round of SELEX, the library/pool was mixed with
biotinylated capture strands (Table 6-1, cDNA-bio) at a molar ratio of 1:5 in selection
buffer (10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, pH 7.4), heated at 95 °C for 10
min, and cooled at room temperature for over 30 min to ensure hybridization between
library and capture strands. A micro-gravity column was prepared by adding 250 μL of
streptavidin-coated agarose beads followed by three washes with 250 µL of selection
buffer. 250 µL of library solution was then flowed through the micro-gravity column
three times in order to conjugate the library to the agarose beads (Figure 6-1A). The
column was subsequently washed 10 times with selection buffer. Then, 250 µL of target
(α-PVP, ethylone or butylone) dissolved in selection buffer was added to the column.
Library molecules that bound to the target underwent a conformational change, which
caused them to detach themselves from the biotinylated cDNA into solution (Figure
6-1B). The eluent containing these strands was collected. This process was repeated
twice, and all eluents were combined (750 µL total). The resulting pool was concentrated
via centrifugation using a 3 kDa cut-off spin filter. The concentrated pool (100 µL) was
then mixed with 1 mL of GoTaq Hot Start Colorless Master Mix with 1 µM forward
primer (Table 6-1, FP) and 1 µM biotinylated reverse primer (Table 6-1, RP-bio) to
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amplify the pool via PCR. Amplification was performed using a BioRad C1000 thermal
cycler with conditions as follows: 2 min at 95 °C; 13 cycles of 95 °C for 15 s, 58 °C for
30 s, and 72 °C for 45 s; and 5 min at 72 °C. The optimal number of amplification cycles
was determined by performing pilot PCR to ensure sufficient amplification of enriched
sequences without generating PCR-related artifacts. Amplification of the enriched pool
and the absence of byproducts was confirmed using 3% agarose gel electrophoresis. If
byproducts with differing lengths from the original library strands were observed, the
pool was purified with a 4% agarose gel and the 73-nt products were recovered by silica
column as reported previously.61 To generate single-stranded DNA from the resulting
double-stranded PCR products, a fresh micro-gravity column was prepared containing
250 µL streptavidin-coated agarose beads. The amplified pool was then flowed through
the column three times to conjugate the pool to the beads. Afterwards, the column was
washed six times with 250 µL of separation buffer (10 mM Tris-HCl, 20 mM NaCl, pH
7.4). The column was then capped, and 300 µL of a 0.2 M NaOH solution was added to
the column and incubated for 10 min to generate single-stranded DNA, after which the
eluent was collected. An additional 100 µL of 0.2 M NaOH was added to elute residual
library strands from the column. Both eluents were combined and neutralized with 0.2 M
HCl, and the pool was then concentrated via centrifugation with a 3 kDa cut-off spin
filter. For every round after the first, counter-SELEX was performed before the positive
selection step. Specifically, the library-immobilized column was washed with 250 µL of
counter-target(s) in selection buffer to remove non-specific DNA strands. This process
was repeated three times for Rounds P1–P3 and S1–S6, and ten times for Rounds P4–P5
and, in the case of α-PVP, Rounds P6–P9. Afterwards, the column was washed 30 times
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with selection buffer to wash away non-specific binders in preparation for positive
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Figure 6-1. Scheme for library-immobilized SELEX. (A) Library molecules are immobilized on
streptavidin-coated agarose beads via a biotinylated complementary DNA (cDNA) strand. (B)
Strands that bind to the target are released into solution via target-induced strand displacement.

6.2.6

Gel elution assay

The enrichment, target affinity, specificity, and cross-reactivity of the pools collected
after Rounds P5 (for α-PVP, ethylone, and butylone), P9 (for α-PVP only), S3, and S6
were evaluated using a modified version of a previously reported gel elution assay
(Figure 6-2).34 Specifically, 50 pmole of enriched library (Figure 6-2A) was incubated
with 250 pmole of biotinylated cDNA in 125 μL of selection buffer, heated at 95°C for
10 min, and cooled at room temperature over 30 min to anneal both strands and form
cDNA-library complex (Figure 6-2B). Afterwards, a microcentrifugation column was
prepared by adding 125 μL of streptavidin-coated agarose beads. The cDNA-library
complex was then added to the column and immobilized on the beads (Figure 6-2C), and
the eluent was collected and recycled through the column twice more. The libraryimmobilized agarose beads were transferred into a microcentrifugation tube and washed
five times by adding 625 µL of selection buffer, incubating on an end-over-end rotator
for 5 min, followed by centrifugation and removal of the supernatant. The volume of the
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library-immobilized bead solution was adjusted to 150 µL with selection buffer and
aliquoted into 7 tubes (20 μL/tube). Afterwards, 50 μL of target at a variety of final
concentrations (0, 10, 50, 100, 250, 500, or 1,000 μM) was added into each tube (Figure
6-2D). After rotating for 60 min on an end-over-end rotator at room temperature, the
beads were settled by centrifugation and 40 µL of the supernatant, which contained the
target-eluted strands, was collected and set aside (Figure 6-2E). Meanwhile the leftover
solution (30 µL) (Figure 6-2F) was mixed with 50 μL of a 95% formamide solution
containing 10 mM EDTA and incubated at 90 °C for 10 min to completely release all
DNA strands from the beads (Figure 6-2G). The resulting solution contained both
leftover target-eluted strands and non-target-eluted strands. We analyzed the target-eluted
aptamer solution and formamide-treated library solution via 15% denaturing
polyacrylamide gel electrophoresis (PAGE) and determined the concentrations of the
strands based on standardized concentrations of ladder loaded in the gel. The elution
percentage was calculated using the equation:

where θ is the fraction of target-eluted strands, cs is the concentration of target-eluted
strands, cb is the concentration of strands in the formamide solution, V1 is the volume of
solution before supernatant collection (estimated as 62 μL, with ~8 μL occupied by
agarose beads), V2 is the volume of the collected supernatant containing target-eluted
strands (40 μL), and V3 is the volume of solution after addition of formamide (80 μL). A
calibration curve was created by plotting the fraction of eluted strands against the
employed target concentration. The resulting curve was fitted with the Langmuir equation
to determine the dissociation constant (KD) of the enriched pool. The same protocol was
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used to determine the target cross-reactivity and specificity of the enriched pool for other
synthetic cathinones (4-MMC, 4-FMC, MDPBP, MDPV, MePBP, methedrone,
methylone,

MPHP,

(acetaminophen,

naphyrone,

pentylone,

amphetamine,

caffeine,

and

pyrovalerone)

cocaine,

or

interferents

ephedrine,

lidocaine,

methamphetamine, procaine, promazine, pseudoephedrine, and sucrose).

Figure 6-2. Scheme of the gel elution assay. (A) Library strands are hybridized with biotinylated
cDNA to form (B) library-cDNA complex. (C) The resulting complex is immobilized on
streptavidin-coated agarose beads. (D) The target is added the solution and (E) the supernatant
containing the target-bound strands is collected and added to a separate tube. (F) The leftover
beads are treated with formamide-EDTA and heat to (G) release remaining non-binding strands
from the beads. The quantity of DNA in the solutions obtained from E and G is determined via
PAGE; the number of eluted strands is used to calculate the pool binding affinity and specificity
using the boxed equation.

6.2.7

High throughput sequencing (HTS) analysis of the aptamer isolation process

HTS of the three final parallel pools and two serial pools was performed using Ion
Torrent Sequencing. To prepare samples for sequencing, 1 µM pool was mixed with
GoTaq® Hot Start Colorless Master Mix, 1 µM forward primer, and 1 µM reverse primer
with a final volume of 100 µL. PCR was then performed with the same PCR conditions
as described in ‘SELEX Procedure’. Then 40 µL of PCR product was added into 16 µL
of ExoSAP-IT™ reagent in an ice bath. The mixture was then incubated at 37 ℃ for 15

min to degrade remaining primers and nucleotides, followed by incubation at 80 ℃ for 15
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min to inactivate ExoSAP-IT reagent. HTS was performed at FIU DNA Core Facility
using an Ion Personal Genome Machine System with an Ion 318 v2 chip (ThermoFisher
Scientific). Upon obtaining the sequencing data, the primer sequences were trimmed by
cutadapt234 and the population of sequences from each pool were calculated using
FASTAptamer.235 Members of the SCA2.1 family are defined as sequences containing
“AGTGGGGTTCGGGTGGAGTT” in any position in the 30-nt random region.
6.2.8

Cloning and sequencing

Cloning and sequencing of the final enriched pool was performed using a previously
reported protocol.61 Briefly, the enriched sequences from the final pool (Round S6) were
amplified by PCR with unlabeled forward and reverse primers (Table 6-1, FP and RP)
using the same program as described above in ‘SELEX procedure’. At the end of the
amplification protocol, an additional 30 min extension step was performed at 72 °C to
add a poly-A tail. Amplicons were cloned into a plasmid vector and transformed into E.
coli cells using the TOPO TA cloning kit (Invitrogen) according to the supplier
recommendations. The plasmids from 50 randomly picked colonies were extracted using
a PureLink Quick Plasmid Miniprep Kit (Invitrogen) and sequenced via Sanger
Sequencing at the Florida International University DNA Core Facility. After removing
the sequences of the plasmid and primers, the aptamer sequences were aligned with
BioEdit software to determine the consensus sequence.
6.2.9

Isothermal titration calorimetry (ITC)

ITC was performed using a MicroCal ITC200 instrument (Malvern). All ITC
experiments were carried out using the following protocol at 23 °C. A solution containing
the aptamer (final concentration 20 µM) was prepared in selection buffer (10 mM Tris-

148

HCl, 0.5 mM MgCl2, 20 mM NaCl, pH 7.4) and loaded into the ITC sample cell. We then
loaded different concentrations of synthetic cathinone (350 µM (±)-α-PVP, 300 µM (±)ethylone, 400 µM (±)-butylone, 300 µM (±)-MDPV, 225 µM (-)-MDPV, or 400 µM (+)MDPV) or interferent (1 mM (±)-amphetamine, (+)-methamphetamine, cocaine,
procaine, or (+)-ephedrine) in the same buffer into the syringe and titrated it into the cell,
with an initial 0.4 μL purge injection followed by 19 successive 2 μL injections. A
spacing of 180 seconds was used between each titration. The heat generated from each
titration was recorded, and the binding stoichiometry (N), enthalpy (ΔH), and KD were
obtained by fitting the resulting titration curve with a single-site binding model (wherein
the aptamer and synthetic cathinone are considered to be the receptor and ligand,
respectively) using the MicroCal analysis kit integrated into Origin 7 software. All
titrations involving racemic synthetic cathinone mixtures were also fitted with a modified
two-site binding model to determine the binding parameters for each enantiomer. This
model assumes that a receptor with two ligand-binding sites independently interacts with
a ligand. Unlike the single-site binding model, the aptamer in the sample cell is
considered as the ligand and the pair of synthetic cathinone enantiomers is considered as
a receptor with two discrete binding sites. For example, titration of 300 µM (±)-MDPV –
containing 150 µM each of (-)-MDPV and (+)-MDPV – into 20 µM SCA2.1 is treated as
titration of 150 µM of a receptor with two independent ‘binding sites’ into 20 µM of
ligand. The binding parameters of the first site (i.e. N1, KD1, ΔH1) reflect the binding of
one of the enantiomers to the aptamer, while those for the second site (i.e. N2, KD2, ΔH2)
reflect the binding of the other.
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6.2.10 Characterization of Cy7 binding to SCA2.1
8 µL of different concentrations of SCA2.1, 8 µL of 20 µM Cy7, and 64 µL of
reaction buffer (final concentration 10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl,
0.01% Tween 20, and 1% DMSO, pH 7.4) were mixed in the wells of a transparent flatbottomed 384-well plate. UV-vis spectra were immediately recorded from 450–900 nm
using a Tecan Infinite M1000 PRO microplate reader at room temperature. The
absorbance value at 775 nm (λmax of Cy7 monomer) was plotted against the concentration
of added aptamer. KD was estimated by non-linear fitting using the Langmuir equation.
6.2.11 Cy7-displacement assay for colorimetric detection of synthetic cathinones
8 µL of SCA2.1 (final concentration: 3 μM), 8 µL of Cy7 (final concentration 2 μM),
8 µL of varying concentrations of target (α-PVP, butylone, or ethylone), and 56 µL of
reaction buffer (final concentration 10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl,
0.01% Tween 20, 1% DMSO, pH 7.4) were mixed in the wells of a transparent flatbottomed 384-well plate. UV-vis spectra were immediately recorded from 450–900 nm
using a Tecan microplate reader at room temperature. The absorbance ratio between 670
nm and 775 nm (A670/A775) was calculated for each sample, and signal gain was
calculated by (R–R0)/R0, where R0 and R represent A670/A775 without and with target,
respectively. Using the same protocol, the cross-reactivity and specificity of the assay
were tested with other synthetic cathinones (naphyrone, MDPV, pentylone, methylone, 4MMC, 4-FMC, 3-FMC, methcathinone and cathinone) and interferents (amphetamine,
methamphetamine,

cocaine,

pseudoephedrine,

ephedrine,

procaine,

lidocaine,

benzocaine, caffeine, acetaminophen, and sucrose) at a concentration of 50 µM. Crossreactivity was calculated using the signal gain of 50 µM ethylone as 100%. For visual
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synthetic cathinone detection, the assay was performed using the same protocol but with
higher concentrations of SCA2.1 (5 μM) and Cy7 (3.5 μM) with 50 μM of the
aformentioned synthetic cathinones or interferents. Samples were loaded into a white
flat-bottomed 384-well plate. Photographs of the samples were taken using a digital
camera immediately after mixing all reaction components.
6.3. Results and discussion
6.3.1

Choosing targets for selection

Synthetic cathinones share the same β-keto phenethylamine chemical core structure
and typically differ at four substituent sites (Figure 6-3A, core structure). Performing
selection directly against this ‘bare core’ (i.e. 2-amino-propiophenone, also known as
cathinone) may yield aptamers with high affinity towards cathinone, but there is no
guarantee that such aptamers will bind other synthetic cathinones that have different
substituents on the core structure. This is supported by previous studies which showed
that small-molecule-binding aptamers isolated for a single target often have lower or no
affinity for compounds with additional/differing substituents.25,110 We rationalized that
performing SELEX with a set of structurally-similar, yet sufficiently diverse, targets
would create selection pressure for isolating aptamers that tolerate variations at all such
sites, greatly increasing the likelihood that the isolated aptamer will have high crossreactivity to this family as a whole. Thus, to isolate class-specific synthetic cathinonebinding aptamers, we selected three targets that share the same core structure but have
variations at all of the substitution sites that are typically modified in this family: αpyrrolidinovalerophenone (α-PVP), ethylone, and butylone (Figure 6-3A).
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Figure 6-3. Isolation of a class-specific aptamer using a parallel-and-serial SELEX strategy. (A)
The core structure of synthetic cathinones and the three targets chosen for parallel-and-serial
SELEX, with substituent moieties shaded in red. (B) Schematic diagram of parallel-and-serial
SELEX. Each of the three targets was subjected to parallel SELEX to enrich for broadly synthetic
cathinone-specific aptamers (top), after which the resulting pools were combined and subjected to
serial SELEX screening (bottom) to eliminate target-specific binders while retaining those
aptamers with broad cross-reactivity for this drug class.

6.3.2

Parallel selection

Parallel selection was performed using three different initial library pools, with one
pool being challenged with α-PVP, one with ethylone, and one with butylone (Figure
6-3B, top). Presumably, challenging the parallel pools with individual targets enriches all
sequences binding to the target, including those that are also cross-reactive to other
synthetic cathinones. In contrast, challenging a single pool with a mixture of targets may
lead to loss cross-reactive aptamers. This is evidenced by a previous study which
demonstrated that performing SELEX with a mixture of four targets yielded aptamers
that specifically bind to just one of the four.37 This may be attributable to competitive
binding among these targets.
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A

[Ethylone]

B

Figure 6-4. Determination of the target-binding affinity, cross-reactivity, and specificity of the
round P5 ethylone pool via gel-elution assay. (A) Polyacrylamide gel electrophoresis (PAGE)
results depict the target elution profile, with lanes representing samples of the pool eluted with 0,
50, 100, 250, 500, or 1,000 µM ethylone (left to right). The percent of target-eluted pool was
plotted against the concentration of ethylone employed for elution to determine the binding
affinity of the enriched pool. (B) PAGE analysis (top) of elution with 500 µM synthetic
cathinones (α-PVP, ethylone, butylone) or interferents (cocaine, procaine, lidocaine) was used to
measure cross-reactivity and specificity of the enriched P5 pool.

A

[Butylone]

B

Figure 6-5. Determination of the target-binding affinity, cross-reactivity, and specificity of the
round P5 butylone pool via gel-elution assay. (A) PAGE results depict the target elution profile,
with lanes representing samples of the pool eluted with 0, 50, 100, 250, 500, or 1,000 µM
butylone (left to right). The percent of target-eluted pool was plotted against the concentration of
butylone employed for elution to determine the binding affinity of the enriched pool. (B) PAGE
analysis (top) of elution with 500 µM synthetic cathinones (α-PVP, ethylone, butylone) or
interferents (cocaine, procaine, lidocaine) was used to measure cross-reactivity and specificity of
the enriched P5 pool.

153

B

A
[α-PVP]

Figure 6-6. Determination of the target-binding affinity, cross-reactivity, and specificity of the
round P5 α-PVP pool via gel-elution assay. (A) PAGE results depict the target elution profile,
with lanes representing samples of the pool eluted with 0, 50, 100, 250, 500, or 1,000 µM α-PVP
(left to right). The percent of target-eluted pool was plotted against the concentration of α-PVP
employed for elution to determine the binding affinity of the enriched pool. (B) PAGE analysis
(top) of elution with 500 µM synthetic cathinones (α-PVP, ethylone, butylone) or interferents
(cocaine, procaine, lidocaine) was used to measure target-cross-reactivity and specificity of the
enriched P5 pool.

A

[α-PVP]

B

Figure 6-7. Determination of the target-binding affinity, cross-reactivity, and specificity of the
round P9 α-PVP pool via gel-elution assay. (A) PAGE results depict the target elution profile,
with lanes representing samples of the pool eluted with 0, 50, 100, 250, 500, or 1,000 µM α-PVP
(left to right). The percent of target-eluted pool was plotted against the concentration of α-PVP
employed for elution to determine the binding affinity of the enriched pool. (B) PAGE analysis
(top) of elution with 500 µM synthetic cathinones (α-PVP, ethylone, butylone) or interferents
(cocaine, procaine, lidocaine) was used to measure target-cross-reactivity and specificity of the
enriched P9 pool.
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To perform parallel selection, we employed a library pool consisting of ~6×1014
unique oligonucleotide sequences, which form an 8-bp stem and a 30-nt random loop as
the putative target-binding domain (Figure 6-1A). During the first round, each initial
library pool was challenged with 1 mM target, and eluted strands were collected and
amplified for the next round of selection. To further establish class-specificity, from the
second round onward we performed counter-SELEX prior to the positive selection step to
remove aptamers binding to structurally-similar interferents (e.g. cocaine, procaine,
lidocaine) that have the same functional groups or partial structural features as our
targets. In round two, counter-SELEX was first performed for each pool against 100 µM
cocaine, followed by positive selection with 500 µM target, as reducing target
concentration increases selection stringency.62–64 In the third round, a mixture of 100 µM
cocaine and 100 µM procaine was used for counter-SELEX, with the same target
concentration for positive selection. In rounds four and five, counter-SELEX was
performed against cocaine, procaine, and lidocaine (each at a concentration of 100 µM)
in a mixture, with 250 µM target used for the positive selection step.
After the fifth round, a gel-elution assay (see methods) was performed to determine
the target-binding affinity of each pool for its respective target. We observed that the
fraction of eluted library increased with increasing target concentrations for the ethylone
and butylone pools (Figure 6-4A and Figure 6-5A), showing that aptamers binding to
these targets had been enriched through parallel selection. In contrast, target elution
remained low for the α-PVP pool (Figure 6-6A) regardless of the employed concentration
of target, which indicated that the pool was not yet enriched. We further determined the
cross-reactivity and specificity of the three pools via the gel-elution assay. The enriched
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ethylone and butylone pools were able to bind to both ethylone and butylone, but not to
α-PVP, which indicated that the population of cross-reactive aptamers was relatively low.
These pools also showed some affinity to procaine, with the ethylone pool also binding to
cocaine. Neither pool displayed any affinity for lidocaine (Figure 6-4B and Figure 6-5B).
In contrast, the α-PVP pool showed no affinity for any of the targets or counter-targets
(Figure 6-6B).
Given that the α-PVP pool was not yet enriched, we performed additional rounds of
selection. From rounds six to eight, we used the same counter-target mixture of 100 µM
cocaine, procaine, and lidocaine from round 5 with a further-reduced α-PVP
concentration of 100 µM for positive selection. For the ninth round, we used the same αPVP concentration but with counter-selection performed with 300 µM of each of the
three counter-targets in a consecutive manner. After the ninth round, we performed the
gel-elution assay with the enriched pool and observed a clear target concentrationdependent elution profile for α-PVP, with an estimated dissociation constant (KD) of 28
µM (Figure 6-7A). Notably, only 30% of the library was eluted, even in the presence of 1
mM α-PVP, which implied that there was just a small population of binders in the pool.
We also determined that this pool displayed affinity to ethylone and butylone but was less
responsive towards the various interferents (Figure 6-7B), which can be attributed to the
fact that more rounds of counter-SELEX were performed. Given that the pools enriched
with individual targets also cross-reacted to other targets, it seemed likely that those pools
contained cross-reactive aptamers. We believed that if parallel selection was continued,
highly target-specific aptamers would have begun to dominate the pool, therefore we
terminated parallel selection before this could occur.
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α-PVP
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Ethylone
Butylone

Figure 6-8. Determination of the target-binding affinity, cross-reactivity and specificity of the
round S3 pool via a gel elution assay. (A) PAGE results depict the target elution profile with
lanes representing samples of the pool eluted with 0, 10 50, 100, 250, 500, or 1,000 µM (left to
right) of α-PVP, ethylone, or butylone. The percent of target-eluted pool was plotted against the
concentration of target used for elution to determine the binding affinity of the enriched pool. (B)
PAGE analysis of enriched pool eluted with 500 µM synthetic cathinones (α-PVP, ethylone,
butylone) or interferents (cocaine, procaine, lidocaine) was used to measure target-crossreactivity and specificity of the enriched S3 pool.
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α-PVP

[Target]

ethylone
butylone

Figure 6-9. Characterization of the affinity and specificity of the final enriched pool via a gelelution assay. (A) PAGE results depict the target elution profile, with lanes representing samples
of the pool eluted with 0, 10, 50, 100, 250, 500, or 1,000 µM (from left to right) α-PVP, ethylone,
or butylone. The percent of target-eluted pool was plotted against the concentration of target to
determine the binding affinity of the enriched pool. (B) Percent elution values for 14 synthetic
cathinones and 11 interferents at a concentration of 50 µM and buffer alone.
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6.3.3

Serial selection

We then performed serial selection to enrich cross-reactive aptamers and exclude
those specific to individual targets (Figure 6-3B, bottom). We combined all three
enriched parallel pool as a starting library. For each cycle of serial selection, we
challenged the combined pool with each target sequentially for a total of three rounds of
selection using butylone (first round), ethylone (second round), and α-PVP (third round).
In each round, we first performed counter-SELEX with 500 µM cocaine, procaine, and
lidocaine sequentially followed by positive selection with 100 µM target. After the first
cycle of serial selection against all three targets, we performed the gel-elution assay to
determine the cross-reactivity and specificity of the resulting pool. We observed that the
cross-reactivity towards ethylone and butylone had substantially increased (KD = 82 µM
and 77 µM, respectively) relative to the individual pools obtained for these targets at the
end of parallel selection, while affinity towards α-PVP was essentially unchanged (KD =
34 µM) (Figure 6-8A). Importantly, this pool exhibited greatly improved specificity, with
minimal affinity for cocaine and lidocaine and only a moderate response to procaine
(Figure 6-8B). We then performed a second cycle of serial selection with an identical
selection procedure but with a three-stage counter-SELEX process entailing sequential
screening against a mixture of 500 µM each of ephedrine, pseudoephedrine,
acetaminophen, methamphetamine, amphetamine, then a mixture of 1 mM each of
cocaine, procaine, and lidocaine, and finally with 500 µM promazine. We believe that the
inclusion of these additional counter-targets, which are similar in structure to synthetic
cathinones and commonly encountered in seized substances, further enhance the
specificity of the enriched pool. After this cycle, we again evaluated the pool binding
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affinity via the gel-elution assay (Figure 6-9A). Each individual target (at a concentration
of 500 µM) eluted more than 70% of the pool. The pool affinity towards ethylone and
butylone had increased by ~10-fold (KD = 6.9 µM and 9.5 µM, respectively), whereas the
affinity towards α-PVP only marginally increased (KD = 21 µM).
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Figure 6-10. Chemical structures. The chemical structures of the (A) synthetic cathinones and
(B) interferent compounds used in this work are shown. Note that racemic MDPV was also used
in this work.

6.3.4

Characterization and sequencing of the final serial pool

We concluded that at this stage, the enriched pool largely comprised of cross-reactive
synthetic-cathinone-binding aptamers. To confirm this, we used the gel-elution assay to
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test the cross-reactivity of this pool by challenging it with the three targets as well as 11
other synthetic cathinones (Figure 6-10A). All of them demonstrated >60% target elution
at a concentration of 50 µM (Figure 6-9B). This shows that the aptamer could recognize
the core structure of synthetic cathinones, while being tolerant even to side-chain
substituents that were not encountered during SELEX. To evaluate the specificity of the
enriched pool, we challenged the pool with 50 µM of the counter targets and other
potential interferents (Figure 6-10B) and found that none of them showed increased
elution compared with buffer alone (Figure 6-9B). We therefore cloned and sequenced
this final enriched pool. The pool was revealed to have low diversity, with 30 of the 50
clones having an identical sequence, which we named SCA2.1 (Table 6-3). Mfold82
predicts that SCA2.1 has a stem-loop structure with a 9-bp stem and a 28-nt loop in our
selection buffer at room temperature (Figure 6-11).

∆G = -6.89 kcal mol-1

Figure 6-11. Secondary structure of SCA2.1 as predicted by Mfold at selection buffer ion
concentrations (20 mM Na+ and 0.5 mM Mg2+) at 23 ºC. Estimated free energy of formation (ΔG)
is also shown.
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Table 6-3. The sequences of the N30 random domain of the oligonucleotides from the final
enriched pool. The prevalence of each oligonucleotide is ranked from highest to lowest based on
the number of counts.
No.
1 (SCA2.1)
2
3
4
5
6
7
8
9
10
11

6.3.5

Sequences (5’ – 3’)
Counts (total 50)
CTTAAGTGGGGTTCGGGTGGAGTTTATGGG
30
TGAGAAGTGTGATTCAGTATGTTTTCCGAA
7
CGAGAAGTGTGTTCAGTGAGTTTTCCGAGG
4
CGCGGGGGTGGCTGGGGGTGTCTAGCAGAG
2
ATTAAGTGGGGTTCGGGTGGAGTTTATGGG
1
CCTTGGGTAGGTCAGTGTGGGGTTAGGGA
1
CTTAAGTGGGGTTCGGGCGGAGTTTATGGG
1
GGGAAGTGGGGTTCGGGTGGTGTTTTCCCA
1
GGGATGGGGTGCTCGGTCGGGGGTTGTGAG
1
GGTAAGAGTGGTTCCAGTTGAGTTTATGCC
1
GGTCAGCACCTGTCGTGGTGGAGGGGTACT
1

HTS analysis of the selection process

We performed a thorough investigation of the parallel-and-serial selection process
using HTS. Specifically, we sequenced our three final parallel pools (butylone P5,
ethylone P5, and α-PVP P9) and two serial pools (S3 and S6) (Figure 6-12). Analysis of
the parallel pools showed that the most prevalent sequence represented 0.0079%
(butylone P5), 0.0012% (ethylone P5), and 4.6% (α-PVP P9) of their respective pool. The
greater enrichment observed in the α-PVP P9 pool is probably due to the additional four
rounds of parallel selection. Nevertheless, no particular sequence dominated any of these
parallel pools, which indicated that they were not yet highly enriched. Meanwhile, the
SCA2.1 family (see methods) comprised 0.011% of the butylone P5 pool and 0.00095%
of the α-PVP P9 pool, which is notably higher than the median sequence abundance in
each pool (0.00019% for butylone P5 and 0.00032% for α-PVP P9), showing that parallel
selection enriches cross-reactive aptamers. We noted that ethylone P5 pool did not show
any signs of enrichment. To determine if cross-reactive aptamers were present or lost in
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the ethylone pool, we performed an additional three rounds of parallel selection for this
pool and then performed high-throughput sequencing with the resulting ethylone P8 pool.
We found that the SCA2.1 family represented 0.1% of this pool, which implies that these
sequences were originally present in the ethylone P5 pool, but at an amount below the
detection capability of the HTS method we employed.

Figure 6-12. Box and whisker plots of the population distribution of sequences. Population
distribution of sequences after parallel selection (butylone P5, ethylone P5, ethylone P8, and αPVP P9) and each round of serial selection (S3 and S6) are shown. The longest horizontal line
indicates the 50th percentile, with the boundaries of the box indicating the 5th- and 95th percentile, and the whiskers indicate the highest and lowest values of the results. Sequences with
population above 95th percentile are plotted as grey dots. The SCA2.1 family is plotted as a red
dot in each pool, except for the ethylone P5 pool where no such sequences were detected. Inset
shows the pool population distribution after eight rounds of parallel selection using ethylone as
target. Given the high diversity of the parallel pools, the lowest value, 5th, 50th, and 95th percentile
all overlap, thus the box and lowest whisker cannot be seen. For the serial pools, the lowest value,
5th and 50th percentile overlap, thus the bottom portion of the box and the lowest whisker is
likewise not apparent.

Upon combining the three parallel pools, the SCA2.1 family consisted of 0.0041% of
the combined pool (median population: 0.000086%) based on our sequencing data. Such
enrichment allowed for exponential enrichment of cross-reactive aptamers during serial
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selection, wherein the population of the SCA2.1 family increased to 0.39% of the S3 pool
and 29% of the S6 pool. Indeed, parallel selection made serial selection highly efficient.
It is likely that performing serial selection without parallel selection would result in loss
of cross-reactive aptamers, given the generally low copy number of such sequences in
initial rounds.
A

C

B

Figure 6-13. Characterization of the target-binding affinity of SCA2.1 using ITC. Top panels
present raw data showing the heat generated from each titration of (A) α-PVP, (B) ethylone and
(C) butylone to SCA2.1, while bottom panels show the integrated heat of each titration after
correcting for dilution heat of the titrant. ITC data were fitted using a single-site model and the
binding parameters are shown in Table 6-4.
Table 6-4. Binding parameters of SCA2.1 to α-PVP, ethylone and butylone, as characterized by
fitting ITC data with a one-site or modified two-site binding model.
Targets
Binding model

α-PVP
One-site

Two-site

Ethylone
One-site

Two-site

Butylone
One-site

Two-site

N1 (target/aptamer)

1.66±0.05 1.10±0.01 1.09±0.01 1.06±0.06 1.20±0.01 1.06±0.09

KD1 / µM

2.36±0.55 0.09±0.02 1.62±0.06 0.10±0.03 1.81±0.13 0.16±0.05

∆H1 / kcal mol-1

-10.8±0.5

-16.5±0.1

-21.5±0.1

-23.1±0.2

-19.9±0.3

-25.9±0.6

N2 (target/aptamer)

0.91±0.16

0.90±0.03

0.98±0.04

KD2 / µM

18.5±7.7

2.22±0.09

1.59±0.14

∆H2 / kcal mol-1

-12.2±4.4

-19.2±0.6

-12.9±2.7
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6.3.6

Characterization of the affinity and specificity of the isolated aptamer

We then characterized the affinity of SCA2.1 for the selection targets and specificity
against interferents using isothermal titration calorimetry (ITC). We titrated a 300–400
µM solution of target into a 20 µM solution of the aptamer, recorded the heat released by
each titration, and integrated these data to generate a binding curve. Curve fitting with a
one-site binding model resulted in atypical binding stoichiometries (N) and less-thanoptimal fitting, especially for α-PVP which has a non-sigmoidal curve (Figure 6-13 and
Table 6-4). Given that synthetic cathinones are chiral molecules and a racemic mixture
of the targets was employed for SELEX, we hypothesized that the aptamer may have
differential binding affinity for each enantiomer. The pure enantiomers of the three
selection targets were not commercially available, but the high cross-reactivity of the
aptamer allowed us to use enantiomers for another synthetic cathinone, (-)- and (+)MDPV, to confirm our hypothesis. ITC data indicated that the aptamer binds to one target
molecule, with N = 0.92 and 0.95 for (-)- and (+)-MDPV, respectively, and exhibits 100fold greater affinity for the (-) enantiomer (KD = 46.5±7.5 nM) relative to the (+)
enantiomer (KD = 3.61±0.12 µM) (Figure 6-14, A and B, and Table 6-5). We also
performed ITC by titrating racemic MDPV into a solution of SCA2.1 and observed a
binding curve similar in appearance to that of α-PVP. Using a modified two-set-of-sites
model (see methods for detail) to fit the result (Figure 6-14C), we obtained similar
binding parameters to those produced by the titration of each enantiomer alone (Table
6-5, (±)-MDPV). This confirmed that the modified model is appropriate to describe such
binding phenomenon.
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A

B

C

Figure 6-14. Characterization of the synthetic-cathinone-binding affinity of SCA2.1 using ITC.
Top panels present raw data showing the heat generated from each titration of (A) (-)-MDPV, (B)
(+)-MDPV and (C) (±)-MDPV to SCA2.1, while bottom panels show the integrated heat of each
titration after correcting for dilution heat of the titrant. ITC data obtained with (-)-MDPV and (+)MDPV were fitted using a single-site model, and ITC data obtained with (±)-MDPV were fitted
with a modified two-site binding model. All binding parameters are shown in Table 6-4.

A

B

C

Figure 6-15. Characterization of the target-binding affinity of SCA2.1 using ITC. Top panels
present raw data showing the heat generated from each titration of (A) α-PVP, (B) ethylone and
(C) butylone to SCA2.1, while bottom panels show the integrated heat of each titration after
correcting for dilution heat of the titrant. ITC data were fitted with a modified two-site binding
model and the binding parameters are shown in Table 6-4.
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Table 6-5. Binding parameters of SCA2.1 to (-)-MDPV, (+)-MDPV, (±)-MDPV, as characterized
by fitting ITC data with a one-site (for (-)- or (+)-MDPV) or modified two-site binding model
(for (±)-MDPV).
Binding parameters

(-)-MDPV

(+)-MDPV

(±)-MDPV

N1 (target/aptamer)

0.92±0.01

1.04±0.06

KD1 / nM

46.5±7.5

17.5±16.4

∆H1 / kcal mol-1

-24.7±0.2

-22.3±0.4

N2 (target/aptamer)

0.95±0.01

0.91±0.08

KD2 / µM

3.61±0.12

3.77±1.34

-17.2±0.2

-17.8±3.5

∆H2 / kcal mol

-1

A

B

D

C

E

Figure 6-16. Characterization of the interferent-binding affinity of SCA2.1 using ITC. Top
panels present raw data showing the heat generated from each titration of (A) amphetamine, (B)
methamphetamine, (C) ephedrine, (D) cocaine, and (E) procaine to SCA2.1, while bottom panels
show the integrated heat of each titration after correcting for dilution heat of the titrant. ITC data
were fitted with a one-site binding model and KDs are shown in the figures.
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We then used this modified two-set-of-sites model to fit the ethylone, butylone, and αPVP binding curves and obtained improved fitting and normal N values (0.9–1.1), with
nanomolar affinity towards one enantiomer and micromolar affinity for the other (Figure
6-15 and Table 6-4). Opposing intuition, these results suggest that SCA2.1 can achieve
not only high target-cross-reactivity, but also superior binding affinity. To determine the
specificity of SCA2.1, we performed ITC with interferents that are most structurallysimilar to synthetic cathinones including amphetamine, methamphetamine, ephedrine,
cocaine, and procaine. All such compounds had very low binding affinity for SCA2.1
(Figure 6-16).
6.3.7

Evaluating the target-binding spectrum and specificity of the isolated

aptamer
We then demonstrated the analytical utility of SCA2.1 in a colorimetric dyedisplacement assay. Cy7 is a small-molecule dye that exists in equilibrium between
monomer and dimer forms, which have absorbance peaks at 760 and 670 nm,
respectively. Previous studies have shown that Cy7 monomers can bind to hydrophobic
target-binding domains of aptamers, which results in strong enhancement of absorbance
at 760 nm.34,101 However, the binding of target to the aptamer can displace Cy7 monomer
from the binding domain within seconds, which causes the dye to dimerize in aqueous
solution, resulting in the reduction of absorbance at 760 nm and enhancement of
absorbance at 670 nm (Figure 6-17). This approach can thus be used as a colorimetric
indicator for small molecule detection. We first examined if such an assay can be
employed to detect synthetic cathinones using SCA2.1. We determined the binding
affinity of Cy7 to SCA2.1 by titrating different concentrations of the aptamer into a
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solution of 2 µM Cy7 (Figure 6-18A). Increasing the amount of aptamer progressively
enhanced the absorbance of Cy7 monomer at ~ 760 nm, indicating binding to the
aptamer. A gradual peak shift from 760 to 775 nm was also observed, which is consistent
with previous studies34,101 showing that absorbance of the monomer can change in
different microenvironments, such as when the dye binds to the aptamer. Based on Cy7
absorbance at 775 nm, we obtained a KD of 1.6 µM (Figure 6-18B). We then investigated
whether the synthetic cathinone targets can efficiently displace Cy7 from SCA2.1. We
first titrated different concentrations of butylone into a mixture of 2 µM Cy7 and 3 µM
SCA2.1, and found that increasing concentrations of butylone progressively reduced the
absorbance of Cy7 at 775 nm while enhancing absorbance at 670 nm (Figure 6-19A).
This change can be attributed to dimerization of the Cy7 monomer when displaced from
the aptamer into solution.34,101 We used the absorbance ratio between 670 nm and 775 nm
(A670/A775) to calculate the signal gain and generate a calibration curve, which displayed
a linear range of 0–10 µM and a measurable detection limit of 250 nM (Figure 6-20). We
obtained equivalent results with both ethylone and α-PVP (Figure 6-19, B and C, and
Figure 6-20), again confirming the high cross-reactivity of SCA2.1. Our Cy7displacement assay is also compatible with biosamples such as urine and saliva, since the
absorbance range of Cy7 is well outside the background absorbance exhibited by these
matrices.34 We obtained calibration curves with ethylone spiked into 50% urine (Figure
6-21) and 50% saliva (Figure 6-22) with a linear range of 0–10 µM and a measurable
detection limit of 80 and 120 nM, respectively. The enhanced sensitivity of the assay in
these biomatrices can be possibly attributed to the higher ionic strength of the media,
which may enhance target-binding to the aptamer or Cy7 dimerization.
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Figure 6-17. Colorimetric detection of synthetic cathinones using a Cy7-displacement assay.
Schematic of the Cy7-displacement assay, wherein binding of a synthetic cathinone molecule
displaces the Cy7 monomer from the binding domain of SCA2.1, inducing formation of Cy7
dimers that produce a change in the absorbance of the dye.
A

B

Figure 6-18. Determination of the binding affinity of Cy7 to SCA2.1 via a colorimetric assay.
(A) Absorbance spectra of 2 µM Cy7 in the presence of 0.2, 0.4, 0.8, 1.6, 3.1, 6.3, 12.5, or 25 µM
SCA2.1, with the black-to-red color gradient representing increasing concentrations. (B) Plot of
the absorbance of Cy7 monomer at its peak wavelength (775 nm) versus concentration of
SCA2.1, fitted with the Langmuir equation to determine the binding affinity of Cy7 to SCA2.1.
A

Butylone

B

Ethylone

C

α-PVP

Figure 6-19. Cy7-displacement colorimetric assay for the detection of synthetic cathinones using
SCA2.1. Absorbance spectra of Cy7 (2 µM) in the presence of 0, 0.1, 0.3, 0.5, 1.1, 2.3, 4.9, 10.3,
21.6, 45.4, 95.2, or 200 µM (A) butylone, (B) ethylone, (C) α-PVP, with the black-to-red color
gradient representing increasing concentrations of target. [SCA2.1] = 3 µM.
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Figure 6-20. Calibration curves based on the absorbance ratio at 670/775 nm in the presence of
different concentrations of α-PVP, ethylone or butylone in buffer. The inset represents the linear
range at 0 to 10 µM target. Error bars show standard deviation from three measurements at each
concentration. [SCA2.1] = 3 µM, [Cy7] = 2 µM.
B

A

Figure 6-21. Detection of ethylone in 50% urine using an SCA2.1-based Cy7-displacement
colorimetric assay. (A) Absorbance spectra of Cy7 (2 µM) in the presence of 0, 0.03, 0.06, 0.12,
0.25, 0.53, 1.11, 2.33, 4.90, 10.28, 21.60, 45.35, 95.24, or 200 µM ethylone, with the black-to-red
color gradient representing increasing concentrations of target. (B) Assay calibration curve
generated using 0-200 µM ethylone, with the inset representing the range of target concentrations
from 0 to 1.1 µM. [SCA2.1] = 3 µM.
A

B

Figure 6-22. Detection of ethylone in 50% saliva using the SCA2.1-based Cy7-displacement
colorimetric assay. (A) Absorbance spectra of Cy7 (2 µM) in the presence of 0, 0.03, 0.06, 0.12,
0.25, 0.53, 1.11, 2.33, 4.90, 10.28, 21.60, 45.35, 95.24, or 200 µM ethylone, with the black-to-red
color gradient representing increasing concentrations of target. (B) Assay calibration curve
generated using 0-200 µM ethylone, with the inset representing the range of target concentrations
from 0 to 1.1 µM. [SCA2.1] = 3 µM.
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We tested the cross-reactivity of this assay for nine other synthetic cathinones,
including naphyrone, MDPV, pentylone, methylone, 4-MMC, 4-FMC, 3-FMC,
methcathinone and cathinone at a concentration of 50 µM. As expected, despite the
diversity of the side chains substituents, all synthetic cathinones induced a significant
change in A670/A775, producing a signal gain ranging from 45% to 130% relative to
ethylone (Figure 6-23A). This implies that SCA2.1 mainly recognizes the β-keto
phenethylamine core structure, and variations in the side chains do not significantly affect
target-binding affinity. Notably, the aptamer is more cross-reactive to a broad range of
synthetic cathinones than antibodies used

in existing immunoassays, which

achieve >20% cross-reactivity for only five synthetic cathinones.236 SCA2.1 shows a
moderate bias towards bulkier synthetic cathinones such as MDPV, naphyrone, and
pentylone. Such ligands may fit better in the binding pocket compared to smaller
synthetic cathinones like methcathinone or 4-FMC, achieving high binding affinity
through greater interaction with the aptamer. This supports the higher signal gain
observed in the assay. Importantly, our assay has excellent specificity, as the aptamer
does not cross-react to non-synthetic cathinone interferents. We tested our assay with 12
different interferent compounds, including common illicit drugs (amphetamine,
methamphetamine and cocaine) and cutting agents found in street samples
(pseudoephedrine, ephedrine, procaine, lidocaine, benzocaine, caffeine, acetaminophen
and sucrose) at a concentration of 50 µM. The assay yielded no response to any of these
interferents (Figure 6-23A), even though many contained a partial β-keto phenethylamine
structure, demonstrating that aptamer specificity can be precisely controlled through a
well-designed selection approach.
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We finally determined the limit of detection for our Cy7-displacement assay for 12
synthetic cathinones and observed detection limits that varied from 40–80 nM in 50%
urine (Figure 6-24). Clearly, the high affinity of this aptamer as well as its
unresponsiveness towards endogenous compounds enables sensitive screening of
synthetic cathinones in biological samples. Given that the concentration of these drugs in
urine typically ranges between high nanomolar to <100 µM within a few hours after
consumption,237 we believe that our assay will be useful for label-free detection of
synthetic cathinones in these matrices.
A

a

B
l

m

w

Figure 6-23. Colorimetric detection of synthetic cathinones using a Cy7-displacement assay. (A)
Signal gain measured via a plate reader from the Cy7-displacement assay with 12 synthetic
cathinones (gray, with the three selection targets shaded) and 11 interferents (white) at a
concentration of 50 μM with 3 µM SCA2.1 and 2 µM Cy7. Cross-reactivity is defined as the ratio
of signal gain between the reference target ethylone and another synthetic cathinone or interferent
multiplied by 100%. Error bars show standard deviations from three measurements. (B) Nakedeye detection of synthetic cathinones using a mixture of 5 μM SCA2.1 and 3.5 µM Cy7. The
color of the solution changes to bright blue within seconds upon addition of 50 µM synthetic
cathinones (a-l). However, the color appears as a faint blue color in the absence of target (-) or 50
μM of a wide range of interferents (m-w).
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Figure 6-24. Calibration curves and linear ranges for the SCA2.1-based Cy7-displcaement assay
in 50% urine based on the absorbance ratio at 670/775 nm in the presence of different
concentrations of various synthetic cathinones. Error bars show standard deviation from three
measurements at each concentration. [SCA2.1] = 3 µM, [Cy7] = 2 µM.
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A

B

Figure 6-25. Naked-eye detection of ethylone in the concentration range of 0.4 µM to 200 µM.
(A) Photograph of the assay. The blue color change can be clearly observed at concentrations
≥6.3 µM target. (B) A calibration curve based on the photograph was made using Image-J
software. [Cy7] = 3.5 µM. [SCA2.1] = 5 µM.

We further fine-tuned our Cy7-displacement assay by using a higher concentration of
the dye and aptamer in order to intensify the target-induced color change and thereby
enable naked-eye detection. We challenged this assay with the aforementioned 12
synthetic cathinones and 11 interferent compounds at a concentration of 50 µM with 3.5
µM Cy7 and 5 µM SCA2.1. In the absence of target, the aptamer-bound Cy7 monomer
has an absorption peak at 775 nm, which is not in the visible range, and thus the sample is
practically colorless. However, when Cy7 is displaced by the target, the resulting
dimerization-associated absorption peak at 670 nm causes the solution to produce a
bright, clearly visible blue color. We observed that all 12 synthetic cathinones
immediately induced a clear-to-blue color change in the solution, while no color change
was identified upon addition of any of the interferent compounds (Figure 6-23B). Using
ethylone as a target, we determined that 6.3 μM is the lowest concentration that can
develop a color distinguishable from the blank with the naked eye (Figure 6-25). These
results demonstrate the feasibility of the Cy7-displacement assay for instrument-free onsite drug screening applications.
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6.4. Conclusions
Class-specificity implies a degree of both receptor promiscuity towards targets within
a designated molecular family and specificity against molecules outside of the family.
The development of class-specific antibodies and aptamers has proven challenging due to
the lack of viable methods to precisely control receptor binding profiles and specificity.
In this work, we sought to develop a new aptamer isolation strategy, parallel-and-serial
selection, as an effective way to select for class-specific aptamers recognizing small
molecules based on a familial molecular core structure. The parallel-and-serial selection
strategy increases the likelihood of isolating broadly-cross reactive aptamers by enriching
oligonucleotide pools in parallel against diversely-structured members of the designated
target family and then combining and challenging the pools serially with these targets to
fine tune specificity towards a particular class of targets. Here, we chose three synthetic
cathinones that vary at all major substituent sites of the targeted family to ensure that
broadly cross-reactive aptamers are isolated. Other target triplets could yield equally
cross-reactive aptamers if they are sufficiently diverse. More targets can be employed to
create broader cross-reactivity, although this will increase labor and cost requirements.
By supplementing our strategy with counter-SELEX, the binding spectrum can be
narrowed down to the target family, thereby avoiding unwanted cross-reactivity to
structurally-similar non-target molecules.
As a demonstration, we isolated a single class-specific DNA aptamer that can bind to
12 diverse synthetic cathinones. This aptamer is insensitive to variations at all substituent
sites on the core structure, and even tolerates many substituents that do not appear in our
selection targets. Importantly, our aptamer does not respond to 11 structurally-similar

175

compounds, some of which only differ from our targets by a single atom. We
subsequently demonstrated the superior class-specificity and affinity of our aptamer in a
single-step, colorimetric Cy7-displacement assay, which can detect clinically-relevant
concentrations of synthetic cathinones in biomatrices237–239 and presents greater targetcross-reactivity than existing antibodies. Advantageously, this assay can also achieve
naked-eye detection of synthetic cathinones at concentrations at low micromolar
concentrations, which is valuable for on-site screening of seized substances.
The aptamer isolated herein displays binding characteristics that confound intuition.
This aptamer has great molecular promiscuity, binding to several molecules sharing a
common, defined core structure. All the while, the aptamer retains the ability to
discriminate against non-target molecules that are closely related in structure to members
of the designated target family, even by a single atom difference in certain instances.
Impressively, the aptamer also can bind to its targets with nanomolar affinity. This was
not as expected, as broad cross-reactivity and high affinity is, on the surface, counterintuitive.
Our findings significantly expand the capability of aptamers as class-specific
biorecognition elements and demonstrate an unprecedented level of control over aptamer
binding profiles through this new parallel-and-serial selection strategy. We believe that
our approach can be used to isolate class-specific aptamers for other families of small
molecules for applications relevant to medical diagnostics, environmental monitoring,
food safety, and forensic science.
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CHAPTER 7: Summary and Future Work
7.1. Summary
Aptamer-based sensors have recently gained considerable attention for diverse sensing
applications such as drug detection, medical diagnostics, and environmental monitor.
However, the detection of small molecules using aptamers has been challenging. This
dissertation aims to remedy this problem by generating functionalized signal-reporting
aptamers via several generally applicable aptamer engineering and isolation strategies.
Split aptamers that reassemble in the presence of a target ligand have excellent targetspecificity and are compatible with various sensing platforms. However, the splitting of
an aptamer is typically accompanied with reduction in target-binding affinity, which
mitigates any overall gains in sensitivity. In Chapter 3, we for the first time present a
simple approach to greatly enhance the target-response of split aptamers utilizing a
cooperative binding mechanism. We experimentally demonstrate that the resulting
CBSAs exhibit higher target binding affinity and are far more responsive in terms of
target-induced aptamer assembly compared to parent split aptamers containing a single
binding domain. Using a fluorescence assay developed from a cocaine-binding CBSA,
we were able to detect cocaine at concentrations as low as 50 nM within 15 minutes in
10% saliva without signal amplification. This limit of detection is 200-fold better than a
similar previously reported fluorescence assay utilizing a split aptamer with a single
binding domain. Given the simplicity of engineering a CBSA from a given aptamer, we
were able to develop CBSA-based assays for other small molecules such as DIS and
MDPV from aptamers with three-way-junction (TWJ) structured binding domains.
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In Chapter 4, we further describe a general and simple approach for the development
of rapid and sensitive CBSA-based EATR-amplified sensor platforms for the detection of
small-molecule targets. As a demonstration, we developed a CBSA-based EATRamplified fluorescence assay to detect DIS, a potential cancer biomarker, in urine
samples. This assay had 100-fold greater sensitivity relative to the same CBSA-based
assay without EATR amplification, with a detection limit of 1 μM in 50% urine and a
turnaround time of 30 minutes. To further demonstrate the generality of our assay, we
utilized a cocaine-binding CBSA to develop rapid instrument-free colorimetric assays
that report target-binding events through EATR-mediated aggregation of CBSA-modified
gold nanoparticles. We achieved naked-eye detection of low micromolar concentrations
of cocaine within 20 minutes.
Most aptamer-based sensors, including CBSA-based assays, utilize structureswitching functionalized aptamers that undergo a major conformational change upon
target binding. However, aptamers usually do not innately undergo target-bindinginduced conformational changes, and the development of these so-called ‘structureswitching aptamers’ typically entails a multi-stage process of sequence engineering and
chemical modification. To simplify the process of aptamer-based sensor development, in
Chapter 5, we for the first time report a simple SELEX strategy for directly isolating
small-molecule-binding aptamers with intrinsic dye-displacement signal-reporting
functionality. These aptamers can transduce target-binding events into a change of dye
absorbance. Specifically, we first demonstrated that the small-molecule dye
diethylthiatricarbocyanine (Cy7), can bind within the central cavities of DNA TWJs in a
sequence-independent manner, and this interaction significantly changes the dye’s
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absorbance spectra. We then designed a TWJ-structured DNA library and employed it to
isolate an aptamer against MDPV, a synthetic cathinone that is an emerging drug of
abuse. This aptamer intrinsically binds Cy7 within its TWJ-structured target-binding
domain, but the presence of MDPV efficiently displaces the dye into solution, resulting in
a significant change in absorption spectra of the dye within seconds. The Cy7displacement assay is label-free, rapid, sensitive, simple, and does not require sequence
engineering or modification of the aptamer. The assay detects MDPV at concentrations as
low as 300 nM with strong cross-reactivity to other synthetic cathinone analogs, while
remaining minimally cross-reactive to structurally-similar non-cathinone compounds and
common cutting agents. Importantly, such dye-displacement assay can be generalized for
any small-molecule target isolated from the same TWJ-structured library.
To further control the target-binding spectra of isolated aptamers, in Chapter 6, we
describe a novel parallel-and-serial SELEX strategy employing multiple structurallyrelated targets for isolating class-specific DNA aptamers. Such aptamers display both
familial promiscuity and specificity towards a designated molecular family and are highly
desirable for various applications, in particular, for the recognition and sensing of
structurally-similar small molecules. As a demonstration, we isolated an aptamer crossreactive to the synthetic cathinone family. The aptamer displays binding characteristics
that confound intuition, having high molecular promiscuity and nanomolar affinity for 12
synthetic cathinones, while retaining the ability to discriminate against 11 non-target
compounds that are closely related in structure, even by a single atom difference in
certain instances. Leveraging the qualities of this aptamer, instantaneous colorimetric
detection of synthetic cathinones at nanomolar concentrations in biological samples is
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achieved. This assay exemplifies the true potential of class-specific aptamers and
generally represents a highly efficient means of screening specific small-molecule
families. As a whole, this work shows that nucleic-acid-based aptamers can exhibit a
combination of broad target-cross-reactivity, high affinity, and remarkable specificity.
Such feat has yet to be achieved by any existing antibodies or other bioreceptors in
general for small molecules.
7.2. Future work
This dissertation demonstrates that CBSAs are highly target-responsive and adaptable
with different sensing platforms for sensitive detection of small-molecule targets. Since
many other optical and electrochemical sensing strategies have been developed that
employ target-induced split aptamer assembly, it should be feasible to integrate our
CBSA into these platforms. For example, split G-quadruplex-structured DNAzymes with
peroxidase activity have been employed as label-free, colorimetric reporters for DNA
detection. Such split DNAzymes can be grafted onto CBSAs for label-free visual
detection of small-molecule targets within minutes. Alternatively, CBSAs can be
incorporated into the well-established electrochemical aptamer-based sensor for rapid
detection of small molecules in complex matrices such as blood. In this work, we have
developed a straightforward strategy to engineer CBSAs from aptamers with TWJ
structures. In the future, new methods can be developed to engineer CBSAs from
aptamers with other secondary structures, for example, stem-loop structured aptamers.
The dye-displacement aptamer-based assay has been demonstrated to be a rapid,
sensitive and label-free method for small molecule detection. In this work, we have
generalized this method to the aptamers with TWJ-structured target-binding domains.
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Inspired by this success, small-molecule dyes binding to other secondary structures such
as stem-loop and G-quadruplex can be screened and employed to develop generally
applicable dye-displacement assays for aptamers with such secondary structures.
Finally, our works have shown that the binding spectra of aptamers can be precisely
manipulated using rationally designed aptamer isolation strategies. In the future, such
selection strategies can be further refined to isolate aptamers with even higher specificity
and affinity. Moreover, the multi-step washing/elution processes can be performed using
an automatic syringe pump, significantly reducing the labor of SELEX and expediting
aptamer isolation.
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